<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006107.pub4" GROUP_ID="MENSTR" ID="876206021308134121" MERGED_FROM="" MODIFIED="2016-03-10 21:41:04 +0000" MODIFIED_BY="Helen Nagels" REVIEW_NO="JB604" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2016-03-10 21:41:04 +0000" MODIFIED_BY="Helen Nagels">
<TITLE MODIFIED="2016-03-01 14:37:04 +1300" MODIFIED_BY="Helen E Nagels">Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women</TITLE>
<CONTACT MODIFIED="2016-03-10 21:41:04 +0000" MODIFIED_BY="Helen Nagels"><PERSON ID="6034200E82E26AA200991D564912EB85" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Julie</FIRST_NAME><LAST_NAME>Brown</LAST_NAME><POSITION>Cochrane Sytematic Reviewer</POSITION><EMAIL_1>j.brown@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Liggins Institute</DEPARTMENT><ORGANISATION>The University of Auckland</ORGANISATION><ADDRESS_1>Park Rd</ADDRESS_1><ADDRESS_2>Grafton</ADDRESS_2><CITY>Auckland</CITY><ZIP>1142</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 3737599</PHONE_1><FAX_1>+64 9 3035969</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-03-10 21:41:04 +0000" MODIFIED_BY="Helen Nagels"><PERSON ID="6034200E82E26AA200991D564912EB85" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Julie</FIRST_NAME><LAST_NAME>Brown</LAST_NAME><POSITION>Cochrane Sytematic Reviewer</POSITION><EMAIL_1>j.brown@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Liggins Institute</DEPARTMENT><ORGANISATION>The University of Auckland</ORGANISATION><ADDRESS_1>Park Rd</ADDRESS_1><ADDRESS_2>Grafton</ADDRESS_2><CITY>Auckland</CITY><ZIP>1142</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 3737599</PHONE_1><FAX_1>+64 9 3035969</FAX_1></ADDRESS></PERSON><PERSON ID="7BB02F2382E26AA201650CEA951025A7" ROLE="AUTHOR"><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Buckingham</LAST_NAME><EMAIL_1>karen@onlinecom.co.nz</EMAIL_1><ADDRESS><ORGANISATION>Repromed</ORGANISATION><ADDRESS_1>105 Remuera Road</ADDRESS_1><CITY>Auckland</CITY><ZIP>1050</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY></ADDRESS></PERSON><PERSON ID="19611" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>William</FIRST_NAME><LAST_NAME>Buckett</LAST_NAME><POSITION>Assistant Professor</POSITION><EMAIL_1>william.buckett@muhc.mcgill.ca</EMAIL_1><ADDRESS><DEPARTMENT>Division of Reproductive Endocrinology and Infertility, Department of Obstetrics &amp; Gynecology</DEPARTMENT><ORGANISATION>McGill University</ORGANISATION><ADDRESS_1>Sherbrooke Street</ADDRESS_1><CITY>Montreal</CITY><REGION>QC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="53513931248679751472100330005007" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ahmed</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Abou-Setta</LAST_NAME><POSITION>Manager</POSITION><EMAIL_1>abousetta_md@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Knowledge Synthesis Platform, George and Fay Yee Centre for Healthcare Innovation</DEPARTMENT><ORGANISATION>University of Manitoba</ORGANISATION><ADDRESS_1>Chown Building</ADDRESS_1><ADDRESS_2>367-753 McDermot Ave</ADDRESS_2><CITY>Winnipeg</CITY><ZIP>R3E 0W3</ZIP><REGION>MB</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 204 296 5246</PHONE_1><FAX_1>+1 204 594 5394</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-12-14 16:50:52 +1300" MODIFIED_BY="Helen E Nagels">
<UP_TO_DATE>
<DATE DAY="6" MONTH="5" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="6" MONTH="5" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="6" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-03-01 15:37:23 +1300" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-03-01 15:37:23 +1300" MODIFIED_BY="Helen E Nagels">
<DATE DAY="1" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>New searches run in May 2015 and four new studies added (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>, <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>, <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>, <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>). Five studies were excluded (<LINK REF="STD-Bodri-2011" TYPE="STUDY">Bodri 2011</LINK>, <LINK REF="STD-Deep-2013" TYPE="STUDY">Deep 2013</LINK>, <LINK REF="STD-Hauzman-2012" TYPE="STUDY">Hauzman 2012</LINK>, <LINK REF="STD-Porat-2010" TYPE="STUDY">Porat 2010</LINK>, <LINK REF="STD-Saharkhiz-2014" TYPE="STUDY">Saharkhiz 2014</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-03-01 15:37:20 +1300" MODIFIED_BY="Helen E Nagels">
<DATE DAY="1" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>The addition of new studies did not lead to a change in the conclusions of this review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-02-27 23:45:34 +1300" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-27 23:45:27 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="6" YEAR="2009"/>
<DESCRIPTION>
<P>Five new studies have been added to the review and the review style altered to the RevMan 5 requirements.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-02-27 23:45:04 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="6" YEAR="2009"/>
<DESCRIPTION>
<P>The conclusions of the updated review have altered with the addition of five newly identified randomised controlled trials, and the review has been amended as a consequence.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-06-22 13:53:29 +1200" MODIFIED_BY="Julie A Brown">
<DATE DAY="6" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-02-27 23:45:34 +1300" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="11" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-03-04 13:12:04 +1300" MODIFIED_BY="Helen E Nagels">
<INTERNAL_SOURCES MODIFIED="2015-12-10 07:41:28 +1300" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-12-10 07:40:24 +1300" MODIFIED_BY="[Empty name]">
<NAME>Liggins Institute, The University of Auckland</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION>
<P>Infrastructure support to update this review</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2015-12-10 07:41:28 +1300" MODIFIED_BY="[Empty name]">
<NAME>Department of Obstetrics and Gynaecology, The University of Auckland</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION>
<P>Infrastructure support to update this review</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-03-04 13:12:04 +1300" MODIFIED_BY="Helen E Nagels">
<SOURCE MODIFIED="2016-03-04 13:12:04 +1300" MODIFIED_BY="Helen E Nagels">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-03-10 08:11:56 +1300" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-03-08 12:19:56 +1300" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-07 09:18:50 +1300" MODIFIED_BY="Julie A Brown">Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women</TITLE>
<SUMMARY_BODY MODIFIED="2016-03-08 12:19:56 +1300" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>We wanted to learn whether ultrasound-guided embryo transfer (UGET) improves pregnancy outcomes compared with clinical touch. The traditional method of embryo transfer, clinical touch relies on the clinician's tactile senses to judge when the transfer catheter is in the correct position.</P>
<P>
<B>Background</B>
</P>
<P>The inability of some women undergoing fertility treatment to achieve a live birth may be due to a number of factors, such as lack of good-quality embryo/s, problems with the uterus, or the transfer technique itself. This review looks at one aspect of the transfer technique, whether ultrasound guidance improves pregnancy outcomes compared with clinical touch (clinical judgement without any technical assistance).</P>
<P>
<B>Study characteristics </B>
</P>
<P>We found 21 randomised controlled trials that compared UGET with clinical touch in a total of 6218 women. The evidence is current to May 2015.</P>
<P>
<B>Key results</B>
</P>
<P>Live birth/ongoing pregnancies were increased for the ultrasound-guided group compared with the clinical touch group, based on low-quality evidence. We estimate that for women with a chance of a live birth/ongoing pregnancy of 23% using clinical touch, this would increase to between 28% and 33% using UGET. Data for live birth should be interpreted carefully, as differences between the studies make drawing a conclusion difficult. The evidence suggests that in studies that used the same brand of transfer catheter in both the ultrasound-guided and the clinical touch groups, ultrasound guidance was linked to an increase in the chance of a live birth. There was no evidence that the risk of harm using UGET, including miscarriage, ectopic pregnancies, and multiple pregnancies, is any different than when clinical touch is used to guide the embryo transfer.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The quality of the evidence for live birth/ongoing pregnancy was low due to poor reporting of study methods and inconsistency in trial results.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-03-10 08:11:43 +1300" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-02-26 08:12:04 +1300" MODIFIED_BY="[Empty name]">
<P>Many women undergoing an assisted reproductive technology (ART) cycle will not achieve a live birth. Failure at the embryo transfer stage may be due to lack of good-quality embryo/s, lack of uterine receptivity, or the transfer technique itself. Numerous methods, including the use of ultrasound guidance for proper catheter placement in the endometrial cavity, have been suggested as more effective techniques of embryo transfer. This review evaluates the efficacy of ultrasound-guided embryo transfer (UGET) compared with 'clinical touch' (CTET), which is the traditional method of embryo transfer and relies on the clinician's tactile senses to judge when the transfer catheter is in the correct position.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-02-26 07:16:32 +1300" MODIFIED_BY="[Empty name]">
<P>To determine whether ultrasound guidance compared with clinical touch improves pregnancy outcomes in women undergoing embryo transfer during ART cycles.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-03-01 14:47:31 +1300" MODIFIED_BY="Helen E Nagels">
<P>For the 2016 update of this review, we ran updated searches in the Cochrane Gynaecology and Fertility Group trials register (May 2015), the Cochrane Central Register of Controlled Trials (the Cochrane Library, May 2015), MEDLINE (2009 to May 2015), and EMBASE (2009 to May 2015). We also handsearched relevant conference proceedings: American Society for Reproductive Medicine (ASRM), European Society for Human Reproduction and Embryology (ESHRE), and International Federation of Gynecology and Obstetrics (FIGO). There were no language restrictions.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-02-26 07:21:13 +1300" MODIFIED_BY="[Empty name]">
<P>We included only randomised controlled trials.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-03-01 14:48:16 +1300" MODIFIED_BY="Helen E Nagels">
<P>Two review authors independently assessed eligibility and quality of trials and extracted data from those selected. We calculated odds ratio (OR) and 95% confidence interval (CI) for dichotomous outcomes. No outcomes were reported using continuous data. We assessed the overall quality of the evidence for the main findings using the GRADE working group methods.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-03-10 08:11:43 +1300" MODIFIED_BY="[Empty name]">
<P>This systematic review now has 21 included studies (four of which we added in the 2016 update), two studies awaiting assessment, and 47 excluded studies. In total, data for meta-analyses were available in 21 trials (n = 6218 women), of which only four reported live births.</P>
<P>UGET was associated with an increased chance of a live birth/ongoing pregnancy compared with CTET (OR 1.47, 95% CI 1.30 to 1.65; 13 trials; n = 5859 women; I<SUP>2</SUP> = 74%; low-quality evidence). Sensitivity analysis by including only trials with low risk of selection bias or by using a random-effects model did not alter the effect. We estimate that for women with a chance of a live birth/ongoing pregnancy of 23% using CTET, this would increase to between 28% and 33% using UGET. We considered the quality of the evidence using GRADE methodology to be low.</P>
<P>UGET was associated with an increase in the chance of a clinical pregnancy (OR 1.31, 95% CI 1.17 to 1.45; 20 trials; n = 6711 women; I<SUP>2</SUP> = 42%; moderate-quality evidence). We identified no differences between groups for the incidence of adverse events including multiple pregnancy, ectopic pregnancy, or miscarriage. These events were relatively rare, and sample sizes limited the ability to detect such differences.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-03-06 16:34:51 +1300" MODIFIED_BY="[Empty name]">
<P>The evidence suggests ultrasound guidance improves the chance of live birth/ongoing and clinical pregnancies compared with clinical touch, without increasing the chance of multiple pregnancy, ectopic pregnancy, or miscarriage. Methodological limitations included: only four studies reporting details of both computerised randomisation techniques and adequate allocation concealment, only four studies reported on the outcome of live birth, and none of the nine studies that reported on ongoing pregnancy reported on live birth, suggesting possible reporting bias. Adequate reporting of randomisation and allocation concealment will improve the quality of future studies. The primary outcome measure of future studies should be the reporting of live births per woman randomised.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-03-10 08:11:56 +1300" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-02-26 11:30:06 +1300" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<CONDITION MODIFIED="2016-02-26 08:51:26 +1300" MODIFIED_BY="[Empty name]">
<P>Since the first pregnancy using in vitro fertilisation was achieved nearly 40 years ago (<LINK REF="REF-Steptoe-1978" TYPE="REFERENCE">Steptoe 1978</LINK>), many aspects of the procedure, such as ovarian stimulation, oocyte recovery, and the in vitro techniques of fertilisation and embryo culture, have undergone major revision. In contrast, the technique of embryo transfer has remained largely unchanged. Approximately 80% of women undergoing in vitro fertilisation/intracytoplasmic sperm injection today will reach the embryo transfer stage with good-quality embryos. However, only a small proportion of these women will then go on to achieve a clinical pregnancy, and even fewer will achieve a live birth. This makes the embryo transfer phase the final and least successful step in assisted reproductive technology. Indeed, it is estimated that up to 85% of replaced embryos fail to implant, despite the selection of apparently normal embryos for transfer (<LINK REF="REF-Sallam-2002" TYPE="REFERENCE">Sallam 2002</LINK>). This failure may be due to lack of good-quality embryo/s, lack of uterine receptivity, or the technique of embryo transfer itself.</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-02-26 11:29:51 +1300" MODIFIED_BY="[Empty name]">
<P>Embryos are usually replaced into the uterine cavity through a transcervical transfer catheter between days 2 to 5 of development. Traditionally, the 'clinical touch' method has been used to guide placement of the transfer catheter to within ~10 mm from the uterine fundus prior to injection of the embryos. This method is essentially 'blind' and relies on the clinician's tactile senses to judge when the transfer catheter is in the correct position. Some clinicians transfer the embryos at a fixed distance from the external os (~6 cm), however this may not take into account variation in cervical length or uterine size, or position (retroverted). Others will conduct a &#8216;dummy&#8217; embryo transfer to determine the length of the endometrial cavity prior to the actual embryo transfer.</P>
<P>Assessment of the transfer catheter position using the clinical touch method is often unreliable. This was demonstrated by Woolcott and Stanger (<LINK REF="STD-Woolcott-1997" TYPE="STUDY">Woolcott 1997</LINK>), who utilised transvaginal ultrasound to observe catheter placement in relation to the endometrial surface and uterine fundus during 121 embryo transfers. They noted suboptimal catheter placement in more than half of cases, with the catheter either indenting or embedded in the endometrium.</P>
<P>It is generally accepted that an easy, atraumatic embryo transfer is essential for successful implantation (<LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>). It is possible that minimising endometrial trauma could decrease myometrial contractions, which could in turn enhance implantation. Most clinicians try to avoid having the catheter tip come into contact with the uterine fundus during embryo transfer (<LINK REF="REF-Kovacs-1999" TYPE="REFERENCE">Kovacs 1999</LINK>), as it has been suggested that this may stimulate uterine contractions (<LINK REF="STD-Lesny-1998" TYPE="STUDY">Lesny 1998</LINK>), which in turn may lead to expulsion of the embryos. Indeed, it has been noted that high-frequency uterine contractions visualised by ultrasound are associated with a lower ongoing clinical pregnancy rate (<LINK REF="REF-Fanchin-1998" TYPE="REFERENCE">Fanchin 1998</LINK>).</P>
<P>The clinical touch method may thus be challenged as a potential cause of cycle failure as a result of (1) initiation of uterine contractility that may lead to immediate or delayed expulsion of the embryo/s, and (2) the inability to accurately identify the ideal location for deposition of embryos, especially in women with acute utero-cervical angulations, cervical stenosis, or anatomical distortion of the cervical canal and uterus.</P>
<P>Numerous methods to improve the technique of embryo transfer have been studied in an attempt to improve pregnancy rates, including changing the type of catheter used, performing a trial, or 'mock' transfer before the actual procedure, removing any cervical mucus prior to transfer, avoiding the use of a tenaculum, encouraging bed rest following embryo transfer, comparing full and empty bladder, as well as performing the procedure under ultrasound guidance. This review currently focuses on the role of transabdominal ultrasound.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-02-26 08:41:14 +1300" MODIFIED_BY="[Empty name]">
<P>The use of abdominal ultrasound to guide embryo transfer was first discussed by Strickler et al (<LINK REF="STD-Strickler-1985" TYPE="STUDY">Strickler 1985</LINK>), who postulated that this would allow accurate and atraumatic positioning of the catheter tip near the uterine fundus, along with visualisation of the injection of the transfer fluid containing the embryos. By allowing identification of the cervical canal and endometrial cavity, ultrasound can facilitate atraumatic penetration of the catheter into the uterus, thereby minimising endometrial trauma. Moreover, its use can confirm that the catheter tip is beyond the internal os of the cervix and that placement of the embryos is at the desired level in the endometrial cavity (<LINK REF="STD-Lorusso-2005" TYPE="STUDY">Lorusso 2005</LINK>). This can be especially helpful in women where the uterine anatomy may be distorted by fibroids or septae (<LINK REF="STD-Hurley-1991" TYPE="STUDY">Hurley 1991</LINK>). For these reasons, ultrasound-guided embryo transfers have been rated as "easier" and "cleaner" by clinicians (<LINK REF="STD-Prapas-2001" TYPE="STUDY">Prapas 2001</LINK>). Disadvantages are the need for a second operator, a longer time to execute, and the inconvenience of filling the woman's bladder (<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>). Another possible drawback is that in some cases moving the catheter to improve identification is required, a motion that is not needed in transfers performed by clinical touch. This manoeuvre can potentially disrupt the endometrium, thus reducing the benefits provided by ultrasound (<LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>). Another disadvantage is the possible unknown side effects of early ultrasound on the pre-implantation embryo.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-02-26 11:30:06 +1300" MODIFIED_BY="[Empty name]">
<P>Studies comparing transabdominal ultrasound guidance with the traditional clinical touch method have reported conflicting results in terms of pregnancy rates. Given the lack of concurrence in the literature, we decided to review the evidence systematically to evaluate this method for successful embryo transfer.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-02-26 08:48:00 +1300" MODIFIED_BY="[Empty name]">
<P>To determine whether ultrasound guidance compared with clinical touch improves pregnancy outcomes in women undergoing embryo transfer during assisted reproductive technology cycles.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-03-04 12:59:20 +1300" MODIFIED_BY="Helen E Nagels">
<SELECTION_CRITERIA MODIFIED="2016-02-26 16:40:41 +1300" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2016-02-26 08:57:43 +1300" MODIFIED_BY="[Empty name]">
<P>We considered all published, unpublished, and ongoing prospective randomised trials that reported data comparing outcomes of women undergoing ultrasound-guided embryo transfer (UGET) versus clinical touch embryo transfer (CTET) through the cervical route following in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) including frozen embryo transfers for inclusion. We excluded quasi-randomised (sampling of every n<SUP>th </SUP>entry from a list), cross-over, and cluster randomised trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-02-26 11:28:14 +1300" MODIFIED_BY="[Empty name]">
<P>Women with any form of infertility undergoing embryo transfer via the cervical route (using either fresh or cryopreserved or donated embryos) after either IVF or ICSI and randomised to either UGET or CTET.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-02-26 11:37:21 +1300" MODIFIED_BY="[Empty name]">
<P>The studies had to compare transcervical embryo transfer using transabdominal ultrasound guidance with clinical touch methods. The studies should have conducted a standard IVF/ICSI procedure, using standard protocols for controlled ovarian stimulation and transcervical replacement of embryos. Standard culture medium and catheters should have been used for culture and transfer of embryos, respectively. We included embryo transfers that involved donated gametes or embryos. There was no restriction on the number of clinicians conducting the transfers nor the type of catheters used.</P>
<P>We excluded studies of embryo transfer via zygote intrafallopian transfer.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-02-26 16:40:41 +1300" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-02-26 11:42:58 +1300" MODIFIED_BY="[Empty name]">
<P>The primary outcome measure for this systematic review was live births/ongoing pregnancies per woman randomised. We defined live birth as a live fetus born after 20 completed weeks. We defined ongoing pregnancies as those continuing for at least 12 weeks after embryo transfer.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-02-26 16:40:41 +1300" MODIFIED_BY="[Empty name]">
<OL>
<LI>Clinical pregnancies per woman randomised (as determined by heart beat detected using ultrasound)</LI>
<LI>Multiple birth per woman randomised</LI>
<LI>Miscarriage rate: miscarriage (confirmed by ultrasound and pregnancy test or histology) per woman randomised (including partial loss of multiple pregnancies)</LI>
<LI>Ectopic pregnancy rate: ectopic gestation per woman randomised</LI>
<LI>Foetal abnormalities as determined by foetal anatomy scan or after delivery per woman randomised</LI>
<LI>Complication rate: any adverse effects/events associated with embryo transfer per woman randomised</LI>
<LI>Ease of transfer as determined by clinician</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-03-01 14:49:59 +1300" MODIFIED_BY="Helen E Nagels">
<P>We searched for all published and unpublished randomised controlled trials comparing ultrasound with clinical touch, without language restriction, and in conjunction with the Cochrane Gynaecology and Fertility Group's Trials Search Co-ordinator.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-03-01 14:49:59 +1300" MODIFIED_BY="Helen E Nagels">
<P>We searched the following electronic databases and trial registries in May 2015.</P>
<P>The Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), and CINAHL (EbscoHost). We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials that appears in Section 6.4.11 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (Version 5.1.0) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We combined the EMBASE, PsycINFO, and CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<A HREF="http://www.sign.ac.uk/methodology/filters.html#random">http://www.sign.ac.uk/methodology/filters.html#random</A>) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>; <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>).</P>
<P>Other electronic sources of trials included:</P>
<UL>
<LI>trials registers of registered and ongoing trials</LI>
<UL>
<LI>
<A HREF="http://clinicaltrials.gov">http://clinicaltrials.gov</A> (a service of the US National Institutes of Health);</LI>
<LI>
<A HREF="http://who.int/trialsearch/Default.aspx">http://who.int/trialsearch/Default.aspx</A> (the World Health Organization International Trials Registry Platform search portal).</LI>
</UL>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-03-01 14:46:43 +1300" MODIFIED_BY="Helen E Nagels">
<P>We searched the citation lists of relevant publications and review articles published from 2009 to the present (September 2015), and handsearched the references of the included studies. We contacted commercial entities and experts in the field, where identified, to locate trials. We contacted authors where necessary for missing data on live birth rates.</P>
<P>We also handsearched relevant conference proceedings: American Society for Reproductive Medicine (ASRM), European Society for Human Reproduction and Embryology (ESHRE), and International Federation of Gynecology and Obstetrics (FIGO). There were no language restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-03-04 12:59:20 +1300" MODIFIED_BY="Helen E Nagels">
<STUDY_SELECTION MODIFIED="2016-02-26 12:08:56 +1300" MODIFIED_BY="[Empty name]">
<P>After an initial screen of the titles and abstracts retrieved in the searches (by JB, a methodologist, and KB, a content expert), we retrieved the full texts of all potentially eligible studies. Two review authors (JB, KB) independently examined these full-text articles for compliance with the inclusion criteria and selected studies eligible for inclusion in the review. We corresponded with study investigators, as required, to confirm study eligibility. Disagreements as to study eligibility were resolved by consensus.<BR/>
</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-02-28 00:01:55 +1300" MODIFIED_BY="[Empty name]">
<P>Two review authors (JB, KB) independently extracted data from the eligible studies using a data extraction form that had been developed and piloted for consistency and completeness. Any disagreements were resolved by consensus. Data extracted included study characteristics and outcome data. Where studies had multiple publications, we collated multiple reports of the same study so that each study, rather than each report, is the unit of interest in the review, and such studies will have the same study ID with multiple references.</P>
<P>We corresponded with study investigators for further information on methods or data/results as required (for example live birth rates).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-02-26 12:16:11 +1300" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the eligible studies for risk of bias using the Cochrane 'Risk of bias' assessment tool (<A HREF="http://www.cochrane-handbook.org">www.cochrane-handbook.org</A>) for the following domains: selection (random sequence generation, allocation concealment), performance (blinding of participants and personnel), detection (blinding of outcome assessors), attrition (incomplete outcome data), reporting (selective reporting), and other bias (refer to risk of bias in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). Disagreements were resolved by consensus.</P>
<P>We took care to search for within-trial selective reporting, such as trials failing to report specific outcomes, or reporting them in insufficient detail to allow for inclusion of data. We sought out published protocols and compared these with the data reported in the published report.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-02-26 12:20:14 +1300" MODIFIED_BY="[Empty name]">
<P>We performed statistical analysis in accordance with the guidelines for statistical analysis developed by the Cochrane Gynaecology and Fertility Group. The outcome of live birth/ongoing pregnancy and clinical pregnancy is considered a positive consequence of fertility treatment, therefore a higher proportion of women with a clinical pregnancy, ongoing pregnancy, or live birth is considered a benefit. Outcomes such as multiple pregnancy are a negative consequence, therefore higher numbers are considered detrimental. This should be taken into account when viewing summary graphs.</P>
<P>For dichotomous data, we used the number of events in the intervention and control groups to calculate the Mantel-Haenszel odds ratio with 95% confidence intervals for all outcomes. The Peto odds ratio had been used in previous versions of this review.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-02-26 12:21:36 +1300" MODIFIED_BY="[Empty name]">
<P>All analyses are reported per woman randomised. In studies that reported on outcome per embryo transfer, we sought verification from the primary author/s.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-02-26 12:25:48 +1300" MODIFIED_BY="[Empty name]">
<P>We have presented data as the outcome per woman randomised. Where we could not collate such data from the paper, we sought verification from the primary author/s. Where possible, we reported data by intention-to-treat. Where data were unobtainable, we only analysed the available data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-02-26 12:27:50 +1300" MODIFIED_BY="[Empty name]">
<P>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta-analysis to provide a clinically meaningful summary. We assessed heterogeneity using the I<SUP>2</SUP> statistic. We considered an I<SUP>2</SUP> greater than 50% to indicate substantial heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-02-26 12:34:28 +1300" MODIFIED_BY="[Empty name]">
<P>We performed a comprehensive search of the literature. We have included published and unpublished data with both positive and negative findings in this review. We identified no pre-publication protocols for the included studies in our search of the trial registries. Additionally, we assessed publication bias using funnel plot techniques, Begg&#8217;s rank test, Egger&#8217;s regression test, and the trim-and-fill plot for outcomes that had at least 10 included trials.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-03-03 11:26:26 +1300" MODIFIED_BY="[Empty name]">
<P>Where data were considered similar enough to combine, we employed a fixed-effect model as the primary analysis in the meta-analysis using Review Manager version 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We combined data for the following comparison:</P>
<UL>
<LI>ultrasound-guided embryo transfer versus clinical touch.</LI>
</UL>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-02-26 12:37:05 +1300" MODIFIED_BY="[Empty name]">
<P>Where statistical heterogeneity was found to exceed 50%, we performed subgroup analysis to try to explain the findings. We explored the use of same or different type of catheters used in the intervention or control groups.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-03-04 12:59:20 +1300" MODIFIED_BY="Helen E Nagels">
<P>We had planned to conduct sensitivity analyses to compare studies judged to have low risk of bias (those judged to be at low risk of bias for all domains of risk of bias) with those classified as having an unclear/high risk of bias. Instead, we undertook a random-effects analysis to assess sensitivity to choice of model for all outcomes where heterogeneity was greater than 50%.</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall quality of the body of evidence: 'Summary of findings' table</HEADING>
<P>We have prepared a 'Summary of findings' table using GRADEpro Guideline Development Tool software (<LINK REF="REF-GRADEpro-GDT" TYPE="REFERENCE">GRADEpro GDT</LINK>). This table evaluates the overall quality of the body of evidence for the main review outcomes (live birth/ongoing pregnancy, clinical pregnancy, multiple pregnancy, miscarriage and ectopic pregnancy) using GRADE (Grades of Recommendation, Assessment, Development and Evaluation) criteria (study limitations (that is risk of bias), consistency of effect, imprecision, indirectness, and publication bias). Judgements about evidence quality (high, moderate, or low) have been justified, documented, and incorporated into reporting of results for each outcome.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-03-10 08:11:56 +1300" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-03-03 13:29:30 +1300" MODIFIED_BY="Helen E Nagels">
<SEARCH_RESULTS MODIFIED="2016-03-03 13:29:30 +1300" MODIFIED_BY="Helen E Nagels">
<P>We identified 104 potential studies in the original search, and an additional six studies in the update in 2009. In the 2016 update, we added four new studies (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>), and excluded five (<LINK REF="STD-Bodri-2011" TYPE="STUDY">Bodri 2011</LINK>; <LINK REF="STD-Deep-2013" TYPE="STUDY">Deep 2013</LINK>; <LINK REF="STD-Hauzman-2012" TYPE="STUDY">Hauzman 2012</LINK>; <LINK REF="STD-Porat-2010" TYPE="STUDY">Porat 2010</LINK>; <LINK REF="STD-Saharkhiz-2014" TYPE="STUDY">Saharkhiz 2014</LINK>) (<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>We requested data from all authors of abstracts (<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>; <LINK REF="STD-Faure-1998" TYPE="STUDY">Faure 1998</LINK>; <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>); we received a response from Dr Bar-Harva, although no data has been forthcoming. We received no correspondence from the other authors. We requested clarification of randomisation from Dr Li but have received no response (<LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>). Dr Blake was unable to identify the study requested; she was the head of the research department that submitted the summary but cannot identify the original authors of the study within the institution (<LINK REF="STD-Blake-1998" TYPE="STUDY">Blake 1998</LINK>). In the 2016 update of this review, we moved <LINK REF="STD-Blake-1998" TYPE="STUDY">Blake 1998</LINK> to the excluded studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-03-03 11:32:01 +1300" MODIFIED_BY="[Empty name]">
<P>We identified 23 publications associated with 21 randomised controlled trials that compared ultrasound guidance with clinical touch. We included 21 trials in the final analysis (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>;<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>). All of the trials included in the review and final analysis were prospective randomised controlled trials.</P>
<SUBSECTION>
<HEADING LEVEL="4">Baseline characteristics of women</HEADING>
<P>Studies emerged from a variety of centres around the world: the UK (<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>), Spain (<LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>), China (<LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>), Belgium (<LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>), Brazil (<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>), Israel (<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>), Argentina (<LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>), Taiwan (<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>), Saudi Arabia (<LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>), the Czech Republic (<LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>), Iran (<LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>), Brazil (<LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>), Egypt (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>), and Mexico/USA (<LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>). All of the studies used transabdominal ultrasound. The 21 included studies reported on 6711 women undergoing embryo transfer.</P>
<P>All couples were infertile and participating in some form of fertility programme. Inclusion criteria reported in the studies was for the women to be on an in-vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) embryo transfer programme (<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>), undergoing IVF but less than 40 years of age (<LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>), to be recipients of oocyte donation programme and undergoing embryo transfer of good-quality embryos (<LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>), aged 28 to 41 years undergoing IVF (including ICSI) (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>), or undergoing ICSI or IVF with frozen-thawed embryos. <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK> required women to be less than 38 years of age and have a body mass index equal to or less than 30 kg/m<SUP>2</SUP>. <LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK> required women to be between 20 and 39 years of age. <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK> and <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK> also required that women have a day 3 follicle-stimulating hormone level of less than 12 IU/ml. In <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>, women were under 40 years of age with fresh embryos undergoing non-donor embryo transfer; exclusions were cryopreserved embryos and women with previous cervical excision for cervical dysplasia. No details of inclusion or exclusion criteria were provided by <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>, <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>, <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>, and <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>.</P>
<P>All studies reported maternal age except <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>, <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>, and <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK> (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Thirteen trials included women who had embryo transfer related to fresh IVF/ICSI cycles (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>); one study had 56.3% fresh embryos in the ultrasound-guided group and 54% in the clinical touch group (<LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>); and <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK> used frozen/thawed embryos in both groups. <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK> included both fresh and frozen embryo transfers. <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK> did not report if embryos were fresh or frozen. <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK> excluded women with cryopreserved embryos, having oocyte donation, or undergoing ICSI, and <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK> excluded women requiring general anaesthesia or refusing to participate. No details were provided by <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>.</P>
<P>Seven studies reported the duration of infertility (<LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>), and seven studies mentioned the primary causes of infertility (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>). The remaining studies provided no details.</P>
<P>Fifteen studies provided IVF protocol information (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>), and 12 described embryo transfer information (<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>). Seven studies described details on the embryo media (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>). All of the studies with the exception of <LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>, <LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>, and <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK> included details of the catheter type used for embryo transfer. The distance from the fundus where the embryos were placed was not detailed by <LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>, <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>, <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>, <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>, <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>, and <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>, and two trials failed to record the number of embryos transferred (<LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>).</P>
<P>Twelve studies detailed ease of transfer (<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>). Details regarding day of embryo transfer were not provided by <LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>, <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>, and <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004,</LINK> and type of ultrasound machine used for the procedure was described by <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>, <LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>, <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>, <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>, <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>, <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>, <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>, <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>, <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>, <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>, <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>, <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>, and <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>.</P>
<P>Details on requirement of full bladder were provided by <LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>, <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>, <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>, <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>, <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>, <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>, <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>, <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>, <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>, <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>, <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>, and <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>. Bed rest post-procedure was detailed by <LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>, <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>, <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>, <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>, <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>, <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>, <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>, <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>, and <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>.</P>
<P>For details of the transfer protocol and IVF protocol, see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. For details of the transfer/replacement procedure, where reported, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. For details of day of transfer, whether women were on bed rest or not, and whether they had a full bladder or not, as well as the type of ultrasound machine used, see <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-02-26 14:01:19 +1300" MODIFIED_BY="[Empty name]">
<P>We rejected 42 of the 104 potential studies outright based on the title or content of the abstract. After retrieving the remaining papers, we rejected a further 42 studies because on more detailed analysis of the content we found they were not randomised controlled trials or because they were comparing catheter types and not ultrasound guidance versus clinical touch methods of embryo transfer. Ten papers were reviews or 'letters to the editor' that did not contain any original data. We excluded a further five trials that compared transvaginal ultrasound with transabdominal ultrasound (<LINK REF="STD-Bodri-2011" TYPE="STUDY">Bodri 2011</LINK>; <LINK REF="STD-Deep-2013" TYPE="STUDY">Deep 2013</LINK>; <LINK REF="STD-Hauzman-2012" TYPE="STUDY">Hauzman 2012</LINK>; <LINK REF="STD-Porat-2010" TYPE="STUDY">Porat 2010</LINK>), or that did not use ultrasound at the time of embryo transfer (<LINK REF="STD-Saharkhiz-2014" TYPE="STUDY">Saharkhiz 2014</LINK>). In the 2016 update, we excluded two studies that had previously been awaiting classification, as multiple attempts to contact the authors of <LINK REF="STD-Faure-1998" TYPE="STUDY">Faure 1998</LINK> were made without reply, and we were unable to identify the authors of the <LINK REF="STD-Blake-1998" TYPE="STUDY">Blake 1998</LINK> study. The studies were old, and the findings were unlikely to affect the results of the meta-analyses. We excluded a total of 49 studies (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-02-27 21:24:20 +1300" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>, and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2016-02-26 15:25:59 +1300" MODIFIED_BY="[Empty name]">
<P>Nine studies used some method of computer-generated randomisation (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>), one study drew lots using a randomisation table on the day of oocyte retrieval (<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>), and one randomised using tables of random sampling numbers (<LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>). The remaining studies provided no details of the randomisation method used.</P>
<P>Five studies described their process of allocation concealment (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-02-26 15:27:45 +1300" MODIFIED_BY="[Empty name]">
<P>None of the trials used blinding. We judged this to be unclear for performance bias, as although blinding is unlikely to affect the outcome of pregnancy, the awareness of the intervention by the clinicians involved may affect the performance of the intervention.</P>
<P>None of the trials provided details as to whether the outcome assessors were blinded, and we judged this as unclear risk of bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-02-26 15:31:26 +1300" MODIFIED_BY="[Empty name]">
<P>Attrition and intention-to-treat analysis: Four women in the trial conducted by <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK> were not analysed due to failure during transfer and are not included in this analysis, as their treatment changed and their outcomes are unknown. All of the remaining trials analysed the same number of women as were randomised.</P>
<P>Live birth rate was poorly reported, with only four of the 21 included studies reporting this primary outcome.<BR/>
</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-02-27 21:24:20 +1300" MODIFIED_BY="[Empty name]">
<P>The review authors have retrieved a wide source of data from conference papers, peer-reviewed data, and personal communication with authors. We could not identify published trial protocols for any of the included trials. In addition, 16 studies did not report on the primary outcome of live birth (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-02-26 15:35:01 +1300" MODIFIED_BY="[Empty name]">
<P>We identified no other sources of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-03-10 08:11:56 +1300" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1.1 Live birth/ongoing pregnancy</HEADING>
<P>Thirteen trials reported on live birth/ongoing pregnancy. Four trials reported on live birth (<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>), and nine trials reported ongoing pregnancy (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>). None of the studies reporting ongoing pregnancy reported on live birth and vice versa.</P>
<P>Personal communication with two authors resulted in additional data on live birth being received (<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>).</P>
<P>The use of ultrasound-guided embryo transfer (UGET) was associated with an increased chance of a live birth/ongoing pregnancy (917 out of 2963) compared with clinical touch embryo transfer (CTET) (686 out of 2896) (odds ratio (OR) 1.47, 95% confidence interval (CI) 1.30 to 1.65; 13 trials; n = 5859 women; I<SUP>2</SUP> = 74%; low-quality evidence). Sensitivity analysis using a random-effects model did not affect the overall results. The subgroup interaction test was not significant, suggesting there was no evidence of a differential effect between studies reporting live birth and those reporting ongoing pregnancy (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). We estimate that for women with a chance of a live birth/ongoing pregnancy of 23% using CTET, this would increase to between 28% and 33% using UGET (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). Using the GRADE approach, we judged the quality of the evidence to be low.</P>
<P>In the review protocol we stated that where there was heterogeneity we would explore it by only including trials with low risk of bias for all the domains. None of the included trials in the review had low risk of bias in all the domains. We therefore looked only at those trials that had low risk of bias for selection bias (allocation). For the outcome of live birth we excluded <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>. For the outcome of ongoing pregnancy we excluded <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK> and <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>. The evidence of an overall benefit for UGET still remained , although the strength of the effect was diminished (OR 1.17, 95%CI 1.01 to 1.36; 8 trials, n = 3904; I<SUP>2</SUP> = 22%; analysis not shown).</P>
<P>For live birth (all trials included), heterogeneity was I<SUP>2</SUP> = 91%. We attempted to explore the reasons for this significant heterogeneity by looking for differences in the trial protocols.</P>
<P>
<B>Fresh versus frozen embryos:</B> <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>, <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>, and <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK> used fresh embryos only. <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK> reported using fresh and frozen embryos (88% fresh and 12% frozen embryos in both groups).</P>
<P>
<B>Type of catheter used:</B> One of the included studies appeared to be an outlier (<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>). We found that in this trial, the catheters used differed between the groups. In the UGET group, 97% of embryo transfers used the Cook EchoTip, 1% Wallace, and 2% Rocket catheters. In the CTET group, 2% used the Cook EchoTip, 51% the Wallace, and 47% the Rocket catheters. There was no difference in the chance of a live birth between groups (OR 0.99, 95% CI 0.79 to 1.25; 1 trial; n = 1649). <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK> and <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK> used the Frydman catheter in both groups, and <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK> used the Labotect catheter in both groups. The use of UGET was associated with an increase in live birth compared to CTET where the same catheter was used in both groups (OR 2.45, 95% CI 1.92 to 3.12; 3 studies; n = 1468; I<SUP>2</SUP> = 57%). The subgroup interaction test was significant, suggesting that using the same catheter type for both intervention groups was associated with an increased chance of a live birth (Chi<SUP>2 </SUP>= 23.06; I<SUP>2 </SUP>= 96.4%; P &lt; 0.00001) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). Sensitivity analysis using a random-effects model did not affect this result.</P>
<P>Publication bias tests did not indicate a significant probability of the presence of publication bias. Even so, the funnel plot appeared asymmetrical with a gap on the left lower corner. The trim-and-fill plot identified that five trials (favouring CTET) would be needed to make the funnel plot symmetrical (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). With the addition of these trials, the adjusted effect estimate would still remain significant, but the magnitude of effect reduced to OR 1.14 (95% CI 1.02 to 1.28).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.2 Clinical pregnancies</HEADING>
<P>Twenty trials reported clinical pregnancies. UGET was associated with an increase in the chance of a clinical pregnancy (1118 out of 3392) compared with CTET (916 out of 3319) (OR 1.31, 95% CI 1.17 to 1.45; 20 studies; n = 6711; I<SUP>2</SUP> = 42%) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>Publication bias tests did not indicate a significant probability of the presence of publication bias. Even so, the funnel plot appeared asymmetrical with a gap on the left lower corner. The trim-and-fill plot identified that six trials (favouring CTET) would be needed to make the funnel plot symmetrical (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). With the addition of these trials, the adjusted effect estimate would still remain significant, but the magnitude of effect reduced to OR 1.19 (95% CI 1.07 to 1.32). Using GRADE methodology, we judged the quality of the evidence for clinical pregnancies to be moderate; the evidence was downgraded one level due to lack of methodological details to be able to make a judgement on risk of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.3 Multiple pregnancies</HEADING>
<P>Multiple pregnancies are viewed as an adverse event, as the aim is to achieve a single live birth. Eight trials reported multiple pregnancies (<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>). There was no evidence of a difference between UGET (140 out of 1693) and CTET (124 out of 1686) in the incidence of multiple pregnancies (OR 1.13, 95% CI 0.87 to 1.45; 8 trials; n = 3379; I<SUP>2</SUP> = 0%) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Using GRADE methodology, we judged the quality of the evidence for multiple pregnancies to be moderate; the evidence was downgraded one level due to lack of methodological details to be able to make a judgement on risk of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.4 Ectopic pregnancies</HEADING>
<P>There was no evidence of a difference in ectopic pregnancies per woman randomised in the eight trials reporting this outcome (<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>): UGET (8 out of 1885) and CTET (13 out of 1876) (OR 0.64, 95% CI 0.28 to 1.49; 8 trials; n = 3761; I<SUP>2</SUP> = 0%) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). Using GRADE methodology, we judged the quality of the evidence for ectopic pregnancies to be moderate; the evidence was downgraded one level due to lack of methodological details to be able to make a judgement on risk of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.5 Miscarriage</HEADING>
<P>Eleven of the papers determined miscarriage (<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>; <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>). There was no evidence to suggest an effect on the incidence of spontaneous miscarriage between UGET (103 out of 2048) and CTET (101 out of 2005) (OR 0.99, 95% CI 0.74 to 1.31; 11 trials; n = 4053; I<SUP>2</SUP> = 0%) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). Using GRADE methodology, we judged the quality of the evidence for miscarriage to be moderate; the evidence was downgraded one level due to lack of methodological details to be able to make a judgement on risk of bias.</P>
<P>Publication bias tests did not indicate a significant probability of the presence of publication bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.6 Blood on catheter tip</HEADING>
<P>Five papers reported blood on the catheter tip as an adverse event following the transfer procedure (<LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>). There was no evidence of a difference between UGET (126 out of 1397) and CTET (124 out of 1383) (OR 1.0, 95% CI 0.77 to 1.30; 5 trials; n = 2780; I<SUP>2</SUP> = 0%) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1.7 Difficulty in transfer</HEADING>
<P>Where reported, we extracted data on transfers that were considered to be difficult. Ten trials reported this outcome (<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>; <LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>; <LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>; <LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>; <LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>; <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>; <LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>; <LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>; <LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>; <LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>). The studies reported that 183 out of 2173 cases were considered to be difficult in UGET compared to 258 out of 2122 for CTET; UGET was associated with a reduction in transfers that were considered to be difficult (OR 0.69, 95% CI 0.57 to 0.82; 10 trials; n = 4295; I<SUP>2</SUP> = 75%). Sensitivity analysis using random-effects model (data not shown) changed the results to a non-significant difference (OR 0.71, 95% CI 0.46 to 1.10) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). The observed difference may be due to the high number of events in the CTET group in the <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK> trial and the low event rates in the UGET group in the <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK> trial. If we remove these two trials from the meta-analysis, the results show no evidence of a difference between the UGET and CTET groups (OR 0.96, 95% CI 0.28 to 1.19; 8 trials; n = 2957), and I<SUP>2</SUP> is reduced to 0%.</P>
<P>Publication bias tests did not indicate a significant probability of the presence of publication bias.</P>
<P>There were no reports in any of the analysed papers on the outcome of foetal abnormalities either at anomaly scan or at birth.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-03-03 11:18:35 +1300" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<SUMMARY_OF_RESULTS MODIFIED="2016-02-26 16:50:23 +1300" MODIFIED_BY="[Empty name]">
<P>The results of this systematic review found an association between ultrasound-guided embryo transfer (UGET) and an increased chance of a live birth/ongoing pregnancy. Heterogeneity was high, with a significant proportion of weighting being attributed to one trial (<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>).</P>
<P>We identified no evidence of a difference between UGET and clinical touch embryo transfer (CTET) with regards to miscarriage, multiple pregnancies, or ectopic pregnancies, and the incidence of such events was relatively small. Data on multiple pregnancies was only reported by six of the studies and may be regarded as a source of reporting bias. We have requested data from all authors with regard to this outcome, and it is recommended that future research takes this into account.</P>
<P>There was no evidence of a difference between transfer procedures for blood on the catheter after embryo transfer. The papers were not always explicit in identifying who was responsible for the embryo transfer and what their level of experience in the procedure was. For the outcome difficult embryo transfer, <LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK> and <LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK> account for the heterogeneity in the analysis.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-02-26 16:52:48 +1300" MODIFIED_BY="[Empty name]">
<P>In general, the studies identified are similar enough to make meaningful comparisons. There is still a lack of data regarding live birth, which needs to be addressed in future research. The odds ratios for live birth and ongoing pregnancy are similar, and we have interpreted this as suggesting that the benefits identified for UGET over CTET for the ongoing pregnancy data are unlikely to represent selective outcome reporting.</P>
<P>During the searches for this review update we identified a number of trials that used transvaginal ultrasound or three-dimensional ultrasound. In subsequent updates of this review, we will include these trials for completeness.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-02-26 17:12:32 +1300" MODIFIED_BY="[Empty name]">
<P>Overall, the included studies could be compromised by their lack of methodological quality. Only two of the studies reported using a computer-generated randomisation and adequate concealment (<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>; <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>). The remaining studies failed to provide adequate detail regarding methodological quality, in particular randomisation method and allocation concealment. Only four studies reported live birth, and none of the nine studies that provided data on ongoing pregnancy reported live birth.</P>
<P>Using GRADE methodology, we judged the quality of the evidence for the primary outcome of live birth to be low. We downgraded quality for high heterogeneity and lack of methodological detail to be able to judge the risk of bias.</P>
<P>For the secondary outcomes of clinical pregnancy, multiple pregnancy, ectopic pregnancy, and miscarriage, we judged the quality of the evidence to be moderate. We downgraded the quality for lack of methodological detail, which meant that we were unable to judge the risk of bias.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-03-03 11:18:35 +1300" MODIFIED_BY="[Empty name]">
<P>We believe that we have conducted a comprehensive and systematic search of published and unpublished trials.</P>
<P>However, publication bias may be an issue, with mainly positive outcomes being reported. During the literature search we identified studies that reported either no difference or a negative effect of UGET; these studies tended to be retrospective studies and were excluded for reasons of their study design. The study by Drakeley did report equivocal results between the groups (<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>). Further, the outcomes ongoing pregnancy/live birth and clinical pregnancy rates had asymmetric funnel plots that may be the result of publication bias. Even so, the conclusions drawn from the pooled results after adjustment remained unchanged.</P>
<P>The review authors felt that the funnel plot for live birth/ongoing pregnancy appeared relatively asymmetrical (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>) .</P>
<P>It has been suggested that the increase in clinical pregnancy and live birth/ongoing pregnancy may be due to a decrease in difficult transfers. The definitions of what was considered difficult varied between the studies and may account for the heterogeneity found for this outcome. Clearer, standardised definitions are required for comparisons to be made, although the subjective nature of this outcome may influence the findings in individual studies.</P>
<P>The exact mechanism by which UGET increases pregnancy rates remains unclear. The main suggested explanations remain the confirmation of the catheter in the uterine cavity , 'ease of transfer' positioning of the catheter, and avoiding touching the fundus or indenting the endometrium.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-02-26 17:30:50 +1300" MODIFIED_BY="[Empty name]">
<P>The evidence of this review is congruent with other published evidence, including two systematic reviews with meta-analyses of randomised controlled trials, both of which found a benefit for live birth and clinical pregnancy with UGET compared with CTET (<LINK REF="REF-Abou_x002d_Setta-2007" TYPE="REFERENCE">Abou-Setta 2007</LINK>; <LINK REF="REF-Teixeira-2015" TYPE="REFERENCE">Teixeira 2015</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-03-08 12:20:29 +1300" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-02-26 17:37:09 +1300" MODIFIED_BY="[Empty name]">
<P>The evidence suggests that, where personnel and resources are available, the chance of an ongoing pregnancy or live birth is better with UGET than with CTET.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-03-08 12:20:29 +1300" MODIFIED_BY="[Empty name]">
<P>The studies highlight a lack of data for the primary outcome measure (live birth) of the systematic review. It is suggested that future research should report on the live birth rate per woman randomised as an outcome measure that is of importance to the target population. Sample size calculations suggest that 759 women in each arm would be sufficient to detect an 8 per cent difference in live birth with 95% power and &#945; 0.5. The same type of transfer catheter should be used in the intervention and control groups where possible to avoid confounding variables.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-02-26 17:44:06 +1300" MODIFIED_BY="[Empty name]">
<P>We wish to acknowledge the peer reviewers and the staff at the Cochrane Gynaecology and Fertility Group for their contribution to this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-02-26 17:48:19 +1300" MODIFIED_BY="[Empty name]">
<P>Ahmed Abou-Setta and William Buckett are both authors of separate, complementary systematic reviews on the topic of ultrasound guidance versus clinical touch during embryo transfer.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-02-26 17:47:42 +1300" MODIFIED_BY="[Empty name]">
<P>Julie Brown took the lead in writing the review and update and was involved in all aspects of review design, search, data extraction, and summary.</P>
<P>Karen Buckingham was a co-author of the review and was involved in the design, data extraction, and summary. She is a clinical expert in the field.</P>
<P>William Buckett and Ahmed Abou-Setta helped review the manuscript and are experienced in the specialised field.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-02-26 17:54:27 +1300" MODIFIED_BY="[Empty name]">
<P>As per the Cochrane Gynaecology and Fertility Group's new guidelines, the Peto odds ratio has been replaced with the Mantel-Haenszel odds ratio.</P>
<P>We have removed the secondary outcome of multiple pregnancy rate - multiple pregnancy (twins, triplets, or higher, order specified if possible) per clinical pregnancy, confirmed by ultrasound or delivery.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-03-04 13:06:54 +1300" MODIFIED_BY="Helen E Nagels">
<STUDIES MODIFIED="2016-03-03 12:33:46 +1300" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-03-03 12:24:27 +1300" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ammar-2013" MODIFIED="2015-09-22 15:03:51 +1200" MODIFIED_BY="[Empty name]" NAME="Ammar 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-09-22 15:03:51 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ammar AR, Mousa KS, Rabei NH, Galal A</AU>
<TI>Effect of ultrasound guided embryo transfer on pregnancy rates</TI>
<SO>New York Science Journal</SO>
<YR>2013</YR>
<VL>6</VL>
<NO>12</NO>
<PG>79-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Azmy-2009" MODIFIED="2016-03-03 12:10:54 +1300" MODIFIED_BY="[Empty name]" NAME="Azmy 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-02-27 20:53:39 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Al-Shemi M</AU>
<SO>Ultrasound Guided Versus Blind Touch Embryo Transfer Among Patients Undergoing Intra Cytoplasm Sperm Injection [Protocol for Thesis]</SO>
<YR>2008</YR>
<PB>Faculty of Medicine, Ain Shams University, Egypt</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-03 12:10:54 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Azmy O, Taha T, Bibars M, Refaat M</AU>
<TI>Ultrasound guided versus blind touch embryo transfer: the Egyptian experience</TI>
<SO>Proceedings of the 15th World Conference of IVF and 4th Congress of IVM</SO>
<YR>2009</YR>
<PG>9-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bar-Hava-2003" MODIFIED="2016-02-27 21:03:09 +1300" MODIFIED_BY="[Empty name]" NAME="Bar Hava 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-02-27 21:03:09 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bar-Hava I, Meltzer S, Rabinson J, Ayash I, Sega S, Tur-Kaspa I</AU>
<TI>Ultrasound guided versus blind tactile embryo transfer: a prospective randomised study</TI>
<SO>Human Reproduction</SO>
<YR>2003</YR>
<VL>18 (suppl 1)</VL>
<NO>7</NO>
<PG>xviii7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2007" MODIFIED="2016-02-27 21:03:32 +1300" MODIFIED_BY="[Empty name]" NAME="Chen 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-02-27 21:03:32 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen S-C, Lai T-H, Lee F-K</AU>
<TI>The influence of abdominal ultrasound-guided embryo transfer on pregnancy rate: a preliminary report</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>87</VL>
<NO>5</NO>
<PG>1235-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coroleu-2000" MODIFIED="2016-02-27 21:24:20 +1300" MODIFIED_BY="[Empty name]" NAME="Coroleu 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-02-27 21:03:54 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coroleu B, Carreras O, Veiga A, Martell A, Martinez F, Belil I, et al</AU>
<TI>Embryo transfer under ultrasound guidance improves pregnancy rates after in-vitro fertilization</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>3</NO>
<PG>616-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coroleu-2002" MODIFIED="2009-11-09 15:42:58 +1300" MODIFIED_BY="jane clarke" NAME="Coroleu 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-09 15:42:58 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coroleu B, Barri P, Carreras O, Martinez F, Veiga A, Balasch J</AU>
<TI>The usefulness of ultrasound guidance in frozen-thawed embryo transfer: a prospective randomised clinical trial</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>11</NO>
<PG>2885-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davar-2007" MODIFIED="2016-02-27 21:04:42 +1300" MODIFIED_BY="[Empty name]" NAME="Davar 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-02-27 21:04:42 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davar R, Ghandi S, Tayebi N</AU>
<TI>Does transabdominal ultrasound-guided embryo transfer improve pregnancy rates in ART cycles?</TI>
<SO>Iranian Journal of Reproductive Medicine</SO>
<YR>2007</YR>
<VL>5</VL>
<NO>3</NO>
<PG>95-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Drakeley-2008" MODIFIED="2016-03-03 12:16:06 +1300" MODIFIED_BY="[Empty name]" NAME="Drakeley 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-02-27 21:05:08 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Drakeley A, Jorgensen A, Sklavounos J, Aust T, Gazvani R, Williamson P, et al</AU>
<TI>A randomized controlled clinical trial of 2295 ultrasound-guided embryo transfers</TI>
<SO>Human Reproduction</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>5</NO>
<PG>1101-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-03 12:16:06 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drakeley AJ, Lunt R, Aust T, Williamson P, Gazvani R, Sklavounos J, et al</AU>
<TI>A randomized trial of 2250 women having ultrasound guided embryo transfer</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>(suppl 1)</NO>
<PG>i82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eskander-2008" MODIFIED="2016-02-27 21:12:21 +1300" MODIFIED_BY="[Empty name]" NAME="Eskander 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-02-27 21:12:21 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eskandar M, Abou-Setta A, Almushait M, El-Amin M, Mohamad S</AU>
<TI>Ultrasound guidance during embryo transfer: a prospective, single-operator, randomized controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2008</YR>
<VL>90</VL>
<NO>4</NO>
<PG>1187-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_Velasco-2002" MODIFIED="2016-03-03 11:51:44 +1300" MODIFIED_BY="[Empty name]" NAME="Garcia-Velasco 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-03-03 11:51:44 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Velasco J, Isaza V, Martinez-Salazar J, Landazabal A, Requena A, Remohi J, et al</AU>
<TI>Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>78</VL>
<NO>3</NO>
<PG>534-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kosmas-2007" MODIFIED="2016-03-03 11:52:09 +1300" MODIFIED_BY="[Empty name]" NAME="Kosmas 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-03-03 11:52:09 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kosmas IP, Janssens R, De Munck L, Al Turki HF, Tournaye H, Van Steirteghem AC, et al</AU>
<TI>Ultrasound guidance during embryo transfer does not offer any benefit in clinical outcome: a randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2007</YR>
<VL>22</VL>
<NO>5</NO>
<PG>1327-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2005" NAME="Li 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li R, Lu L, Hao G, Zhong K, Cai Z, Wang W</AU>
<TI>Abdominal ultrasound guided embryo transfer improves clinical pregnancy rates after in vitro fertilization: experiences from 330 clinical investigations</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>1</NO>
<PG>3-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maldonado-2005" MODIFIED="2016-02-27 21:14:03 +1300" MODIFIED_BY="[Empty name]" NAME="Maldonado 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-27 21:14:03 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maldonado LG, Ajzen Sa, Busato WC, Iaconelli A Jr, Bibancos M, Borges E Jr</AU>
<TI>Impact of previous hysterosonometry on embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<VL>84</VL>
<PG>S364</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marconi-2003" MODIFIED="2016-02-27 21:15:10 +1300" MODIFIED_BY="[Empty name]" NAME="Marconi 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-02-27 21:15:10 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marconi G, Young E Jr, Vilela M, Bello A, Young E Sr, Sueldo C</AU>
<TI>Prospective randomized comparison of an ultrasound-guided embryo transfer versus a blind catheter placement</TI>
<SO>Fertility and Sterility</SO>
<YR>2003</YR>
<VL>80</VL>
<NO>suppl 3</NO>
<PG>S130</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Martins--2004" MODIFIED="2016-03-03 11:52:42 +1300" MODIFIED_BY="[Empty name]" NAME="Martins  2004" YEAR="2004">
<REFERENCE MODIFIED="2016-03-03 11:52:42 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martins A, Baruffi R, Mauri A, Petersen C, Oliveira J, Contart P, et al</AU>
<TI>Ultrasound guidance is not necessary during easy embryo transfers</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2004</YR>
<VL>21</VL>
<NO>12</NO>
<PG>421-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Matorras-2002" MODIFIED="2009-11-09 15:44:24 +1300" MODIFIED_BY="jane clarke" NAME="Matorras 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-09 15:44:24 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matorras R, Urquijo E, Mendoza R, Corcostegui B, Exposito A, Rodriguez-Escudero F</AU>
<TI>Ultrasound-guided embryo transfer improves pregnancy rates and increases the frequency of easy transfers</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>7</NO>
<PG>1762-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moraga_x002d_Sanchez--2004" MODIFIED="2016-03-03 12:24:27 +1300" MODIFIED_BY="[Empty name]" NAME="Moraga-Sanchez  2004" YEAR="2004">
<REFERENCE MODIFIED="2016-03-03 12:24:27 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moraga-Sanchez M, Llata E, Resendiz V, Haliscak R, Galache-Vega P, Ayup S, et al</AU>
<TI>Ultrasound influence and 30 second wait in embryo transfer</TI>
<SO>Human Reproduction</SO>
<YR>2004</YR>
<VL>19</VL>
<PG>i127</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tang-2001" MODIFIED="2016-02-27 21:17:51 +1300" MODIFIED_BY="[Empty name]" NAME="Tang 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-02-27 21:17:51 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tang O, Ng E, So W, Ho P</AU>
<TI>Ultrasound guided embryo transfer: a prospective randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>11</NO>
<PG>2310-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Weissman-2003" MODIFIED="2016-02-27 21:18:37 +1300" MODIFIED_BY="[Empty name]" NAME="Weissman 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-02-27 21:18:37 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weissman A, Farhi J, Steinfeld Z, Mustafi R, Nahum H, Levran D</AU>
<TI>A prospective randomized study of ultrasound-guided embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2003</YR>
<VL>80 (Suppl 1)</VL>
<PG>S122</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wisanto-1989" MODIFIED="2016-02-27 21:19:28 +1300" MODIFIED_BY="[Empty name]" NAME="Wisanto 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-02-27 21:19:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wisanto A, Janssens R, Desacht J, Camus M, Devroey P, Van Steirtegham AC</AU>
<TI>Performance of different embryo transfer catheters in a human in vitro fertilization program</TI>
<SO>Fertility and Sterility</SO>
<YR>1989</YR>
<VL>52</VL>
<NO>1</NO>
<PG>79-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zakova-2008" MODIFIED="2016-02-27 21:19:58 +1300" MODIFIED_BY="[Empty name]" NAME="Zakova 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-02-27 21:19:58 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zakova J, Crha L, Ventruba P, Lobsova E, Huser M</AU>
<TI>Does ultrasound-guided embryo transfer improve pregnancy rate in in vitro fertilization?</TI>
<SO>Human Reproduction</SO>
<YR>2008</YR>
<VL>23 (Supplement 1)</VL>
<PG>i135</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-03-03 12:33:46 +1300" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Shawaf-1993" MODIFIED="2009-11-10 12:06:27 +1300" MODIFIED_BY="jane clarke" NAME="Al-Shawaf 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-11-10 12:06:27 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Shawaf T, Yang D, Al-Magid Y, Seaton A, Iketubosin F, Craft I</AU>
<TI>Ultrasonic monitoring during replacement of frozen/thawed embryos in natural and hormone replacement cycles</TI>
<SO>Human Reproduction</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>12</NO>
<PG>2068-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Shawaf-1993b" MODIFIED="2016-02-27 21:20:49 +1300" MODIFIED_BY="[Empty name]" NAME="Al-Shawaf 1993b" YEAR="1993b">
<REFERENCE MODIFIED="2016-02-27 21:20:49 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Shawaf T, Dave R, Harper J, Linehan D, Riley P, Craft I</AU>
<TI>Transfer of embryos into the uterus: How much do technical factors affect pregnancy rates?</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1993</YR>
<VL>10</VL>
<NO>1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-2002" MODIFIED="2016-02-27 21:21:11 +1300" MODIFIED_BY="[Empty name]" NAME="Anderson 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-02-27 21:21:11 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson RE, Nugent NL, Gregg AT, Nunn SL, Behr BR</AU>
<TI>Transvaginal ultrasound-guided embryo transfer improves outcome in patients with previous failed in vitro fertilization cycles</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>77</VL>
<NO>4</NO>
<PG>769-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baba-2000" MODIFIED="2016-02-27 21:21:34 +1300" MODIFIED_BY="[Empty name]" NAME="Baba 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-02-27 21:21:34 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baba K, Ishihara O, Hayashi N, Saioh M, Taya J, Kinoshita K</AU>
<TI>Three dimensional ultrasound in embryo transfer</TI>
<SO>Ultrasound in Obsterics and Gynecology</SO>
<YR>2000</YR>
<VL>16</VL>
<PG>372-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Blake-1998" MODIFIED="2016-03-03 12:25:28 +1300" MODIFIED_BY="[Empty name]" NAME="Blake 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-03-03 12:25:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Blake</AU>
<TI>Unpublished</TI>
<SO>Personal communicaton</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bodri-2011" MODIFIED="2016-02-27 21:22:47 +1300" MODIFIED_BY="[Empty name]" NAME="Bodri 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-02-27 21:22:47 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bodri D, Colodron M, Garcia D, Obradors Am Vernaeve V, Coll O</AU>
<TI>Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2011</YR>
<VL>95</VL>
<NO>7</NO>
<PG>2263-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Broussin-1998" MODIFIED="2016-03-03 11:53:54 +1300" MODIFIED_BY="[Empty name]" NAME="Broussin 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-03-03 11:53:54 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Broussin B, Jayot S, Subtil D, Parneix I, Audebert A, Dubecq F, et al</AU>
<TI>Difficult embryo transfer: the ultrasonography contribution</TI>
<SO>Fertilite Contraception Sexualite</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>7-8</NO>
<PG>492-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coroleu-2002a" MODIFIED="2016-02-27 21:24:47 +1300" MODIFIED_BY="[Empty name]" NAME="Coroleu 2002a" YEAR="2002">
<REFERENCE MODIFIED="2009-11-09 15:47:13 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coroleu B, Barri PN, Carreras O, Martinez F, Parriego M, Hereter L, Parera N, Veiga A, Balasch J</AU>
<TI>The influence of the depth of embryo placement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>2</NO>
<PG>341-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cruickshank-2003" MODIFIED="2016-02-27 21:25:59 +1300" MODIFIED_BY="[Empty name]" NAME="Cruickshank 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-02-27 21:25:59 +1300" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cruickshank B, Fasciani A, Di Berardino A, Hannam TG, Casper RF, Greenblatt E</AU>
<TI>The ultrasound guided embryo transfer significantly increases the ongoing pregnancy rates when a 'laminar flow' pattern is observed</TI>
<SO>Human Reproduction</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>(Suppl 1) Issue 6</NO>
<PG>Xviii6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deep-2013" MODIFIED="2015-09-22 15:05:18 +1200" MODIFIED_BY="[Empty name]" NAME="Deep 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-09-22 15:05:18 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deep JP, Li Y, Liu H</AU>
<TI>The effect of embryo transfer on IVF treatment: Comparing the trans-vaginal versus transabdominal ultrasound approach</TI>
<SO>Journal of Minimally Invasive Gynecology</SO>
<YR>2013</YR>
<VL>1</VL>
<PG>S42-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Englert--1986" MODIFIED="2016-02-27 21:27:22 +1300" MODIFIED_BY="[Empty name]" NAME="Englert  1986" YEAR="1986">
<REFERENCE MODIFIED="2016-02-27 21:27:22 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Englert Y, Puissant F, Camus M, Van Hoeck J, Leroy F</AU>
<TI>Clinical study on embryo transfer after human in vitro fertilisation</TI>
<SO>Journal of In Vitro Fertilization and Embryo Transfer</SO>
<YR>1986</YR>
<VL>3</VL>
<NO>4</NO>
<PG>243-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eskander-2007" MODIFIED="2016-02-27 21:27:45 +1300" MODIFIED_BY="[Empty name]" NAME="Eskander 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-02-27 21:27:45 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eskander M, Abou-Setta A</AU>
<TI>Ultrasound-guided embryo transfer is superior to clinical touch alone: A single operator randomized controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>88 (suppl 1)</VL>
<PG>S326-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faure-1998" MODIFIED="2016-03-03 12:26:22 +1300" MODIFIED_BY="[Empty name]" NAME="Faure 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-03-03 12:26:22 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faure JM, Dechaud H, Deschamps F, Arnal F, Humeau C, Hedon B</AU>
<TI>Ultrasound guided embryo transfer. Effects on implantation and pregnancy rates</TI>
<SO>Fertility and Sterility</SO>
<YR>1998</YR>
<PG>S26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flisser-2006" MODIFIED="2016-02-27 21:29:39 +1300" MODIFIED_BY="[Empty name]" NAME="Flisser 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-02-27 21:29:39 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flisser E, Grifo JA, Krey L, Noyes N</AU>
<TI>Transabdominal ultrasound-assisted embryo transfer and pregnancy outcome</TI>
<SO>Fertility and Sterility</SO>
<YR>2006</YR>
<VL>85</VL>
<NO>2</NO>
<PG>353-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia_x002d_Velasco-2001" MODIFIED="2016-02-27 21:30:16 +1300" MODIFIED_BY="[Empty name]" NAME="Garcia-Velasco 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-02-27 21:30:16 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Velasco J, Martinez-Salazar J, Isaza A, Landazabal A, Requena A, Simon C</AU>
<TI>Does ultrasound guidance at embryo transfers improve pregnancy rates in oocyte recipients?</TI>
<SO>Fertility and Sterility</SO>
<YR>2001</YR>
<VL>76</VL>
<PG>75-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garzo-2006" MODIFIED="2009-11-09 15:47:46 +1300" MODIFIED_BY="jane clarke" NAME="Garzo 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-09 15:47:46 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garzo G</AU>
<TI>Embryo transfer technique</TI>
<SO>Clinical Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>49</VL>
<NO>1</NO>
<PG>117-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gergely-2005" MODIFIED="2016-02-27 21:31:58 +1300" MODIFIED_BY="[Empty name]" NAME="Gergely 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-27 21:31:58 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gergely R, DeUgarte C, Danzer H, Surrey M, Hill D, DeCherney A</AU>
<TI>Three dimensional/four dimensional ultrasound-guided embryo transfer using the maximal implantation potential point</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<VL>84</VL>
<NO>2</NO>
<PG>500-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghazzawi-1999" MODIFIED="2009-11-09 15:47:58 +1300" MODIFIED_BY="jane clarke" NAME="Ghazzawi 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-11-09 15:47:58 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghazzawi I, Hassani S, Karaki R, Souso S</AU>
<TI>Transfer technique and catheter choice influence the incidence of transcervical embryo expulsion and the outcome of IVF</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>3</NO>
<PG>677-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hauzman-2012" MODIFIED="2016-02-27 21:32:44 +1300" MODIFIED_BY="[Empty name]" NAME="Hauzman 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-02-27 21:32:44 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hauzman E, Kohls G, Barrio A, Martinez Salazar J, Iglesias C, Garcia-Velasco JA</AU>
<TI>Comparison of embryo transfer in egg donation recipients with transvaginal and transabdominal ultrasound: A randomized pilot study</TI>
<SO>Human Reproduction</SO>
<YR>2013</YR>
<VL>28</VL>
<PG>i241</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hurley-1991" MODIFIED="2009-11-09 15:48:04 +1300" MODIFIED_BY="jane clarke" NAME="Hurley 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-11-09 15:48:04 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hurley V, Osborn J, Leoni M, Leeton J</AU>
<TI>Ultrasound-guided embryo transfer: a controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>1991</YR>
<VL>55</VL>
<NO>3</NO>
<PG>559-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kan-1999" MODIFIED="2009-11-09 15:48:10 +1300" MODIFIED_BY="jane clarke" NAME="Kan 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-11-09 15:48:10 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kan AKS, Abdalla HI, Gafar AH, Nappi L, Ogunyemi BO, Thomas A, Ola-ojo OO</AU>
<TI>Embryo transfer: ultrasound-guided versus clinical touch</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>5</NO>
<PG>1259-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karande-2002" MODIFIED="2009-11-09 15:48:17 +1300" MODIFIED_BY="jane clarke" NAME="Karande 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-09 15:48:17 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karande V, Hazlett D, Vietzke M, Cleicher N</AU>
<TI>A prospective randomized comparison of the Wallace catheter and the Cook Echo-Tip catheter for ultrasound guided embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>77</VL>
<NO>4</NO>
<PG>826-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kojima-2001" MODIFIED="2009-11-09 15:48:28 +1300" MODIFIED_BY="jane clarke" NAME="Kojima 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-09 15:48:28 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kojima K, Nomiyama M, Kumamoto T, Matsmoto Y, Iwasaka T</AU>
<TI>Transvaginal ultrasound guided embryo transfer improves pregnancy and implantation rates after IVF</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>12</NO>
<PG>2578-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kolankaya-2001" MODIFIED="2016-03-03 12:33:46 +1300" MODIFIED_BY="[Empty name]" NAME="Kolankaya 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-03-03 12:33:46 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kolankaya A, Enginsu ME, Camlibel TF, Sarikamis B, Kurt E, Yildiz K, Hunerli C</AU>
<TI>Ultrasound guided embryo transfer improves pregnancy rates</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>(Suppl 1)</NO>
<PG>155</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kosmas-2006a" MODIFIED="2016-03-03 11:54:49 +1300" MODIFIED_BY="[Empty name]" NAME="Kosmas 2006a" YEAR="2006">
<REFERENCE MODIFIED="2016-03-03 11:54:49 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kosmas IP, Janssens R, De Munck L, Al Turki HF, Tournaye H, Van Steirteghem AC, et al</AU>
<TI>Ultrasound guidance during embryo transfer does not offer any benefit in clinical outcome: a randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>6</NO>
<PG>i101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kreiner-2000" MODIFIED="2016-03-03 11:55:11 +1300" MODIFIED_BY="[Empty name]" NAME="Kreiner 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-03-03 11:55:11 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kreiner D, Moschella J, Carlson N, Jelicks J, Bolkas M, Moodie G, et al</AU>
<TI>Pregnancy rates of a two step ultrasound guided embryo transfer 1-112 cm from the top of the uterine cavity</TI>
<SO>Fertility and Sterility</SO>
<YR>2000</YR>
<VL>74</VL>
<NO>3 (suppl 1)</NO>
<PG>S206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenz-1987a" MODIFIED="2016-02-27 21:39:49 +1300" MODIFIED_BY="[Empty name]" NAME="Lenz 1987a" YEAR="1987">
<REFERENCE MODIFIED="2016-02-27 21:39:09 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenz S, Leeton J, Rogers P, Trouson A</AU>
<TI>Transfundal transfer of embryos using ultrasound</TI>
<SO>Journal of In Vitro Fertilization and Embryo Transfer</SO>
<YR>1987</YR>
<VL>4</VL>
<NO>1</NO>
<PG>13-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lenz-1987b" MODIFIED="2016-02-27 21:40:06 +1300" MODIFIED_BY="[Empty name]" NAME="Lenz 1987b" YEAR="1987b">
<REFERENCE MODIFIED="2016-02-27 21:40:06 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lenz S, Leeton J</AU>
<TI>Evaluating the possibility of uterine transfer by ultrasonically guided transabdominal puncture</TI>
<SO>Journal of In Vitro Fertilization and Embryo Transfer</SO>
<YR>1987</YR>
<VL>4</VL>
<NO>1</NO>
<PG>18-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leong-1986" MODIFIED="2016-02-27 21:40:40 +1300" MODIFIED_BY="[Empty name]" NAME="Leong 1986" YEAR="1986">
<REFERENCE MODIFIED="2016-02-27 21:40:40 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leong M, Leung C, Tucker M, Wong C, Chan H</AU>
<TI>Ultrasound assisted embryo transfer</TI>
<SO>Journal of In Vitro Fertilization and Embryo Transfer</SO>
<YR>1986</YR>
<VL>3</VL>
<NO>6</NO>
<PG>383-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lesny-1998" MODIFIED="2016-02-27 21:41:31 +1300" MODIFIED_BY="[Empty name]" NAME="Lesny 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-02-27 21:41:31 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lesny P, Killick SR, Tetlow RL, Robinson J, Maguiness SD</AU>
<TI>Embryo transfer - can we learn anything new from the observation of junctional zone contractions?</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>6</NO>
<PG>1540-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Letterie-2005" MODIFIED="2016-02-27 21:41:57 +1300" MODIFIED_BY="[Empty name]" NAME="Letterie 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-27 21:41:57 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Letterie GS</AU>
<TI>Three-dimensional ultrasound-guided embryo transfer: A preliminary study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>192</VL>
<PG>1983-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindheim-1999" MODIFIED="2016-02-27 21:42:23 +1300" MODIFIED_BY="[Empty name]" NAME="Lindheim 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-02-27 21:42:23 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindheim SR, Cohen MA, Sauer MV</AU>
<TI>Ultrasound guided embryo transfer significantly improves pregnancy rates in women undergoing oocyte donation</TI>
<SO>International Journal of Gynecology and Obstetrics</SO>
<YR>1999</YR>
<VL>66</VL>
<PG>281-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lorusso-2005" MODIFIED="2009-11-09 16:33:44 +1300" MODIFIED_BY="jane clarke" NAME="Lorusso 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-09 16:33:44 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorusso F, Depalo R, Bettocchi S, Vacca M, Vimercati A, Selvaggi L</AU>
<TI>Outcome of in vitro fertilization after transabdominal ultrasound-assisted embryo transfer with a full or empty bladder</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<VL>84</VL>
<NO>4</NO>
<PG>1046-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinez-2001" MODIFIED="2009-11-09 16:33:55 +1300" MODIFIED_BY="jane clarke" NAME="Martinez 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-09 16:33:55 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez F, Coroleu B, Parriego M, Carreras O, Belil I, Parera N, Hereter L, Buxaderas R, Barri PN</AU>
<TI>Ultrasound-guided embryo transfer: immediate withdrawal of the catheter versus a 30 second wait</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>5</NO>
<PG>871-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parsons-1987" MODIFIED="2009-11-09 15:50:24 +1300" MODIFIED_BY="jane clarke" NAME="Parsons 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-11-09 15:50:24 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parsons JH, Bolton VN, Wilson L, Campbell S</AU>
<TI>Pregnancies following in vitro fertilization and ultrasound-directed surgical embryo transfer by perurethral and transvaginal techniques</TI>
<SO>Fertility and Sterility</SO>
<YR>1987</YR>
<VL>48</VL>
<NO>4</NO>
<PG>691-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porat-2010" MODIFIED="2015-09-22 15:05:52 +1200" MODIFIED_BY="[Empty name]" NAME="Porat 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-09-22 15:05:52 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porat N, Boehnlein LM, Schouweiler CM, Kang J, Lindheim SR</AU>
<TI>Interim analysis of a randomized clinical trial comparing abdominal versus transvaginal ultrasound-guided embryo transfer</TI>
<SO>The Journal of Obstetrics and Gynaecology Research</SO>
<YR>2010</YR>
<VL>36</VL>
<NO>2</NO>
<PG>384-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prapas-1995" MODIFIED="2016-03-03 11:56:28 +1300" MODIFIED_BY="[Empty name]" NAME="Prapas 1995" YEAR="1995">
<REFERENCE MODIFIED="2016-03-03 11:56:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prapas Y, Prapas N, Hatziparasidou A, Prapa S, Nijs M, Vanderzwalmen P, et al</AU>
<TI>The echoguide embryo transfer maximises the IVF results</TI>
<SO>Acta Europaea Fertilitatis</SO>
<YR>1995</YR>
<VL>26</VL>
<NO>3</NO>
<PG>113-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prapas-2001" MODIFIED="2016-03-03 11:56:37 +1300" MODIFIED_BY="[Empty name]" NAME="Prapas 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-03-03 11:56:37 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prapas Y, Prapas N, Hatziparasidou A, Vanderzwalmen P, Nijs M, Prapa S, et al</AU>
<TI>Ultrasound-guided embryo transfer maximizes the IVF results on day 3 and day 4 embryo transfer but has no impact on day 5</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>9</NO>
<PG>1904-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saharkhiz-2014" MODIFIED="2015-09-22 15:06:00 +1200" MODIFIED_BY="[Empty name]" NAME="Saharkhiz 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-09-22 15:06:00 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saharkhiz N, Nikbakht R, Salehpour S</AU>
<TI>Comparison between conventional blind embryo transfer and embryo transfer based on previously measured uterine length</TI>
<SO>International Journal of Fertility and Sterility</SO>
<YR>2014</YR>
<VL>8</VL>
<NO>3</NO>
<PG>249-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sallam-2001" NAME="Sallam 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sallam H, Agameya A, Rahman A, Ezzeldin F, Sallam A</AU>
<TI>Ultrasound measurement of the uterocervical angle before embryo transfer: a prospective controlled study</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>abstract book 1</NO>
<PG>126</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sallam-2002a" MODIFIED="2016-02-27 21:51:43 +1300" MODIFIED_BY="[Empty name]" NAME="Sallam 2002a" YEAR="2002b">
<REFERENCE MODIFIED="2016-02-27 21:51:43 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sallam HN, Agameya AF, Rahman AF, Ezzeldin F, Sallam AN</AU>
<TI>Ultrasound measurement of the uterocervical angle before embryo transfer: a prospective controlled study</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>7</NO>
<PG>1767-772</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sasy-2003" MODIFIED="2016-03-03 11:56:44 +1300" MODIFIED_BY="[Empty name]" NAME="Sasy 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-03-03 11:56:44 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sasy M, Salem W, Fattah A, Ashraf M, Abozaid T, Khan I, et al</AU>
<TI>Comparison between ultrasound-guided embryo transfer and tubal embryo transfer after intracytoplasmic sperm injection</TI>
<SO>Middle East Fertility Society Journal</SO>
<YR>2003</YR>
<VL>8</VL>
<NO>3</NO>
<PG>223-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholtes-1994" MODIFIED="2016-02-27 21:53:12 +1300" MODIFIED_BY="[Empty name]" NAME="Scholtes 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-02-27 21:53:12 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scholtes M, Roozenburg B, Verhoeff, Zeilmaker G</AU>
<TI>A randomised trial of transcervical intrafallopian transfer of pronucleate embryos controlled by ultrasound versus intrauterine transfer of four to eight cell embryos</TI>
<SO>Fertility and Sterility</SO>
<YR>1994</YR>
<VL>61</VL>
<NO>1</NO>
<PG>102-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shamonki-2005" MODIFIED="2009-11-09 16:35:18 +1300" MODIFIED_BY="jane clarke" NAME="Shamonki 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-09 16:35:18 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shamonki MI, Spandorfer SD, Rosenwaks Z</AU>
<TI>Ultrasound-guided embryo transfer and the accuracy of trial embryo transfer</TI>
<SO>Human Reproduction</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>3</NO>
<PG>709-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silberstein-2005" MODIFIED="2016-02-27 21:54:16 +1300" MODIFIED_BY="[Empty name]" NAME="Silberstein 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-27 21:54:16 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silberstein T, Trimarchi JR, Shackelton R, Weitzen S, Frankfurter D, Plosker S</AU>
<TI>Ultrasound guided mid-uterine cavity embryo transfer is associated with a decreased incidence of retained embryos in the transfer catheter</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<VL>84</VL>
<NO>5</NO>
<PG>1510-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strickler-1985" MODIFIED="2016-02-27 21:56:19 +1300" MODIFIED_BY="[Empty name]" NAME="Strickler 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-02-27 21:56:19 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strickler RC, Christianson C, Crane JP, Curato A, Knight AB, Yang V</AU>
<TI>Ultrasound guidance for human embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>1985</YR>
<VL>43</VL>
<NO>1</NO>
<PG>54-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-2000" MODIFIED="2016-02-27 21:56:45 +1300" MODIFIED_BY="[Empty name]" NAME="Wood 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-02-27 21:56:45 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood EG, Batzer F, Go KJ, Gutmann JN, Corson SL</AU>
<TI>Ultrasound-guided soft catheter embryo transfers will improve pregnancy rates in in-vitro fertilization</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>1</NO>
<PG>107-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woolcott-1997" MODIFIED="2016-02-27 21:56:56 +1300" MODIFIED_BY="[Empty name]" NAME="Woolcott 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-02-27 21:56:56 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woolcott R, Stanger J</AU>
<TI>Potentially important variables identified by transvaginal ultrasound-guided embryo transfer</TI>
<SO>Human Reproduction</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>5</NO>
<PG>963-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yovich-1985" MODIFIED="2016-02-27 21:57:22 +1300" MODIFIED_BY="[Empty name]" NAME="Yovich 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-02-27 21:57:22 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yovich J, Turner S, Murphy A</AU>
<TI>Embryo transfer technique as a cause of ectopic pregnancies in in-vitro fertilization</TI>
<SO>Fertility and Sterility</SO>
<YR>1985</YR>
<VL>44</VL>
<NO>3</NO>
<PG>318-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-12-10 07:29:03 +1300" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-03-04 13:06:54 +1300" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_REFERENCES MODIFIED="2016-03-03 11:57:46 +1300" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abou_x002d_Setta-2007" MODIFIED="2016-01-27 14:34:53 +1300" MODIFIED_BY="[Empty name]" NAME="Abou-Setta 2007" TYPE="JOURNAL_ARTICLE">
<AU>Abou-Setta AM, Mansour RT, Al-Inany HG, Aboulghar MM, Aboulghar MA, Serour GI</AU>
<TI>Among women undergoing embryo transfer is the probability of pregnancy and live birth improved with ultrasound guidance over clinical touch alone? A systematic review and meta-analysis of prospective randomised controlled trials</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>88</VL>
<NO>2</NO>
<PG>333-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fanchin-1998" MODIFIED="2016-02-27 21:58:49 +1300" MODIFIED_BY="[Empty name]" NAME="Fanchin 1998" TYPE="JOURNAL_ARTICLE">
<AU>Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R</AU>
<TI>Uterine contractions at the time of embryo transfer alter pregnancy rates after in vitro fertilization</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<PG>1968-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT" MODIFIED="2016-02-27 22:00:05 +1300" MODIFIED_BY="[Empty name]" NAME="GRADEpro GDT" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT: GRADEpro Guideline Development Tool</TI>
<YR>2015</YR>
<PB>McMaster University (developed by Evidence Prime Inc). Available from gradepro.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-02-27 22:02:59 +1300" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins J, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kovacs-1999" MODIFIED="2009-11-09 16:50:38 +1300" MODIFIED_BY="jane clarke" NAME="Kovacs 1999" TYPE="JOURNAL_ARTICLE">
<AU>Kovacs GT</AU>
<TI>What factors are important for successful embryo transfer after in-vitro fertilization?</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>590-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2016-03-03 11:25:46 +1300" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sallam-2002" MODIFIED="2016-02-27 22:04:17 +1300" MODIFIED_BY="[Empty name]" NAME="Sallam 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sallam HN, Saad-el-Din S</AU>
<TI>Performing embryo transfer under ultrasound guidance - A meta analysis of randomized trials</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>78</VL>
<NO>3 (Suppl 1)</NO>
<PG>S46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steptoe-1978" MODIFIED="2016-02-27 22:04:33 +1300" MODIFIED_BY="[Empty name]" NAME="Steptoe 1978" TYPE="JOURNAL_ARTICLE">
<AU>Steptoe PC, Edwards RG</AU>
<TI>Birth after the reimplantation of a human embryo</TI>
<SO>The Lancet</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>366</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Teixeira-2015" MODIFIED="2016-03-03 11:57:46 +1300" MODIFIED_BY="[Empty name]" NAME="Teixeira 2015" TYPE="JOURNAL_ARTICLE">
<AU>Teixeira DM, Dassuncao LA, Vieira CV, Barbosa MA, Coelho Neto MA, Nastri CO, et al</AU>
<TI>Ultrasound guidance during embryo transfer: a systemtic review and meta-analysis of randomised controlled trials</TI>
<SO>Ultrasound in Obstetrics and Gynecology</SO>
<YR>2015</YR>
<VL>45</VL>
<NO>2</NO>
<PG>139-48</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-03-04 13:06:54 +1300" MODIFIED_BY="Helen E Nagels">
<REFERENCE ID="REF-Brown-2010" MODIFIED="2016-03-04 13:06:52 +1300" MODIFIED_BY="Helen E Nagels" NAME="Brown 2010" TYPE="COCHRANE_REVIEW">
<AU>Brown J, Buckingham K, Abou-Setta AM, Buckett W</AU>
<TI>Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2016-03-04 13:06:00 +1300" MODIFIED_BY="Helen E Nagels">
<IDENTIFIER MODIFIED="2016-03-04 13:06:00 +1300" MODIFIED_BY="Helen E Nagels" TYPE="DOI" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-03-03 13:44:38 +1300" MODIFIED_BY="Helen E Nagels">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-03-03 13:44:38 +1300" MODIFIED_BY="Helen E Nagels" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-03-03 13:43:30 +1300" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Ammar-2013">
<CHAR_METHODS MODIFIED="2015-06-25 14:27:47 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial, single centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-03 13:43:30 +1300" MODIFIED_BY="Helen E Nagels">
<P>90 infertile women from Egypt</P>
<P>Inclusion criteria: Women undergoing ICSI. Age 20 to 39 years, male factor infertility, ovarian factor, and unexplained infertility</P>
<P>Exclusion criteria: Tubal factor infertility, endometriosis, FSH concentration &gt; 16 IU/mL on cycle day 3, less than 2 embryos grade A, difficult embryo transfer that needs cervical dilatation, tenaculum, or anaesthesia</P>
<P>Setting: Maternity hospital, Egypt</P>
<P>Timing: September 2009 to August 2011</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 17:58:03 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer</P>
<P>Clinical touch</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 17:58:43 +1300" MODIFIED_BY="[Empty name]">
<P>Primary outcomes were not prespecified. Outcomes listed as clinical pregnancy, ongoing pregnancy, and miscarriage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-25 14:27:43 +1200" MODIFIED_BY="[Empty name]">
<P>Sample size calculation - Not reported</P>
<P>ITT analysis - Yes</P>
<P>Funding - No details of funding reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-03 13:44:25 +1300" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Azmy-2009">
<CHAR_METHODS MODIFIED="2015-06-25 14:28:06 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-03 13:44:25 +1300" MODIFIED_BY="Helen E Nagels">
<P>853 women undergoing ICSI</P>
<P>Inclusion: &lt; 38 years, &#8804; BMI 30 kg/m<SUP>2</SUP>, basal FSH &#8804; 12 IU/mL, embryo quality was &#8805; grade B on day 3 and number of fresh embryos replaced was &#8804; 3</P>
<P>Setting: ART unit in Cairo, Egypt</P>
<P>Timing: Not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:05:57 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 435)</P>
<P>versus</P>
<P>Clinical touch (n = 418)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-25 14:28:06 +1200" MODIFIED_BY="[Empty name]">
<P>Live birth, other outcomes were not prespecified but ease of transfer, implantation rate, miscarriage rate, multiple pregnancy rate, ectopic pregnancy rate, preterm birth, chemical pregnancy rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 18:06:18 +1300" MODIFIED_BY="[Empty name]">
<P>No power calculation</P>
<P>ITT analysis: All women randomised appear to be analysed</P>
<P>Funding - no details</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 18:08:43 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bar-Hava-2003">
<CHAR_METHODS MODIFIED="2016-02-26 18:07:22 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial, no details of randomisation method. No details of allocation concealment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 18:08:16 +1300" MODIFIED_BY="[Empty name]">
<P>131 women participating in this Israeli study attending an IVF programme. Age 31 +/- 5.5 for UGET and 33.2 +/- 6.0 for clinical touch. No details of inclusion or exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:08:37 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 65) versus clinical touch (n = 66)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pregnancy and implantation rates</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 18:08:43 +1300" MODIFIED_BY="[Empty name]">
<P>Unable to extract pregnancy data directly from abstract, authors contacted and awaiting response</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-03 13:44:38 +1300" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Chen-2007">
<CHAR_METHODS MODIFIED="2016-02-26 18:09:13 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised by means of a computer-generated random number sequence</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-03 13:44:38 +1300" MODIFIED_BY="Helen E Nagels">
<P>50 women undergoing IVF in Taiwan</P>
<P>Inclusion: At least 1 grade 2 embryo available for transfer; embryo to be transferred at the 8-cell stage</P>
<P>Exclusion: Woman age &#8805; 40 years; cleaved embryos with less than 8 cells; patient history of 3 previous failed assisted conception cycles; anticipated difficulty in the transfer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-17 13:48:25 +1300" MODIFIED_BY="Julie A Brown">
<P>UGET = 27 women</P>
<P>Clinical touch = 23 women</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-17 13:48:28 +1300" MODIFIED_BY="Julie A Brown">
<P>Clinical pregnancy </P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-17 13:46:30 +1300" MODIFIED_BY="Julie A Brown">
<P>Clinical pregnancy confirmed by ultrasound scan showing at least 1 sac in the uterine cavity 2 weeks after the positive pregnancy test</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-03 11:34:52 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coroleu-2000">
<CHAR_METHODS MODIFIED="2016-02-26 18:13:43 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. No details of randomisation procedure</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-03 11:34:52 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Spain. 362 women on the IVF embryo transfer programme<BR/>Mean age 34.6 +/- 4.0 (UGET), 34.5 +/- 4.1 (clinical touch)<BR/>Main causes of infertility were male and tubal for both UGET and clinical touch groups. No details on duration of infertility<BR/>No details of exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:14:59 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 182) versus clinical touch (n = 180)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Embryos retrieved and transferred, pregnancy rate, ongoing pregnancies, pregnancy by embryos transferred, ease of transfer, number of clinical pregnancies, implantation rate, adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 18:24:48 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coroleu-2002">
<CHAR_METHODS MODIFIED="2016-02-26 18:18:52 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomised on day of transfer using computer-generated randomisation table</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 18:24:14 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Spain. 184 women<BR/>Inclusion: on the IVF embryo transfer programme who had their own cryopreserved pre-embryos<BR/>Exclusion: Oocyte donation cycles were excluded<BR/>Mean age: 36.6 +/- 3.4 (UGET), 36.2 +/- 3.0 (clinical touch)<BR/>Main causes of infertility were male and tubal for both UGET and clinical touch groups Duration of infertility was 6.0 +/- 2.3 years for UGET, 5.6 +/- 1.8 years for clinical touch</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:24:26 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 93) versus clinical touch (n = 91)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 18:24:48 +1300" MODIFIED_BY="[Empty name]">
<P>Embryos retrieved and replaced, ease of transfer, clinical pregnancies, implantation rate, adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 18:28:29 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Davar-2007">
<CHAR_METHODS MODIFIED="2015-06-25 11:03:24 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial, single centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 18:28:05 +1300" MODIFIED_BY="[Empty name]">
<P>180 infertile women (20 to 39 years) undergoing treatment with IVF and ICSI. Only first embryo transfers were included</P>
<P>No other details of inclusion or exclusion</P>
<P>Setting: Centre for Infertility, Yazd, Iran</P>
<P>Timing: 2005 to 2006</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:28:29 +1300" MODIFIED_BY="[Empty name]">
<P>Fresh embryos transferred in all women</P>
<P>Transabdominal ultrasound-guided embryo transfer with full bladder (n = 90)</P>
<P>versus</P>
<P>Clinical touch embryo transfer (n = 90)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-09-17 12:07:33 +1200" MODIFIED_BY="Julie A Brown">
<P>Ease of transfer, clinical pregnancy, ongoing pregnancy, implantation rate, number of embryos transferred, miscarriage rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-26 13:19:15 +1200" MODIFIED_BY="[Empty name]">
<P>Sample size calculation - no details</P>
<P>ITT analysis - data available for all women randomised</P>
<P>No details on funding</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 18:58:40 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Drakeley-2008">
<CHAR_METHODS MODIFIED="2015-05-26 13:36:12 +1200" MODIFIED_BY="[Empty name]">
<P> Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 18:31:49 +1300" MODIFIED_BY="[Empty name]">
<P>No details of inclusion or exclusion</P>
<P>No details of mean age or main reasons for or duration of infertility</P>
<P>Setting : Women attending a centre for reproductive medicine in the UK</P>
<P>Timing: February 2003 to May 2005</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:33:35 +1300" MODIFIED_BY="[Empty name]">
<P>Some women had more than 1 attempt at embryo transfer during the trial, therefore we used the data for first attempts only, as this reflects per woman randomised</P>
<P>Ultrasound-guided embryo transfer = 834</P>
<P>Clinical touch = 816</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 18:34:46 +1300" MODIFIED_BY="[Empty name]">
<P>Biochemical and clinical pregnancy and live birth; blood on catheter tip; ease of transfer; types of catheter</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 18:58:40 +1300" MODIFIED_BY="[Empty name]">
<P>Biochemical pregnancy defined as positive beta-hCG, clinical pregnancy defined as the observation of foetal heart on ultrasound at 7 weeks gestation</P>
<P>Sample size calculation - Yes based on pregnancy rates</P>
<P>ITT analysis - Yes</P>
<P>Funding - UK government, NHS</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:00:09 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eskander-2008">
<CHAR_METHODS MODIFIED="2016-02-26 18:54:18 +1300" MODIFIED_BY="[Empty name]">
<P>Randomisation was performed using dark, sealed envelopes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 18:54:41 +1300" MODIFIED_BY="[Empty name]">
<P>373 women undergoing embryo transfer in an assisted reproduction unit in Saudi Arabia</P>
<P>Inclusion: Criteria not specified. Authors note that they used broad criteria so as to truly represent the patient population</P>
<P>Exclusion: No details</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 18:54:55 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 183) versus clinical touch (n = 190)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 18:55:31 +1300" MODIFIED_BY="[Empty name]">
<P>Live birth, ongoing pregnancy, clinical pregnancy rates per woman randomised</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 19:00:09 +1300" MODIFIED_BY="[Empty name]">
<P>Live birth - delivery of living foetus after &gt; 28 weeks</P>
<P>Clinical pregnancy - positive hCG measurement 2 weeks after transfer and viable gestational sac with foetal heartbeat at 3 weeks on ultrasound</P>
<P>Ongoing pregnancy - &gt; 14 weeks gestation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:03:07 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<CHAR_METHODS>
<P>Prospective randomised trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:02:30 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Spain on 374 infertile women<BR/>Mean age UGET 37.8 +/- 0.3, mean age clinical touch 38.2 +/- 0.4<BR/>Main causes of infertility were male and age-related factors. No details on duration of infertility<BR/>Inclusion: Recipients of oocyte donation programme and be undergoing embryo transfer of good-quality embryos</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:02:47 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 187) versus clinical touch (n = 187)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 19:03:07 +1300" MODIFIED_BY="[Empty name]">
<P>Embryos transferred, clinical pregnancies, implantation rate, adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-03 11:35:58 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kosmas-2007">
<CHAR_METHODS MODIFIED="2016-02-26 19:04:11 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomisation was computer generated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-03 11:35:58 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Belgium on 196 women. Women undergoing IVF or ICSI. Aged less than 40 years who had undergone fresh, non-donor embryo transfer. BMI 20 to 30 kg/m<SUP>2</SUP>. Women with previous cervical surgery for cervical intraepithelial neoplasia excluded. Mean age UGET 32.05 +/- 4.31 years, clinical touch group 32.31 +/- 3.92 years. Over 80% of women were undergoing ICSI</P>
<P>Mean duration of infertility for the UGET group was 3.19 +/- 2.25 years, and the main cause of infertility was male factor (54%). Mean duration of infertility for the clinical touch group was 3.37 +/- 2.67 years, and the main cause of infertility was male factor (65.3%)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:11:16 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 150)</P>
<P>Clinical touch embryo transfer (n = 150)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 19:11:45 +1300" MODIFIED_BY="[Empty name]">
<P>Embryos transferred, implantation rates and pregnancy rates, adverse events, difficulty of transfer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 19:15:06 +1300" MODIFIED_BY="[Empty name]">
<P>Pregnancy rate - rising hCG level 2 weeks after embryo transfer</P>
<P>Clinical pregnancy - pregnancy sac with a positive heartbeat at 7-week scan</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:19:54 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2005">
<CHAR_METHODS MODIFIED="2016-02-26 19:17:15 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomly divided on day of transfer</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:19:40 +1300" MODIFIED_BY="[Empty name]">
<P>330 infertile Chinese women<BR/>Mean age UGET group 32.2 +/- 3.9 years, clinical touch group 32.5 +/- 4.2<BR/>Main cause of infertility was tubal and male factors in both groups, duration of infertility was 5.8 +/- 2.1 years for UGET and 5.6 +/- 1.6 years for clinical touch<BR/>Inclusion: 28 to 41 years of age undergoing treatment with IVF (including ICSI)<BR/>No details of exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:19:54 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 178) versus clinical touch (n = 152)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Embryos transferred, clinical pregnancies, implantation rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:21:27 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maldonado-2005">
<CHAR_METHODS MODIFIED="2015-09-22 15:00:33 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:21:21 +1300" MODIFIED_BY="[Empty name]">
<P>26 Brazilian women</P>
<P>Inclusion criteria: Women attending clinic for infertility</P>
<P>Exclusion criteria: No details</P>
<P>Setting: Fertility centre in Brazil</P>
<P>Timing: Not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:21:27 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer no hysterosonometry (n = 13)</P>
<P>versus</P>
<P>Hysterosonometry followed by clinical touch embryo transfer (n = 13)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-09-22 15:00:33 +1200" MODIFIED_BY="[Empty name]">
<P>Not prespecified in the conference abstract</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-09-22 15:00:33 +1200" MODIFIED_BY="[Empty name]">
<P>Sample size calculation - No</P>
<P>ITT analysis - Unclear as conference abstract</P>
<P>Funding - Not reported in abstract</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:26:22 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marconi-2003">
<CHAR_METHODS>
<P>Prospective randomised trial. No details of randomisation method or allocation concealment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:26:22 +1300" MODIFIED_BY="[Empty name]">
<P>Argentinian study of 83 women undergoing IVF treatment at a university-affiliated IVF unit. All women were under the age of 38 and day 3 FSH &lt; 12 IU/mL, mean age UGET 31.8 +/- 2.67, clinical touch group 32.5 +/- 3.88. No details on exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:24:32 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 41) versus clinical touch (n = 42)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pregnancy rate, ongoing pregnancy rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:27:34 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martins--2004">
<CHAR_METHODS MODIFIED="2016-02-26 19:25:32 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomisation was done by drawing lots using a randomisation table on the day of oocyte retrieval</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:27:08 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Brazil on 100 women participating in an ICSI program who were submitted to mock transfer during a cycle preceding the process and were considered likely to have an easy transfer<BR/>No exclusion details<BR/>Mean age UGET group 32.1 +/- 4.1, mean age clinical touch group 32.0 +/- 3.2<BR/>No details on cause or duration of infertility</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:27:28 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 50) versus clinical touch (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 19:27:34 +1300" MODIFIED_BY="[Empty name]">
<P>Embryos transferred, clinical pregnancies, implantation rate, abortion rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:31:28 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matorras-2002">
<CHAR_METHODS MODIFIED="2016-02-26 19:30:04 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomisation was computer-generated random table, took place on the morning of embryo transfer</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:31:10 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in Spain on 515 women<BR/>Inclusion: less than 40 years of age undergoing IVF<BR/>Exclusion: cryopreserved embryos, oocyte donation, ICSI<BR/>Mean age 33.98 +/- 3.12 (UGET), 34.21 +/- 2.98 (clinical touch)<BR/>Main causes of infertility were male and tubal for both UGET and clinical touch groups Duration of infertility was 4.7 +/- 2.48 years for UGET and 5.10 +/- 2.81 years for clinical touch</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:31:21 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 255) versus clinical touch (n = 260)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-26 19:31:28 +1300" MODIFIED_BY="[Empty name]">
<P>Fertilisation rate, embryos replaced, ease of transfer, clinical pregnancies, implantation rate, adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:32:58 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<CHAR_METHODS>
<P>Prospective randomised trial. No details of randomisation method or allocation concealment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:32:41 +1300" MODIFIED_BY="[Empty name]">
<P>Mexican/USA study of 67 women. No details of inclusion or exclusion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:32:58 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 33) versus clinical touch (n = 34)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pregnancy and implantation rates</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Conference abstract only. Authors contacted, no response</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:37:11 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tang-2001">
<CHAR_METHODS MODIFIED="2016-02-26 19:33:49 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomised by computer-generated random number table on day of transfer</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:36:54 +1300" MODIFIED_BY="[Empty name]">
<P>Study conducted in China on 800 infertile women<BR/>Mean age UGET 34.2 +/- 4.1, clinical touch 34.4 +/- 3.5 years<BR/>Main cause of infertility was tubal and male. Duration of infertility was 6.6 +/- 2.9 years for UGET and 6.6 +/- 2.8 for clinical touch<BR/>Inclusion: ICSI, frozen thawed, treated for IVF<BR/>Exclusion: Required general anaesthesia or refused to participate<BR/>441 fresh embryo transfer and 359 frozen-thawed embryo transfer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:37:11 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 400) versus clinical touch (n = 400)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ease of transfer, clinical pregnancies, implantation rate, adverse events, ongoing pregnancy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Published data only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:43:27 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weissman-2003">
<CHAR_METHODS MODIFIED="2016-02-26 19:37:52 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial, no details of method of randomisation or of allocation concealment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:40:46 +1300" MODIFIED_BY="[Empty name]">
<P>Israeli study of 155 women attending an IVF unit. Mean age of women was 34.6 +/- 5.9 in the UGET group and 33.6 +/- 6.2 years in the clinical touch group from the conference abstract and 34.9 +/- 5.6 (UGET) and 34.0 +/- 6.2 (clinical touch) from personal communication<BR/>No details of inclusion or exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:41:16 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 88 conference abstract and total of 160 from personal communication) versus clinical touch (n = 67 conference abstract and total of 124 from personal communication)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pregnancy and implantation rates, miscarriage rates, and difficulty of transfer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 19:43:27 +1300" MODIFIED_BY="[Empty name]">
<P>Conference abstract. Authors contacted for further details. Through personal communication some data provided that was for a larger sample size than in the conference abstract. Updated data is presented in the analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:48:32 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wisanto-1989">
<CHAR_METHODS MODIFIED="2016-02-26 19:44:15 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective randomised trial. Randomisation using tables of random sampling numbers</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:45:37 +1300" MODIFIED_BY="[Empty name]">
<P>200 women undergoing fresh embryo transfer for infertility<BR/>No exclusion details<BR/>Mean age 32.8 +/- 5 for UGET, 32.2 +/- 4.4 for clinical touch<BR/>Main cause of infertility was tubal</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:45:56 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer (n = 100) versus clinical touch (n = 100)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pregnancy rates, adverse events, ease of transfer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-26 19:48:32 +1300" MODIFIED_BY="[Empty name]">
<P>Study was a trial comparing 3 catheter types, only part of the study compared ultrasound guidance and clinical touch, the data for this has been abstracted separately from the rest of the study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-26 19:49:46 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zakova-2008">
<CHAR_METHODS MODIFIED="2016-02-26 19:49:29 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised to 2 groups - no details</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-26 19:49:40 +1300" MODIFIED_BY="[Empty name]">
<P>Women attending medical centre in the Czech Republic; no details of inclusion or exclusion criteria, infertility causes or duration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-26 19:49:46 +1300" MODIFIED_BY="[Empty name]">
<P>UGET = 308</P>
<P>Clinical touch = 309</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-23 11:45:11 +1300" MODIFIED_BY="Julie A Brown">
<P>Clinical pregnancies</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-09 15:35:29 +1300" MODIFIED_BY="jane clarke">
<P>No definitions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ART: assisted reproductive technology<BR/>hCG: human chorionic gonadotropin<BR/>BMI: body mass index<BR/>FSH: follicle-stimulating hormone<BR/>ICSI: intracytoplasmic sperm injection<BR/>ITT: intention-to-treat<BR/>IVF: in-vitro fertilisation<BR/>NHS: National Health Service<BR/>UGET: ultrasound-guided embryo transfer</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-03-03 11:39:30 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:40:24 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Shawaf-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:40:24 +1300" MODIFIED_BY="[Empty name]">
<P>Retrospective study of ultrasonic monitoring did not compare ultrasound guidance and clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 15:33:21 +1300" MODIFIED_BY="jane clarke" STUDY_ID="STD-Al_x002d_Shawaf-1993b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 15:33:21 +1300" MODIFIED_BY="jane clarke">
<P>Transfer of embryos into the uterus, however randomisation was on the basis of availability of the sonographer and was therefore rejected</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Anderson-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study and did not compare with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:40:44 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baba-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:40:44 +1300" MODIFIED_BY="[Empty name]">
<P>Three-dimensional ultrasound in embryo transfer but not randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-10 07:29:35 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Blake-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-10 07:29:35 +1300" MODIFIED_BY="[Empty name]">
<P>No details found regarding this study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:41:14 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bodri-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:41:14 +1300" MODIFIED_BY="[Empty name]">
<P>Comparison was abdominal versus transvaginal ultrasound, therefore both groups had ultrasound-guided embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Broussin-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study not compared with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:41:21 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coroleu-2002a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:41:21 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised trial comparing implantation differences but not comparing with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:41:51 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cruickshank-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:41:51 +1300" MODIFIED_BY="[Empty name]">
<P>Cohort study, not a randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:41:59 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deep-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:41:59 +1300" MODIFIED_BY="[Empty name]">
<P>Comparison was abdominal versus transvaginal ultrasound, therefore both groups had ultrasound-guided embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Englert--1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Characteristics of replacement procedure, however did not compare with ultrasound transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-24 13:39:40 +1300" MODIFIED_BY="Julie A Brown" STUDY_ID="STD-Eskander-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-24 13:39:40 +1300" MODIFIED_BY="Julie A Brown">
<P>Conference proceeding superceded by full publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:43:22 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faure-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:43:22 +1300" MODIFIED_BY="[Empty name]">
<P>Abstract only. Attempts to contact authors on multiple occasions. No response received</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:43:34 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flisser-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:43:34 +1300" MODIFIED_BY="[Empty name]">
<P>Transabdominal ultrasound-assisted transfer, but design was retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 15:35:17 +1300" MODIFIED_BY="jane clarke" STUDY_ID="STD-Garcia_x002d_Velasco-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 15:35:17 +1300" MODIFIED_BY="jane clarke">
<P>Study excluded because of duplication of data with <LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garzo-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Paper is a review of transfer techniques not a clinical trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:43:55 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gergely-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:43:55 +1300" MODIFIED_BY="[Empty name]">
<P>Used ultrasound guidance for embryo transfer, but study was retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:44:02 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghazzawi-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:44:02 +1300" MODIFIED_BY="[Empty name]">
<P>Paper reports on catheter type, not comparing ultrasound guidance and clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:44:13 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hauzman-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:44:13 +1300" MODIFIED_BY="[Empty name]">
<P>Comparison was abdominal versus transvaginal ultrasound, therefore both groups had ultrasound-guided embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:44:19 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hurley-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:44:19 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised trial of ultrasound versus clinical touch. However, randomisation for this study was based on availability of authors</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:44:36 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kan-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:44:36 +1300" MODIFIED_BY="[Empty name]">
<P>Prospective controlled study of ultrasound versus clinical touch, but randomisation was dependent upon the availability of ultrasound</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Karande-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomised comparison of catheter types using ultrasound but not comparing it with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kojima-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study using ultrasound</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kolankaya-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised trial, retrospective analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-24 13:23:42 +1300" MODIFIED_BY="Julie A Brown" STUDY_ID="STD-Kosmas-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-24 13:23:42 +1300" MODIFIED_BY="Julie A Brown">
<P>Conference abstract superceded by full publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kreiner-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Prospective randomised trial using ultrasound to replace embryos at a specific point, does not compare with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lenz-1987a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Transfundal transfer of embryos using ultrasound. Not a randomised trial and not comparing with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lenz-1987b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Transfundal transfer of embryos using ultrasound. Not a randomised trial and not comparing with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Leong-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Describes technique, not a randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lesny-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study was based on mock transfers without embryos</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:47:01 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Letterie-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:47:01 +1300" MODIFIED_BY="[Empty name]">
<P>Compares 2D and 3D ultrasound transfer, not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:47:14 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindheim-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:47:14 +1300" MODIFIED_BY="[Empty name]">
<P>Retrospective analysis of women undergoing ultrasound-guided embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lorusso-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomised trial but not comparing ultrasound with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:47:31 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martinez-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:47:31 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised trial of ultrasound-guided embryo transfer, however main outcome was immediate withdrawal versus a 30-second delay</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:47:38 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Parsons-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:47:38 +1300" MODIFIED_BY="[Empty name]">
<P>Paper of case reports of ultrasound-directed surgical embryo transfer. Not randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:47:59 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porat-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:47:59 +1300" MODIFIED_BY="[Empty name]">
<P>Comparison was abdominal versus transvaginal ultrasound, therefore both groups had ultrasound-guided embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:48:19 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Prapas-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:48:19 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer, study was not a randomised trial and choice of transfer type was dependent on the room available for the procedure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:48:28 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Prapas-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:48:28 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided embryo transfer, study was not a randomised trial and choice of transfer type was dependent on the room available for the procedure</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:48:47 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saharkhiz-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:48:47 +1300" MODIFIED_BY="[Empty name]">
<P>There was no ultrasound guidance at the time of embryo transfer in the intervention group. Ultrasound had been previously performed to measure uterine length</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:49:08 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sallam-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:49:08 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound measurement of the uterocervical angle before embryo transfer, study rejected as allocation was done alternately, not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:49:30 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sallam-2002a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:49:30 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound measurement of the uterocervical angle before embryo transfer, study rejected as allocation was done alternately, not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:49:43 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sasy-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:49:43 +1300" MODIFIED_BY="[Empty name]">
<P>Retrospective study comparing ultrasound-guided embryo transfer and tubal embryo transfer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:51:14 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scholtes-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:51:14 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised trial of transcervical intrafallopian transfer of pronucleate embryos controlled by ultrasound versus intrauterine transfer of 4- to 8-cell embryos. Randomisation was dependent on day of the week menstrual bleeding started. Also not compared with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:53:39 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shamonki-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:53:39 +1300" MODIFIED_BY="[Empty name]">
<P>Study looking at accuracy of transfer, not a randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:54:34 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Silberstein-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:54:34 +1300" MODIFIED_BY="[Empty name]">
<P>Ultrasound-guided mid-uterine cavity embryo transfer, retrospective analysis of effectiveness, but did not compare with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Strickler-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Ultrasound guidance for human embryo transfer, not a randomised trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-03-03 11:39:30 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wood-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-03-03 11:39:30 +1300" MODIFIED_BY="[Empty name]">
<P>Retrospective analysis of ultrasound and embryo transfers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:55:55 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Woolcott-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:55:55 +1300" MODIFIED_BY="[Empty name]">
<P>Evaluating transvaginal ultrasound-guided embryo transfer, not a randomised controlled trial and not compared with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-26 20:56:35 +1300" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yovich-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-26 20:56:35 +1300" MODIFIED_BY="[Empty name]">
<P>Evaluating embryo transfer technique, but does not compare ultrasound with clinical touch</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-12-10 07:29:03 +1300" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-02-26 19:50:11 +1300" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-02-26 19:49:57 +1300" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 17:59:51 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>Randomised by computer-generated random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-11 15:07:08 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>'randomised'. No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 11:36:40 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>No details of randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:10:47 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>Randomised by means of a computer-generated random number sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:07:28 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>No details of randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:11:22 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>No details of randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-11 11:25:32 +1200" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>'computer-generated random table'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:41:03 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>Block randomisation with random block size using computer randomisation software. Randomisation stratified for age and fresh/frozen embryos</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-17 12:13:36 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>No details of randomisation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:16:57 +1300" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>Randomised using permuted blocks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:16:03 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>Randomised using computer-generated sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:22:03 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>Randomly divided on day of transfer, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:22:30 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>'randomised', no other details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:23:49 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>'Randomised' but no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:27:57 +1300" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>Randomised by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:32:05 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>Computer-generated random table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:33:18 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>'Randomised', no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:37:21 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>Randomised by computer-generated random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:59:09 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>No details of randomisation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 13:00:11 +1300" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>Tables of randomly selected numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:49:57 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>Randomised to 2 groups - no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-02-26 19:16:20 +1300" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 14:28:00 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>A nurse not involved with the recruitment kept the randomisation table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 14:28:12 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 14:28:18 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-17 13:39:48 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 14:28:35 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 14:28:51 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:29:47 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>The randomisation table was made and kept by a nurse who was not involved in the recruitment of the women</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:41:21 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>Randomisation codes were prepared independently from the authors by the hospital research and development office and allocations sealed in 4 different-coloured, sequentially numbered envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:00:40 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>Dark, sealed envelopes used, but no details on sequential numbering or on where allocation was performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:03:19 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>Adequate opaque, sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:16:20 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>Randomisation list was kept in the embryo transfer room. Participant allocation was done by an accompanying nurse not involved in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:26 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:37 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:44 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:50 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:58 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:01:04 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:01:12 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:01:19 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:01:26 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>Unclear, no details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-23 11:44:48 +1300" MODIFIED_BY="Julie A Brown" RESULT="UNKNOWN" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-02-26 19:50:07 +1300" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1" REF_IDS="CMP-001.02 CMP-001.03 CMP-001.05 CMP-001.04 CMP-001.06 CMP-001.07">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:00:26 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:07:00 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:08:56 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:11:01 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:18:19 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:25:52 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:30:51 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>Not reported, but unlikely to have occurred. Although blinding for this intervention is unlikely to affect the outcome for the woman, it might influence the researcher's performance</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 18:41:39 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>Not reported, but unlikely to have occurred. Although blinding for this intervention is unlikely to affect the outcome for the woman, it might influence the researcher's performance</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:00:52 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:03:37 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:16:32 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:20:08 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:22:44 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:24:56 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:27:52 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:32:13 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:33:28 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:37:31 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:43:54 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:49:01 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-26 19:50:07 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>No details, but unlikely. Unlikely to affect participant outcomes, but may affect clinical performance of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-09-22 15:01:32 +1200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1" REF_IDS="CMP-001.02 CMP-001.03 CMP-001.05 CMP-001.04 CMP-001.06 CMP-001.07">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:00 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:12 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:25 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:30 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:40 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:28:57 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-26 13:16:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-26 13:44:01 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-25 14:29:06 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:10 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:18 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:26 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:37 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:44 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:00:58 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:01:04 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:01:12 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:01:19 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:01:26 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-09-22 15:01:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-02-26 19:50:11 +1300" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-25 14:28:00 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>All women randomised were analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-25 14:28:12 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>All women randomised appear to be analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 18:08:59 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>No pre-publication protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-03-17 13:48:19 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>No details of follow up to live birth. Does not appear to be any attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 18:18:25 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>No pre-study protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 18:26:29 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>No pre-study protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-17 12:09:56 +1200" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>All women randomised appear to have been analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 18:42:22 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>Analysis by ITT, follow to live birth, no details of adverse events such as miscarriage</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:01:02 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>No pre-study protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:03:58 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>No pre-study protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:17:00 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>ITT analysis. A power calculation suggested a sample of 772 was required to detect a difference. After an interim analysis found no difference between the groups; recruitment was halted at n = 300. There was no loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:20:10 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>No pre-publication protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-22 15:00:37 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>Conference abstract, no details of attrition provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:25:00 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>No pre-publication protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:27:58 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>No pre-publication protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:32:17 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>No pre-publication protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-09 15:36:09 +1300" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>Conference abstract not fully published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:37:36 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>No pre-published protocol identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:43:59 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>Conference abstract, not fully published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:49:06 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>Conference abstract, not fully published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-26 19:50:11 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>Conference abstract, not fully published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-02-26 19:17:05 +1300" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:00:44 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ammar-2013">
<DESCRIPTION>
<P>All outcomes listed in the methods were reported on. Live birthrate not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:07:13 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Azmy-2009">
<DESCRIPTION>
<P>Outcomes are not clearly prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 11:39:26 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Bar-Hava-2003">
<DESCRIPTION>
<P>Did not follow up to live birth. No adverse events reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-17 13:47:12 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Chen-2007">
<DESCRIPTION>
<P>No details of adverse events or live birth/ongoing pregnancies</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:18:37 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Coroleu-2000">
<DESCRIPTION>
<P>No details of follow up to live birth, although adverse events were included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:26:41 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coroleu-2002">
<DESCRIPTION>
<P>No details of follow up to live birth, although adverse events were included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:31:11 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Davar-2007">
<DESCRIPTION>
<P>No details on live birth were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 18:52:34 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drakeley-2008">
<DESCRIPTION>
<P>Adverse events such as miscarriage or multiple pregnancies are not included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:15:45 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Eskander-2008">
<DESCRIPTION>
<P>Unable to separate live birth from ongoing pregnancies. Data includes adverse effects of importance</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:19:19 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Garcia_x002d_Velasco-2002">
<DESCRIPTION>
<P>Not followed up to live birth</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-26 19:17:05 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kosmas-2007">
<DESCRIPTION>
<P>Not followed up to live birth. Details of adverse events included, although not mentioned in methods section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:23:16 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Li-2005">
<DESCRIPTION>
<P>Did not follow up to live birth, no adverse events reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-09-22 15:00:37 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Maldonado-2005">
<DESCRIPTION>
<P>Conference abstract only, no full paper identified. Outcomes were not prespecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:27:29 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Marconi-2003">
<DESCRIPTION>
<P>Not followed to live birth, no adverse events</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:28:59 +1300" MODIFIED_BY="Julie A Brown" RESULT="YES" STUDY_ID="STD-Martins--2004">
<DESCRIPTION>
<P>Main outcomes reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-25 11:36:19 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matorras-2002">
<DESCRIPTION>
<P>Main outcomes discussed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 15:36:12 +1300" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Moraga_x002d_Sanchez--2004">
<DESCRIPTION>
<P>No details of follow up to live birth. No details of adverse events</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:58:45 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Tang-2001">
<DESCRIPTION>
<P>Not followed up to live birth, although some adverse events were described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 12:59:43 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Weissman-2003">
<DESCRIPTION>
<P>Not followed up to live birth</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-03-31 13:00:38 +1300" MODIFIED_BY="Julie A Brown" RESULT="NO" STUDY_ID="STD-Wisanto-1989">
<DESCRIPTION>
<P>Not followed up to live birth</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 15:35:26 +1300" MODIFIED_BY="jane clarke" RESULT="NO" STUDY_ID="STD-Zakova-2008">
<DESCRIPTION>
<P>No details of live birth or adverse events except ease of transfer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-05-02 15:49:26 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-03-04 12:59:58 +1300" MODIFIED_BY="Helen E Nagels">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-03-04 12:59:58 +1300" MODIFIED_BY="Helen E Nagels" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-02-26 20:37:55 +1300" MODIFIED_BY="[Empty name]">Ultrasound-guided embryo transfer versus clinical touch</TITLE>
<TABLE COLS="7" ROWS="13">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Ultrasound guided embryo transfer versus clinical touch</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>Women undergoing embryo transfer as part of IVF or ICSI cycle<BR/>
<B>Intervention: </B>Ultrasound guided embryo transfer<BR/>
<B>Comparison: </B>Clinical touch</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="BOTTOM">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="BOTTOM">
<P>Risk with 'clinical touch'</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="BOTTOM">
<P>Risk with ultrasound-guided embryo transfer</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Live birth and ongoing pregnancy (per woman randomised)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>229 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>304 per 1000<BR/>(279 to 329)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 1.47<BR/>(1.30 to 1.65)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>5859<BR/>(13 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW<SUP>1 2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Live birth</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>210 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>290 per 1000<BR/>(256 to 324)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 1.53<BR/>(1.29 to 1.80)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>3117<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW<SUP>2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Ongoing pregnancy</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>263 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>333 per 1000<BR/>(298 to 372)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 1.40<BR/>(1.19 to 1.66)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>2742<BR/>(9 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Clinical pregnancy (per woman randomised)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>267 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>323 per 1000<BR/>(299 to 346)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 1.31<BR/>(1.17 to 1.45)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>6711<BR/>(20 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Multiple pregnancy (per woman randomised)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>60 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>67 per 1000<BR/>(53 to 85)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 1.13<BR/>(0.87 to 1.45)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>3379<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Miscarriage (per woman randomised)</P>
</TD>
<TD>
<P>44 per 1000</P>
</TD>
<TD>
<P>44 per 1000<BR/>(33 to 57)</P>
</TD>
<TD>
<P>OR 0.99<BR/>(0.74 to 1.31)</P>
</TD>
<TD>
<P>4053<BR/>(11 RCTs)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>3</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>Ectopic pregnancy (per woman randomised)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>5 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000<BR/>(1 to 7)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>OR 0.64<BR/>(0.28 to 1.49)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>3761<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the median risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> confidence interval; <B>ICSI:</B> intracytoplasmic sperm injection; <B>IVF:</B> in-vitro fertilisation; <B>RCT:</B> randomised controlled trial; <B>RR:</B> risk ratio; <B>OR:</B> odds ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1 </SUP>Lack of clarity for the majority of the elements of risk of bias. Only four of the included studies reported on live birth. None of the studies reporting ongoing pregnancy reported live birth. Downgraded one level.</P>
<P>
<SUP>2 </SUP>I<SUP>2</SUP> &gt; 70%; downgraded one level.</P>
<P>
<SUP>3 </SUP>Lack of detail to be able to make a judgement on most of the elements of risk of bias. Downgraded one level.</P>
<P>
<SUP>4 </SUP>Lack of detail to be able to make a judgement on most of the elements of risk of bias, none of these trials reported on live birth. Downgraded one level.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-03-04 13:00:36 +1300" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2016-03-03 11:43:54 +1300" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Additional data</TITLE>
<TABLE COLS="5" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Frozen or fresh</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>IVF protocol</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Embryo transfer protocol</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Age of women</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Long protocol, pituitary down-regulation with triptorelin (0.1 mg SC) daily starting from day 21 of cycle and decreased to 0.05 mg/day with the onset of menstruation. HMG started on day 2 of menstrual cycle (150 to 300 IU/day).</P>
<P>When 3 or more follicles were &gt; 18 mm in diameter, 10,000 IU of hCG given IM. Oocytes retrieved 36 hours later</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Dorsolithotomy position and sterile speculum inserted into vagina. When cervix was visualised it was washed with a sponge soaked with the transfer media.</P>
<P>Catheter removed after 10 seconds of releasing embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29.0 +/- 5.0 in UGET group and 30.0 +/- 5.0 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.4 +/- 4.1 in UGET group and 33.2 +/- 3.6 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standard procedure for institution</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.7 +/- 4.2 in UGET group and 32.5 +/- 4.4 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh and frozen embryos used</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details of mean age</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh transfer from both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Down-regulation with GnRH agonist protocol followed by ovarian stimulation with recombinant FSH or hMG, or both, until the day of hCG administration. When the leading follicle reached &gt; 18 mm, hCG was given and oocyte retrieval performed 34 to 36 hours later. Luteal phase support provided by daily P vaginal suppositories</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Standardised procedure not described</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.41 +/- 5.47 in UGET group and 31.69 +/- 5.46 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh transfers from both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Down-regulated with the a GnRH analogue. On day 3 of the treatment cycle, recombinant FSH at a dose of 225 to 300 IU/day combined with hMG 150 IU/day administered for 3 days. From day 6 follitropin alfa (Gonal-F) 300 IU/day administered for 4 days. HCG administered when leading follicles &gt; 18 mm diameter and at least 2 other follicles &gt; 14 mm diameter. Luteal phase support through micronised P beginning on the day of embryo retrieval</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>External genitalia and cervix prepared</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34 +/- 3.6 in UGET group and 32.6 +/- 3.6 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>100% frozen from each group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Leuprolide acetate for pituitary suppression. A 'flare up' protocol was used in women with poor response and/or basal FSH &gt; 10.5 IU/L (leuprolide acetate + hMG). HCG administered when 2 or more follicles &gt; 18 mm in diameter were present. Oocyte aspiration 35 to 37 hours post hCG injection. Embryo transfer protocol: women given IM triptorelin (Decapeptyl) on days 20 to 22 of menstrual cycle. At onset of menses or 14 to 16 days after Decapeptyl and with estradiol levels &lt; 50 pg/ml estradiol valerate 8 mg/day given for 13 days. On day 14, 200 mg vaginal micronised progesterone 3 times per day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum; exocervix cleaned with phosphate-buffered saline; endocervical mucus removed with sterile Teflon catheter</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>36.6 +/- 3.4 for UGET group and 36.2 +/- 3.0 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Leuprolide (0.5 mg/day SC) down-regulation, routine ovarian stimulation (Neo Fertinorm; Serono, Madrid, Spain)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum; exocervix cleaned with phosphate-buffered saline; endocervical mucus removed with sterile Teflon catheter</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34.6 +/- 4.0 in UGET group and 34.5 +/- 4.1 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryo</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Treated with a long protocol. Down-regulated with buserelin acetate (0.5 mg SC per day) from day 21. Stimulated with hMG from day 2 of menstrual cycle 150 to 300 IU/day. When 3 follicles &gt; 18 mm were observed, women received 10,000 IU hCG and oocyctes retrieved 36 hours later</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Full bladder in UGET group. Dorsolithotomy position, cervix washed with a sponge soaked in transfer medium. Cervix mucus aspirated from the external os</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29.39 +/- 4.2 in UGET group and 30.21 +/- 5.1 in</P>
<P>clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56.3% fresh embryos in UGET group, 54% fresh embryos in clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Buserelin (150 micrograms, intra-nasally, four times daily) down-regulation from day 21. HMG started on day 2 of the treatment cycle, hCG given when leading follicle greater than or equal to 18 mm and at least 3 follicles greater than or equal to 15 mm in diameter. For frozen transfers, embryo transfer based on natural cycles, clomiphene citrate-induced cycles, or controlled cycles using pituitary down-regulation followed by HRT depending on woman's ovulatory history</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum; cervix cleansed with sterile saline and then culture medium</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34.2 +/- 4.1 for UGET group and 34.4 +/- 3.5 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>74% of UGET group and 60% of clinical touch group received buserelin, hMG; 26% of UGET group and 40% clinical touch group received clomiphene citrate, hMG</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Indomethacin suppositories 100 mg given 30 mins pre-transfer. Lithotomy position, exocervix cleaned with cotton swab and culture medium containing HEPES (Sigma; St Louis, MO)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.8 +/- 5 for UGET group and 32.2 +/- 4.4 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Nafarelin acetate 400 micrograms/day intra-nasally down-regulation from the 21st day of cycle to day of hCG. FSH given 14 days after use of nafarelin (150 to 450 IU for 7 days). HCG administered when minimum of 2 follicles have a minimum diameter of 17 mm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum, mucus and secretions removed with culture medium</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.1 +/- 4.1 in UGET group and 32.0 +/- 3.2 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Nafarelin acetate SC daily down-regulation from day 20 to 22; recombinant FSH started on day 2 of treatment cycle, hCG 10,000 IU administered IM when at least 3 follicles &gt; 18 mm. Luteal phase supported with micronised progesterone</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum, exocervix cleansed with Ham's F-10 medium (Invitrogen Corp; UK). Mucus not removed</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>33.98 +/- 3.12 in UGET group and 34.21 +/- 2.98 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Recipients: pituitary desensitisation with IM leuprorelin. HRT given to all women from day 1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cervix cleansed with sterile saline and endocervical mucus aspirated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>37.8 +/- 0.3 in UGET group and 38.2 +/- 0.4 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh, non-donor embryos</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Down-regulation with agonist and antagonist protocols. Ovarian stimulation with various forms of urinary and recombinant FSH. OPU performed 36 hrs after administration of hCG 10,000 units when at least 3 follicles &#8805; 17 mm. Vaginal progesterone given for luteal support</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Woman placed in dorsal lithotomy position and cervix visualised with bivalve speculum. Pericervical area and cervix cleaned with gauze moistened with 0.5 M NaCl. Endocervical mucus removed with aseptic gauze</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.05 +/- 4.3 for UGET group and 32.31 +/- 3.92 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31.6 +/- 5.5 in UGET group and 33.2 +/- 6.0 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34.9 +/- 5.6 for UGET group and 34.0 +/- 6.2 for clinical touch (personal communication)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryo</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Regular regimen: IM GnRH on day 21 of cycle, then FSH (150 to 300 IU/day) on days 3 to 5 of next cycle. HCG given when leading follicles &gt; 18 mm diameter.</P>
<P>'Mini-dose' regimen: Oral contraceptives for at least 21 days, then 3 days later triptorelin (Decapeptyl) 0.1 mg given daily. FSH 150 to 300 IU/day given on days 2 to 3 of menstrual cycle. 10,000 IU of hCG injected when leading follicle &gt; 18 mm.</P>
<P>'Oral contraceptives + GnRHa': Oral contraceptives for 21 to 28 days and in last 7 days. Decapeptyl 0.1 mg daily. On days 2 to 3 of menstrual cycle FSH 75 to 150 IU/day then 10,000 IU hCG when lead follicle &gt; 18 mm.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lithotomy position, cervix exposed using bivalve speculum, cervix cleansed with saline</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>32.2 +/- 3.9 in UGET group and 32.5 +/- 4.2 in clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Fresh embryo</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>rFSH from either day 2 or 3 at 225 IU SC daily. GnRH antagonist at 0.25 mg SC daily given when largest follicle reached 14 to 15 mm diameter. HCG 10,000 IU administered when leading follicle was at least 18 mm in diameter 35 to 36 hrs prior to oocyte retrieval</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31.8 +/- 2.67 in UGET group and 32.5 +/- 3.88 in clinical touch group</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>FSH: follicle-stimulating hormone<BR/>GnRHa: gonadotropin-releasing hormone agonist<BR/>hCG: human chorionic gonadotropin<BR/>hMG: human menopausal gonadotropin<BR/>HRT: hormone replacement therapy<BR/>IM: intramuscularly<BR/>IVF: in-vitro fertilisation<BR/>OPU: ovum pick-up<BR/>P: progesterone<BR/>QDS: 4 times a day<BR/>rFSH: recombinant follicle-stimulating hormone<BR/>SC: subcutaneously<BR/>UGET: ultrasound-guided embryo transfer<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2016-03-03 11:50:11 +1300" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Replacement procedure</TITLE>
<TABLE COLS="6" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Medium type</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Distance from fundus</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Ease of transfer</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Type of catheter</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Number of embryos</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G-1<SUP>TM</SUP> version 3 (Vitrolife, Goteborg, Sweden)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.5 cm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Labotect catheter</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Maximum of 3</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 to 15 mm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>There were no difficult transfers in either group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Soft catheter (Labotect embryo transfer catheter set)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.23 +/- 0.5 for UGET group and 2.34 +/- 0.6 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.5 cm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8.9% of UGET group versus 13.3% of clinical touch group were difficult transfers</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>An ultrasoft catheter</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.11 +/- 0.6 for UGET group and 2.29 +/- 0.6 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>89.5% in UGET group and 91.8% in clinical touch group were ideal transfers</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook Soft-Pass EchoTip in the UGET group; Cook Sydney IVF Embryo Transfer Catheter Set in the clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 mm from the endometrial fundus in the sagittal plane in the UGET group; 6 cm from the external cervical os in the clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Ease of transfer not compared between groups; overall data provided only</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook Soft-Pass EchoTip in the UGET group; soft non-echogenic Wallace or Rocket Embryon catheters in the clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.89 +/- 0.35 for UGET group and clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Approximately 2 cm from fundus in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No significant differences between groups in the incidence of easy transfers</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.36 +/- 1.07 for UGET group and 3.32 +/- 1.04 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET = within 1 cm of the fundus; clinical touch based on judgement but as close to the fundus as possible without touching</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Frydman soft catheter</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5.0 +/- 1.6 for UGET group and 4.5 +/- 1.7 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50% synthetic serum substitute (Irvine Scientific) plus IVF50 for early cleavage or G2.2 (Scandinavian IVF Science) for blastocysts. Quantity: 30 microliters for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET = 1.5 cm; clinical touch based on judgement ("as close to fundus without touching")</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>98.3% in UGET group and 97.2% in clinical touch group were easy and very easy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Edwards Wallace</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.9 +/- 0.8 for UGET group and 2.8 +/- 0.8 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50% synthetic serum substitute and IVF50 medium. Quantity: 30 microliters</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET = 1.5 to 2.0 cm, clinical touch = 1.5 to 2.0 cm as predicted from ultrasonic measurement of uterine cavity performed within 3 months of embryo transfer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>93.5% in UGET group and 87.9% in clinical touch group were very easy, easy or moderate</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Edwards Wallace</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.1 +/- 0.8 for UGET group and 2.2 +/- 0.9 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The catheter tip was placed above the half point of the endometrial cavity</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 cm in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>96.9% in UGET group and 80.8% in clinical touch group were easy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Frydman</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.54 +/- 1.07 for UGET group and 3.4 +/- 1.20 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>IVF-20/-100 (Scandinavian IVF Science, Sweden). Quantity: 5 microliters</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 cm from external os and &lt; 1 cm from fundus in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26.6% in UGET group and 23.8% in clinical touch group were easy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Jansen-Anderson</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.2 +/- 0.6 for UGET group and 2.3 +/- 0.6 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Garcia_x002d_Velasco-2001" TYPE="STUDY">Garcia-Velasco 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET = 1.5 cm; clinical touch = judgement</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Delphin</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.2 +/- 0.04 for UGET group and 3.2 +/- 0.04 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Earle's culture medium (Gibco Europe Ltd, Paisley, Scotland). Quantity: 10 to 25 microlitres</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 cm in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET 6% were difficult and 2% failed; clinical touch 7% were difficult and 2% failed</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>TDT (Prodimed; Neuilly-en-Thelle, France)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.4 +/- 0.7 for UGET group and 2.6 +/- 0.7 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details. Quantity: &lt; 30 microliters culture medium</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET group = 0.5 to 1.0 cm from fundus; clinical touch group = distance estimated from mock transfer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Frydman</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.6 +/- 0.9 for UGET group and 2.3 +/- 0.6 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 mm from the uterine fundus in the UGET group; 6 cm from the cervical os in the clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>95.3% in UGET group and 94% in clinical touch group were considered easy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook K-J-SPPE EchoTip in UGET group; Cook K-Soft in clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.49 +/- 0.61 for UGET group and 1.43 +/- 0.57 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.2 +/- 1.0 for UGET group and 2.0 +/- 1.2 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15% in UGET group and 8% in clinical touch group were difficult</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.63 +/- 0.9 for UGET group and 2.51 +/- 0.9 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HTF Medium</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET group = 1.5 to 2.0 cm; clinical touch group = clinical judgement ("inserted into the uterine cavity about 6 cm. The embryos were slowly released according to clinicians' judgement")</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Wallace all using outer sheath</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.3 +/- 0.53 for UGET group and 2.2 +/- 0.46 for clinical touch group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>At least 1 embryo of good quality</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cook EchoTip for UGET group and Frydman for clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.48 +/- 0.67 for UGET group and 3.65 +/- 0.69 for clinical touch group</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>UGET: ultrasound-guided embryo transfer</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2016-03-04 13:00:36 +1300" MODIFIED_BY="Helen E Nagels" NO="3">
<TITLE>Other data</TITLE>
<TABLE COLS="5" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Day of embryo transfer</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Bed rest</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Full bladder</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>USS machine used</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ammar-2013" TYPE="STUDY">Ammar 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes after procedure</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Advised for women in the UGET group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Azmy-2009" TYPE="STUDY">Azmy 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Advised for women in the UGET group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz transabdominal probe (Medison, SonoAce 3200, Korea)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Davar-2007" TYPE="STUDY">Davar 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not clearly stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes after procedure</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, only for UGET group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hitachi, Japan, 2000, EZU-PC3A, 220V and 3.5 MHz</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Zakova-2008" TYPE="STUDY">Zakova 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3 or 4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Drakeley-2008" TYPE="STUDY">Drakeley 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 2 in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hitachi EUB-525</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Eskander-2008" TYPE="STUDY">Eskander 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2101 Falcon 3.5 MHz probe; BK Medical; Herlev, Denmark</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chen-2007" TYPE="STUDY">Chen 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD-500</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Garcia_x002d_Velasco-2002" TYPE="STUDY">Garcia-Velasco 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 2 UGET 113/187, clinical touch 118/187; Day 3 UGET 62/187, clinical touch 59/187; Day 6 UGET 12/187, clinical touch 10/187</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes for UGET and clinical touch</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Required for both UGET and clinical touch</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD 1400</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Wisanto-1989" TYPE="STUDY">Wisanto 1989</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48 to 60 hours after retrieval</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, 4 hours for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tang-2001" TYPE="STUDY">Tang 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48 hours after retrieval in both UGET and clinical touch groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not required</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Required for UGET but not for clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD -620</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2000" TYPE="STUDY">Coroleu 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 2 or 3 with cleaved embryos and day 5 or 6 with blastocysts. 93% of UGET transferred on days 2 or 3, 91% of clinical touch transferred on days 2 or 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Toshiba TOSBEE (SSA-240A) convex 3.75 MHz</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Coroleu-2002" TYPE="STUDY">Coroleu 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>UGET day 2 (15%) and day 3 (85%); clinical touch day 2 (11%) and day 3 (89%)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes for both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Required for UGET but not for clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Toshiba TOSBEE (SSA-240A) convex 3.75 MHz</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Maldonado-2005" TYPE="STUDY">Maldonado 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Martins--2004" TYPE="STUDY">Martins 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>All embryos were transferred on day 2 in both groups, any additional embryos were cryopreserved at the end of the second day</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD 1100</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Matorras-2002" TYPE="STUDY">Matorras 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>85.9% of UGET took place on day 2 to 3, 87.7% of clinical touch transfers took place on days 2 to 3.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 to 15 minutes in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Required for UGET but not for clinical touch group</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD 1200</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kosmas-2007" TYPE="STUDY">Kosmas 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3 or 5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, 2 hours prior to leaving hospital</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Full bladder not a prerequisite</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka 3500</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bar-Hava-2003" TYPE="STUDY">Bar Hava 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Weissman-2003" TYPE="STUDY">Weissman 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 2 to 3 transfers in both UGET and clinical touch groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes, in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Moraga_x002d_Sanchez--2004" TYPE="STUDY">Moraga-Sanchez 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Days of embryo culture in vitro UGET 2.45 +/- 0.4, clinical touch 2.42 +/- 0.2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Minimum 6 hours in both UGET and clinical touch groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.5 MHz, Aloka SSD 1400</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Marconi-2003" TYPE="STUDY">Marconi 2003</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Day 3 post aspiration in both groups</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No details</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>UGET: ultrasound-guided embryo transfer</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-03-08 12:18:15 +1300" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2016-03-08 12:18:15 +1300" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Ultrasound-guided embryo transfer versus 'clinical touch'</NAME>
<DICH_OUTCOME CHI2="45.90660373322979" CI_END="1.6487538276660807" CI_START="1.3026530295218606" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4655218075978889" ESTIMABLE="YES" EVENTS_1="917" EVENTS_2="686" I2="73.85996997352753" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.21715581679237642" LOG_CI_START="0.11482875383187942" LOG_EFFECT_SIZE="0.16599228531212792" METHOD="MH" MODIFIED="2016-03-08 12:18:15 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="7.200138495755404E-6" P_Q="0.49039647455901403" P_Z="2.0332981666345343E-10" Q="0.47565633064493346" RANDOM="NO" SCALE="1.370419750833854" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2963" TOTAL_2="2896" WEIGHT="100.0" Z="6.3588046311631885">
<NAME>Live birth and ongoing pregnancy (per woman randomised)</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>CTET</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CTET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours UGET</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="32.47070769326644" CI_END="1.799107526612137" CI_START="1.2943207072770608" DF="3" EFFECT_SIZE="1.5259823479687125" ESTIMABLE="YES" EVENTS_1="450" EVENTS_2="320" I2="90.76090355547711" ID="CMP-001.01.01" LOG_CI_END="0.25505712044326306" LOG_CI_START="0.11204189931854645" LOG_EFFECT_SIZE="0.18354950988090477" MODIFIED="2016-03-08 12:18:15 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="4.16456412688504E-7" P_Z="4.88083363534715E-7" STUDIES="4" TAU2="0.0" TOTAL_1="1574" TOTAL_2="1543" WEIGHT="50.22474405810971" Z="5.030939027571497">
<NAME>Live birth</NAME>
<DICH_DATA CI_END="4.1024571502799905" CI_START="2.2095258631864576" EFFECT_SIZE="3.010728346456693" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="80" LOG_CI_END="0.6130440535900578" LOG_CI_START="0.34429908947985743" LOG_EFFECT_SIZE="0.4786715715349576" MODIFIED="2016-03-08 12:18:15 +1300" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.15786212222735888" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.024920449634125593" WEIGHT="10.371986830744504"/>
<DICH_DATA CI_END="1.2468649666796188" CI_START="0.7873215139283462" EFFECT_SIZE="0.9907994818480752" ESTIMABLE="YES" EVENTS_1="190" EVENTS_2="187" LOG_CI_END="0.09581942268356734" LOG_CI_START="-0.1038478810961393" LOG_EFFECT_SIZE="-0.004014229206285979" MODIFIED="2016-03-08 11:56:08 +1300" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.11728556260929361" STUDY_ID="STD-Drakeley-2008" TOTAL_1="834" TOTAL_2="815" VAR="0.013755903196578531" WEIGHT="31.79758247766252"/>
<DICH_DATA CI_END="3.706965942740529" CI_START="0.7376317208506152" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832343" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2016-03-08 11:53:16 +1300" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.41187602214913804" STUDY_ID="STD-Martins--2004" TOTAL_1="50" TOTAL_2="50" VAR="0.16964185762139725" WEIGHT="1.9984807519098933"/>
<DICH_DATA CI_END="2.7741531374602775" CI_START="1.1051736079393248" EFFECT_SIZE="1.7509771077610274" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="36" LOG_CI_END="0.44313043111300526" LOG_CI_START="0.04343050521373338" LOG_EFFECT_SIZE="0.24328046816336932" MODIFIED="2016-03-08 11:56:34 +1300" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.2347857150197751" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="0.05512433197734705" WEIGHT="6.056693997792785"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.051324473617319" CI_END="1.6625869038157588" CI_START="1.1865023040409006" DF="8" EFFECT_SIZE="1.4045152872238966" ESTIMABLE="YES" EVENTS_1="467" EVENTS_2="366" I2="38.703539122242724" ID="CMP-001.01.02" LOG_CI_END="0.2207843552450583" LOG_CI_START="0.07426858590041019" LOG_EFFECT_SIZE="0.14752647057273421" MODIFIED="2016-03-08 12:18:13 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1100959706045419" P_Z="7.914693862265402E-5" STUDIES="9" TAU2="0.0" TOTAL_1="1389" TOTAL_2="1353" WEIGHT="49.77525594189029" Z="3.946968580681709">
<NAME>Ongoing pregnancy</NAME>
<DICH_DATA CI_END="6.52382098444679" CI_START="0.613137609008012" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.8145020353643136" LOG_CI_START="-0.21244204403635136" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2016-03-06 16:28:08 +1300" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.6032320356951286" STUDY_ID="STD-Ammar-2013" TOTAL_1="45" TOTAL_2="45" VAR="0.36388888888888893" WEIGHT="0.8707977132504982"/>
<DICH_DATA CI_END="3.3304323468193093" CI_START="1.397034138809849" EFFECT_SIZE="2.157018239492466" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="52" LOG_CI_END="0.522500615983727" LOG_CI_START="0.14520701893850713" LOG_EFFECT_SIZE="0.3338538174611171" MODIFIED="2016-03-08 12:18:11 +1300" MODIFIED_BY="[Empty name]" ORDER="66228" O_E="0.0" SE="0.22162412653778837" STUDY_ID="STD-Coroleu-2000" TOTAL_1="182" TOTAL_2="180" VAR="0.049117253463637635" WEIGHT="6.0667177702147965"/>
<DICH_DATA CI_END="3.8067145703707217" CI_START="0.7348024918235296" EFFECT_SIZE="1.672478206724782" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" LOG_CI_END="0.5805503143872156" LOG_CI_START="-0.13382937960714672" LOG_EFFECT_SIZE="0.22336046739003443" MODIFIED="2016-02-11 13:53:24 +1300" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.41963016848880536" STUDY_ID="STD-Davar-2007" TOTAL_1="90" TOTAL_2="90" VAR="0.17608947830594318" WEIGHT="1.9423626770559723"/>
<DICH_DATA CI_END="2.5723906049955563" CI_START="1.0656173738388077" EFFECT_SIZE="1.6556521739130434" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="50" LOG_CI_END="0.4103369147631489" LOG_CI_START="0.027601292626538813" LOG_EFFECT_SIZE="0.21896910369484385" MODIFIED="2016-03-08 12:18:12 +1300" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.22482079901492957" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="0.050544391669711364" WEIGHT="6.711912669155984"/>
<DICH_DATA CI_END="1.7065108536001994" CI_START="0.7578140098314206" EFFECT_SIZE="1.137197358767425" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="94" LOG_CI_END="0.2321090547849979" LOG_CI_START="-0.12043737011376195" LOG_EFFECT_SIZE="0.05583584233561797" MODIFIED="2015-09-15 09:14:13 +1200" MODIFIED_BY="[Empty name]" ORDER="66229" O_E="0.0" SE="0.20708751511847995" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="0.042885238917946655" WEIGHT="9.520566442463334"/>
<DICH_DATA CI_END="1.4810870724607976" CI_START="0.46599388221394905" EFFECT_SIZE="0.8307692307692308" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="38" LOG_CI_END="0.17058059125426864" LOG_CI_START="-0.3316197848940427" LOG_EFFECT_SIZE="-0.08051959681988705" MODIFIED="2015-09-15 09:14:13 +1200" MODIFIED_BY="[Empty name]" ORDER="66230" O_E="0.0" SE="0.2949949868814726" STUDY_ID="STD-Kosmas-2007" TOTAL_1="101" TOTAL_2="95" VAR="0.08702204228520018" WEIGHT="5.486914162573292"/>
<DICH_DATA CI_END="7.179067476270779" CI_START="1.1672130694882878" EFFECT_SIZE="2.8947368421052633" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="12" LOG_CI_END="0.8560680352991593" LOG_CI_START="0.06715014178367054" LOG_EFFECT_SIZE="0.4616090885414149" MODIFIED="2016-03-08 12:18:12 +1300" MODIFIED_BY="[Empty name]" ORDER="66235" O_E="0.0" SE="0.46341427585755335" STUDY_ID="STD-Marconi-2003" TOTAL_1="41" TOTAL_2="42" VAR="0.21475279106858053" WEIGHT="1.1960354133802023"/>
<DICH_DATA CI_END="1.8405170096071246" CI_START="0.9318282112424293" EFFECT_SIZE="1.3095975232198143" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="76" LOG_CI_END="0.264939835444396" LOG_CI_START="-0.030664145356517073" LOG_EFFECT_SIZE="0.11713784504393945" MODIFIED="2015-09-15 09:14:13 +1200" MODIFIED_BY="[Empty name]" ORDER="66232" O_E="0.0" SE="0.1736392415857605" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.0301505862184781" WEIGHT="12.65704476209599"/>
<DICH_DATA CI_END="1.7446217348972337" CI_START="0.567919467413251" EFFECT_SIZE="0.9953917050691244" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="28" LOG_CI_END="0.2417012787136575" LOG_CI_START="-0.24571324410885473" LOG_EFFECT_SIZE="-0.0020059826975986042" MODIFIED="2016-03-08 12:18:13 +1300" MODIFIED_BY="[Empty name]" ORDER="66234" O_E="0.0" SE="0.28630970344674384" STUDY_ID="STD-Weissman-2003" TOTAL_1="160" TOTAL_2="124" VAR="0.08197324628776241" WEIGHT="5.322904331700228"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="32.68159782386864" CI_END="1.4538263828034124" CI_START="1.1741537272419251" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="OR" EFFECT_SIZE="1.3065280961890076" ESTIMABLE="YES" EVENTS_1="1118" EVENTS_2="916" I2="41.86330759469917" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.1625125457991622" LOG_CI_START="0.06972496107019578" LOG_EFFECT_SIZE="0.11611875343467899" METHOD="MH" MODIFIED="2015-10-18 16:11:10 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.02615317430710784" P_Q="1.0" P_Z="9.31504893815361E-7" Q="0.0" RANDOM="NO" SCALE="29.402977755848397" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3392" TOTAL_2="3319" WEIGHT="100.00000000000001" Z="4.905582472621664">
<NAME>Clinical pregnancies (per woman randomised)</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.5194311648618815" CI_START="0.5322936048330014" EFFECT_SIZE="1.5510204081632653" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.6550837760707118" LOG_CI_START="-0.27384875156615657" LOG_EFFECT_SIZE="0.1906175122522777" MODIFIED="2015-05-02 15:52:28 +1200" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.5456595650240685" STUDY_ID="STD-Ammar-2013" TOTAL_1="45" TOTAL_2="45" VAR="0.29774436090225564" WEIGHT="0.922340276862299"/>
<DICH_DATA CI_END="3.76300822670063" CI_START="0.8041389838616277" EFFECT_SIZE="1.7395348837209301" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="15" LOG_CI_END="0.5755351677768886" LOG_CI_START="-0.09466888320713895" LOG_EFFECT_SIZE="0.2404331422848748" MODIFIED="2015-05-26 14:36:52 +1200" MODIFIED_BY="[Empty name]" ORDER="66248" O_E="0.0" SE="0.39368117711157513" STUDY_ID="STD-Bar-Hava-2003" TOTAL_1="65" TOTAL_2="66" VAR="0.15498486921195537" WEIGHT="1.6682303496450057"/>
<DICH_DATA CI_END="4.606908650805509" CI_START="0.25297188999525333" EFFECT_SIZE="1.0795454545454546" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6634096008256298" LOG_CI_START="-0.5969277345482715" LOG_EFFECT_SIZE="0.03324093313867916" MODIFIED="2009-03-17 13:49:06 +1300" MODIFIED_BY="Julie A Brown" ORDER="61" O_E="0.0" SE="0.7403283895690573" STUDY_ID="STD-Chen-2007" TOTAL_1="27" TOTAL_2="23" VAR="0.548086124401914" WEIGHT="0.5963212238979109"/>
<DICH_DATA CI_END="2.9806476663004404" CI_START="1.2768021649125285" EFFECT_SIZE="1.9508196721311475" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="61" LOG_CI_END="0.4743106423778258" LOG_CI_START="0.1061236103857017" LOG_EFFECT_SIZE="0.2902171263817637" ORDER="66236" O_E="0.0" SE="0.21627488514737583" STUDY_ID="STD-Coroleu-2000" TOTAL_1="182" TOTAL_2="180" VAR="0.04677482594551061" WEIGHT="5.195534771875476"/>
<DICH_DATA CI_END="4.15813723204212" CI_START="1.0885344503015" EFFECT_SIZE="2.1275045537340618" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="18" LOG_CI_END="0.6188988183612849" LOG_CI_START="0.03684217829129263" LOG_EFFECT_SIZE="0.32787049832628873" ORDER="66237" O_E="0.0" SE="0.34190295160394957" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.11689762831549268" WEIGHT="2.0218648216400266"/>
<DICH_DATA CI_END="3.1137090212484804" CI_START="0.6777719521809942" EFFECT_SIZE="1.4527162977867203" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="14" LOG_CI_END="0.49327802494030126" LOG_CI_START="-0.16891640726768725" LOG_EFFECT_SIZE="0.162180808836307" MODIFIED="2012-09-17 12:12:54 +1200" MODIFIED_BY="Julie A Brown" ORDER="63" O_E="0.0" SE="0.38897628739427736" STUDY_ID="STD-Davar-2007" TOTAL_1="90" TOTAL_2="90" VAR="0.15130255215503546" WEIGHT="1.8710331330635208"/>
<DICH_DATA CI_END="1.2360411042125474" CI_START="0.7910333277597114" EFFECT_SIZE="0.9888122713200113" ESTIMABLE="YES" EVENTS_1="207" EVENTS_2="204" LOG_CI_END="0.0920329133384511" LOG_CI_START="-0.1018052184527375" LOG_EFFECT_SIZE="-0.004886152557143208" MODIFIED="2009-03-23 11:26:51 +1300" MODIFIED_BY="Julie A Brown" ORDER="57" O_E="0.0" SE="0.11386147812837139" STUDY_ID="STD-Drakeley-2008" TOTAL_1="834" TOTAL_2="815" VAR="0.012964436201577594" WEIGHT="26.281167341892463"/>
<DICH_DATA CI_END="2.692593960150762" CI_START="1.1360421514228043" EFFECT_SIZE="1.7489711934156378" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="54" LOG_CI_END="0.43017086727661213" LOG_CI_START="0.055394445627386546" LOG_EFFECT_SIZE="0.24278265645199934" MODIFIED="2009-03-17 13:01:42 +1300" MODIFIED_BY="Julie A Brown" ORDER="56" O_E="0.0" SE="0.22014552524996212" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="0.0484640522875817" WEIGHT="5.297564857684341"/>
<DICH_DATA CI_END="1.8360959925154265" CI_START="0.8077970420526922" EFFECT_SIZE="1.217864077669903" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="103" LOG_CI_END="0.26389538270943264" LOG_CI_START="-0.09269774143905049" LOG_EFFECT_SIZE="0.08559882063519106" ORDER="66238" O_E="0.0" SE="0.20946456628925172" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="0.04387540453074433" WEIGHT="6.998331086854889"/>
<DICH_DATA CI_END="1.581765581053179" CI_START="0.6322049309823615" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="63" LOG_CI_END="0.19914212113472052" LOG_CI_START="-0.19914212113472052" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-03-23 12:40:35 +1300" MODIFIED_BY="Julie A Brown" ORDER="66239" O_E="0.0" SE="0.23395413544786547" STUDY_ID="STD-Kosmas-2007" TOTAL_1="150" TOTAL_2="150" VAR="0.05473453749315818" WEIGHT="6.190220886712972"/>
<DICH_DATA CI_END="2.8477189144203763" CI_START="1.097481518181069" EFFECT_SIZE="1.7678571428571428" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="38" LOG_CI_END="0.4544971198171152" LOG_CI_START="0.0403972153655838" LOG_EFFECT_SIZE="0.2474471675913495" ORDER="66246" O_E="0.0" SE="0.24324433370241574" STUDY_ID="STD-Li-2005" TOTAL_1="178" TOTAL_2="152" VAR="0.05916780587833219" WEIGHT="4.369736792199567"/>
<DICH_DATA CI_END="1.0333500489193812" CI_START="0.03402162707280501" EFFECT_SIZE="0.1875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.014247464367578226" LOG_CI_START="-1.468244920240103" LOG_EFFECT_SIZE="-0.7269987279362623" MODIFIED="2015-05-26 14:36:53 +1200" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.0" SE="0.8708233651742088" STUDY_ID="STD-Maldonado-2005" TOTAL_1="13" TOTAL_2="13" VAR="0.7583333333333333" WEIGHT="1.0425196221991448"/>
<DICH_DATA CI_END="6.848890780195666" CI_START="1.1549543574082244" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="15" LOG_CI_END="0.8356202405365807" LOG_CI_START="0.062564821702257" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2015-05-26 14:36:54 +1200" MODIFIED_BY="[Empty name]" ORDER="66247" O_E="0.0" SE="0.454096579709321" STUDY_ID="STD-Marconi-2003" TOTAL_1="41" TOTAL_2="42" VAR="0.20620370370370372" WEIGHT="0.9797172353196784"/>
<DICH_DATA CI_END="3.857037845145657" CI_START="0.740188381936105" EFFECT_SIZE="1.6896551724137931" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="15" LOG_CI_END="0.5862539001720546" LOG_CI_START="-0.1306577359129394" LOG_EFFECT_SIZE="0.2277980821295576" MODIFIED="2015-05-26 14:36:54 +1200" MODIFIED_BY="[Empty name]" ORDER="66240" O_E="0.0" SE="0.42111744380615784" STUDY_ID="STD-Martins--2004" TOTAL_1="50" TOTAL_2="50" VAR="0.17733990147783252" WEIGHT="1.473862115884041"/>
<DICH_DATA CI_END="2.4614392522405555" CI_START="1.05976183654257" EFFECT_SIZE="1.6150973291081938" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="47" LOG_CI_END="0.39118912195225686" LOG_CI_START="0.025208275928076875" LOG_EFFECT_SIZE="0.20819869894016685" ORDER="66241" O_E="0.0" SE="0.21497896058900878" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="0.04621595349593059" WEIGHT="5.813210871979193"/>
<DICH_DATA CI_END="7.613183109651067" CI_START="1.049691563665347" EFFECT_SIZE="2.826923076923077" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="13" LOG_CI_END="0.8815662754198318" LOG_CI_START="0.021061706806922143" LOG_EFFECT_SIZE="0.45131399111337694" MODIFIED="2015-05-26 14:36:55 +1200" MODIFIED_BY="[Empty name]" ORDER="66245" O_E="0.0" SE="0.5054646431695351" STUDY_ID="STD-Moraga_x002d_Sanchez--2004" TOTAL_1="33" TOTAL_2="34" VAR="0.2554945054945055" WEIGHT="0.7888917141118903"/>
<DICH_DATA CI_END="1.6733292225793936" CI_START="0.8752663451603293" EFFECT_SIZE="1.2102102102102101" ESTIMABLE="YES" EVENTS_1="104" EVENTS_2="90" LOG_CI_END="0.22358139552499115" LOG_CI_START="-0.05785977025541203" LOG_EFFECT_SIZE="0.08286081263478955" ORDER="66242" O_E="0.0" SE="0.16531993393564798" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.027330680556487012" WEIGHT="11.282668611250244"/>
<DICH_DATA CI_END="1.5968498994223361" CI_START="0.5796832406685095" EFFECT_SIZE="0.9621159621159621" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="39" LOG_CI_END="0.20326409527669498" LOG_CI_START="-0.23680925541739553" LOG_EFFECT_SIZE="-0.01677258007035027" MODIFIED="2015-05-26 14:36:56 +1200" MODIFIED_BY="[Empty name]" ORDER="66244" O_E="0.0" SE="0.2585012645959275" STUDY_ID="STD-Weissman-2003" TOTAL_1="160" TOTAL_2="124" VAR="0.0668229037976937" WEIGHT="5.164601829093423"/>
<DICH_DATA CI_END="5.558909356542255" CI_START="1.0175562385049386" EFFECT_SIZE="2.378340365682138" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="9" LOG_CI_END="0.7449895924997099" LOG_CI_START="0.007558421236241026" LOG_EFFECT_SIZE="0.37627400686797546" MODIFIED="2015-05-26 14:36:56 +1200" MODIFIED_BY="[Empty name]" ORDER="66243" O_E="0.0" SE="0.4331707203433314" STUDY_ID="STD-Wisanto-1989" TOTAL_1="98" TOTAL_2="98" VAR="0.18763687296276058" WEIGHT="1.2290827637738133"/>
<DICH_DATA CI_END="1.582694200376124" CI_START="0.8074539524059665" EFFECT_SIZE="1.1304656949875578" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="97" LOG_CI_END="0.19939701093403916" LOG_CI_START="-0.09288223529557568" LOG_EFFECT_SIZE="0.05325738781923174" MODIFIED="2015-05-26 14:36:57 +1200" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.17168627604087838" STUDY_ID="STD-Zakova-2008" TOTAL_1="308" TOTAL_2="309" VAR="0.029476177380784695" WEIGHT="10.813099694060117"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.2684168958756725" CI_END="1.4548527638852504" CI_START="0.8748327340885328" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1281634726962189" ESTIMABLE="YES" EVENTS_1="140" EVENTS_2="124" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.16281904344719647" LOG_CI_START="-0.05807497509936585" LOG_EFFECT_SIZE="0.0523720341739153" METHOD="MH" MODIFIED="2015-10-18 16:11:38 +1300" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6404029019300318" P_Q="1.0" P_Z="0.3526919217271586" Q="0.0" RANDOM="NO" SCALE="9.497281525060547" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1693" TOTAL_2="1686" WEIGHT="100.0" Z="0.9293805369051934">
<NAME>Multiple pregnancies (per woman randomised)</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.39071323152099" CI_START="0.5992093573428064" EFFECT_SIZE="0.9128682170542636" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="50" LOG_CI_END="0.14323758663650007" LOG_CI_START="-0.22242141324815073" LOG_EFFECT_SIZE="-0.03959191330582532" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.21478990657348526" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.04613470396584653" WEIGHT="40.492780667756485"/>
<DICH_DATA CI_END="3.149181172760815" CI_START="0.30311100172918903" EFFECT_SIZE="0.9770114942528736" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4981976463675531" LOG_CI_START="-0.5183983001762046" LOG_EFFECT_SIZE="-0.010100326904325779" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.5971534912308974" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.35659229208924953" WEIGHT="5.064054172792174"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.0" STUDY_ID="STD-Davar-2007" TOTAL_1="90" TOTAL_2="90" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.485655393165118" CI_START="0.25875327984326646" EFFECT_SIZE="1.5666666666666667" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9770673430055726" LOG_CI_START="-0.5871141365734628" LOG_EFFECT_SIZE="0.19497660321605503" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.918807943927924" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="0.844208037825059" WEIGHT="1.7228177272695944"/>
<DICH_DATA CI_END="1.7399495662980853" CI_START="0.5231914356678602" EFFECT_SIZE="0.9541104294478527" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2405366601240487" LOG_CI_START="-0.2813393737675656" LOG_EFFECT_SIZE="-0.020401356821758462" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.3065525656359654" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="0.09397447549799287" WEIGHT="19.449196932609937"/>
<DICH_DATA CI_END="2.695211147940796" CI_START="0.26034256814128665" EFFECT_SIZE="0.8376623376623377" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.4305927943069758" LOG_CI_START="-0.5844548153814041" LOG_EFFECT_SIZE="-0.0769310105372141" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.5962439904976574" STUDY_ID="STD-Martins--2004" TOTAL_1="50" TOTAL_2="50" VAR="0.3555068962045706" WEIGHT="5.4978942161011135"/>
<DICH_DATA CI_END="3.3197684665203764" CI_START="0.8291629100031793" EFFECT_SIZE="1.6591048436542" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="14" LOG_CI_END="0.5211077953850612" LOG_CI_START="-0.08136013294240446" LOG_EFFECT_SIZE="0.2198738312213284" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.3538926433638959" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="0.12524000302708563" WEIGHT="11.306349094011999"/>
<DICH_DATA CI_END="2.8511568204448006" CI_START="0.8936279670920355" EFFECT_SIZE="1.5962059620596205" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="20" LOG_CI_END="0.45502110520170436" LOG_CI_START="-0.048843247945621844" LOG_EFFECT_SIZE="0.20308892862804126" MODIFIED="2015-05-02 12:07:01 +1200" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.29597241520751294" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.08759967056376845" WEIGHT="16.46690718945869"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.167742173618323" CI_END="1.3088931148045841" CI_START="0.7419106933325941" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9854348270194877" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="101" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.11690418318494492" LOG_CI_START="-0.12964836928584084" LOG_EFFECT_SIZE="-0.006372093050447959" METHOD="MH" MODIFIED="2016-03-01 15:24:03 +1300" MODIFIED_BY="Helen E Nagels" NO="4" P_CHI2="0.8796945516594294" P_Q="1.0" P_Z="0.9193046786516311" Q="0.0" RANDOM="NO" SCALE="23.48780497381613" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2048" TOTAL_2="2005" WEIGHT="100.0" Z="0.10130962149739509">
<NAME>Miscarriage (per woman randomised)</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.589192695124256" CI_START="0.04271913832494203" EFFECT_SIZE="0.48863636363636365" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7473490827750632" LOG_CI_START="-1.3693775159162274" LOG_EFFECT_SIZE="-0.3110142165705821" MODIFIED="2015-05-02 15:54:25 +1200" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="1.243375682036914" STUDY_ID="STD-Ammar-2013" TOTAL_1="45" TOTAL_2="45" VAR="1.5459830866807611" WEIGHT="2.036011172300485"/>
<DICH_DATA CI_END="1.7352429189989116" CI_START="0.6934329851131238" EFFECT_SIZE="1.096938775510204" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="38" LOG_CI_END="0.2393602808536947" LOG_CI_START="-0.1589955037354362" LOG_EFFECT_SIZE="0.040182388559129256" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.23399615976059152" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.05475420278270427" WEIGHT="36.36307708132956"/>
<DICH_DATA CI_END="6.2669133715202" CI_START="0.500108238235957" EFFECT_SIZE="1.7703488372093024" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7970536914239569" LOG_CI_START="-0.3009359913012664" LOG_EFFECT_SIZE="0.24805885006134526" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66260" O_E="0.0" SE="0.6449645747693824" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.4159793027074502" WEIGHT="3.8929660260883776"/>
<DICH_DATA CI_END="4.041729366481267" CI_START="0.10747894949346169" EFFECT_SIZE="0.6590909090909091" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6065672298673688" LOG_CI_START="-0.9686765870418315" LOG_EFFECT_SIZE="-0.18105467858723137" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.9253060156351157" STUDY_ID="STD-Davar-2007" TOTAL_1="90" TOTAL_2="90" VAR="0.8561912225705329" WEIGHT="3.054016758450727"/>
<DICH_DATA CI_END="4.942418809437493" CI_START="0.34519648599893443" EFFECT_SIZE="1.3061797752808988" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6939395437615529" LOG_CI_START="-0.46193363392739534" LOG_EFFECT_SIZE="0.11600295491707872" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.6789656262389956" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="0.4609943216141114" WEIGHT="3.974762244729925"/>
<DICH_DATA CI_END="2.8820736087000074" CI_START="0.5111258653839166" EFFECT_SIZE="1.2137142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.45970506858206395" LOG_CI_START="-0.29147214113578995" LOG_EFFECT_SIZE="0.08411646372313702" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66261" O_E="0.0" SE="0.44124521137542483" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="0.19469733656174334" WEIGHT="9.743308204828827"/>
<DICH_DATA CI_END="2.378960927673592" CI_START="0.1817395487206272" EFFECT_SIZE="0.6575342465753424" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3763873091935912" LOG_CI_START="-0.7405505546833286" LOG_EFFECT_SIZE="-0.18208162274486872" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.6560948301728983" STUDY_ID="STD-Kosmas-2007" TOTAL_1="150" TOTAL_2="150" VAR="0.4304604261796042" WEIGHT="6.080269728188266"/>
<DICH_DATA CI_END="1.2991339603181775" CI_START="0.050427148636117504" EFFECT_SIZE="0.25595238095238093" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.11365393569762278" LOG_CI_START="-1.2973355879901756" LOG_EFFECT_SIZE="-0.5918408261462763" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66262" O_E="0.0" SE="0.8288222307249997" STUDY_ID="STD-Martins--2004" TOTAL_1="50" TOTAL_2="50" VAR="0.6869462901439647" WEIGHT="6.996474755723484"/>
<DICH_DATA CI_END="2.494926341173454" CI_START="0.4173401043851044" EFFECT_SIZE="1.0204081632653061" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.3970577282783948" LOG_CI_START="-0.37950987966338445" LOG_EFFECT_SIZE="0.008773924307505152" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66263" O_E="0.0" SE="0.45615965697665684" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="0.20808163265306123" WEIGHT="9.906011992326938"/>
<DICH_DATA CI_END="2.0379456526838435" CI_START="0.3108454077987586" EFFECT_SIZE="0.7959183673469388" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.30919259819139605" LOG_CI_START="-0.5074555441954249" LOG_EFFECT_SIZE="-0.09913147300201446" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66264" O_E="0.0" SE="0.47970316131151963" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.23011512297226583" WEIGHT="10.203192352096748"/>
<DICH_DATA CI_END="2.7538729282893115" CI_START="0.36038181731080293" EFFECT_SIZE="0.9962157048249763" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4399438967720406" LOG_CI_START="-0.44323712901592" LOG_EFFECT_SIZE="-0.0016466161219397507" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66265" O_E="0.0" SE="0.5187849063644334" STUDY_ID="STD-Weissman-2003" TOTAL_1="160" TOTAL_2="124" VAR="0.26913777907155395" WEIGHT="7.749909683936664"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.987989312612334" CI_END="1.491674313712429" CI_START="0.27844509374982346" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6444760617166947" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.17367401134205476" LOG_CI_START="-0.555260430049857" LOG_EFFECT_SIZE="-0.19079320935390118" METHOD="MH" MODIFIED="2016-03-01 15:24:03 +1300" MODIFIED_BY="Helen E Nagels" NO="5" P_CHI2="0.5511465717678239" P_Q="1.0" P_Z="0.3048858428181134" Q="0.0" RANDOM="NO" SCALE="206.88095445061387" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1885" TOTAL_2="1876" WEIGHT="99.99999999999999" Z="1.0260122106849487">
<NAME>Ectopic pregnancy (per woman randomised)</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.0" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="15.932888975166376" CI_START="0.06138388652589472" EFFECT_SIZE="0.988950276243094" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2022945298637358" LOG_CI_START="-1.2119456176423185" LOG_EFFECT_SIZE="-0.004825543889291328" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66254" O_E="0.0" SE="1.4181366133265245" STUDY_ID="STD-Coroleu-2000" TOTAL_1="182" TOTAL_2="180" VAR="2.0111114540572244" WEIGHT="7.190159862978515"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66255" O_E="0.0" SE="0.0" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="77.36652021251828" CI_START="0.12675166364430163" EFFECT_SIZE="3.1315068493150684" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8885530636213648" LOG_CI_START="-0.8970463317437509" LOG_EFFECT_SIZE="0.49575336593880703" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="1.636274873776861" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="2.6773954625534824" WEIGHT="3.499211133316211"/>
<DICH_DATA CI_END="1.6117162594811891" CI_START="0.004857907442037551" EFFECT_SIZE="0.08848484848484849" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2072885872284108" LOG_CI_START="-2.313550764087349" LOG_EFFECT_SIZE="-1.0531310884294691" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66256" O_E="0.0" SE="1.4807535133189147" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="2.1926309672063096" WEIGHT="39.44070403562018"/>
<DICH_DATA CI_END="7.193389967937919" CI_START="0.13901651439128962" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8569336049042588" LOG_CI_START="-0.8569336049042588" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66257" O_E="0.0" SE="1.0067340828210365" STUDY_ID="STD-Kosmas-2007" TOTAL_1="150" TOTAL_2="150" VAR="1.0135135135135136" WEIGHT="14.188582129610936"/>
<DICH_DATA CI_END="22.720907065422637" CI_START="0.18449848818649556" EFFECT_SIZE="2.047430830039526" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3564256653155813" LOG_CI_START="-0.734007188176751" LOG_EFFECT_SIZE="0.3112092385694151" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66258" O_E="0.0" SE="1.227930605950908" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="1.5078135730309643" WEIGHT="7.064506583819667"/>
<DICH_DATA CI_END="2.7315925901283835" CI_START="0.09060419590104109" EFFECT_SIZE="0.49748743718592964" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4364159259563399" LOG_CI_START="-1.0428516895806534" LOG_EFFECT_SIZE="-0.30321788181215675" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66259" O_E="0.0" SE="0.8689291198592224" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.7550378153393228" WEIGHT="28.61683625465449"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.0540214522717406" CI_END="1.3011509565932688" CI_START="0.7691974537948418" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0004209128233301" ESTIMABLE="YES" EVENTS_1="126" EVENTS_2="124" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.11432768534888624" LOG_CI_START="-0.11396216203714615" LOG_EFFECT_SIZE="1.827616558700252E-4" METHOD="MH" MODIFIED="2015-10-18 16:12:26 +1300" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.5488261782323849" P_Q="1.0" P_Z="0.9974961061016829" Q="0.0" RANDOM="NO" SCALE="16.439131272872576" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1397" TOTAL_2="1383" WEIGHT="99.99999999999999" Z="0.0031381707716019013">
<NAME>Blood on catheter</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5849674485924545" CI_START="0.06116348319661279" EFFECT_SIZE="0.31135531135531136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.20002034728446869" LOG_CI_START="-1.2135077899373954" LOG_EFFECT_SIZE="-0.5067437213264633" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66266" O_E="0.0" SE="0.8303134248812496" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.6894203835380305" WEIGHT="5.337210230809105"/>
<DICH_DATA CI_END="1.3854671147715885" CI_START="0.7401664574755209" EFFECT_SIZE="1.012658030279382" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="86" LOG_CI_END="0.1415962218954212" LOG_CI_START="-0.13067059995336752" LOG_EFFECT_SIZE="0.005462810971026854" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.15993087889648278" STUDY_ID="STD-Drakeley-2008" TOTAL_1="834" TOTAL_2="815" VAR="0.025577886024601443" WEIGHT="69.8833247209218"/>
<DICH_DATA CI_END="7.434607515557697" CI_START="0.41236582077207007" EFFECT_SIZE="1.750936329588015" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8712580463849795" LOG_CI_START="-0.3847173386970567" LOG_EFFECT_SIZE="0.24327035384396134" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.7377661583756135" STUDY_ID="STD-Eskander-2008" TOTAL_1="183" TOTAL_2="190" VAR="0.544298904444311" WEIGHT="2.574968468895793"/>
<DICH_DATA CI_END="2.000245737262039" CI_START="0.32719120863959567" EFFECT_SIZE="0.8089887640449438" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.3010833535544936" LOG_CI_START="-0.48519837398178234" LOG_EFFECT_SIZE="-0.09205751021364433" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66267" O_E="0.0" SE="0.46186577891213165" STUDY_ID="STD-Garcia_x002d_Velasco-2002" TOTAL_1="187" TOTAL_2="187" VAR="0.21331999773011007" WEIGHT="9.416306263707165"/>
<DICH_DATA CI_END="2.4417540886458404" CI_START="0.6005721345267243" EFFECT_SIZE="1.2109704641350212" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="18" LOG_CI_END="0.3877019236048386" LOG_CI_START="-0.22143482215706162" LOG_EFFECT_SIZE="0.08313355072388849" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66269" O_E="0.0" SE="0.35780993973606146" STUDY_ID="STD-Wisanto-1989" TOTAL_1="100" TOTAL_2="100" VAR="0.12802795297392394" WEIGHT="12.788190315666125"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="35.33954544273193" CI_END="0.821329960697383" CI_START="0.5743688409161535" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6868379266868317" ESTIMABLE="YES" EVENTS_1="183" EVENTS_2="258" I2="74.53277939133488" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-0.08548233457166177" LOG_CI_START="-0.24080912828042436" LOG_EFFECT_SIZE="-0.1631457314260431" METHOD="MH" MODIFIED="2016-01-27 12:03:21 +1300" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="5.190063489945995E-5" P_Q="1.0" P_Z="3.834171507634865E-5" Q="0.0" RANDOM="NO" SCALE="133.31750129007042" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2173" TOTAL_2="2122" WEIGHT="100.00000000000001" Z="4.117251765668167">
<NAME>Not considered an easy transfer</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UGET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CTET</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.49832772207582227" CI_START="0.22994133330634273" EFFECT_SIZE="0.3385057471264368" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="88" LOG_CI_END="-0.302484952263683" LOG_CI_START="-0.6383829547273131" LOG_EFFECT_SIZE="-0.4704339534954981" MODIFIED="2016-01-27 12:03:20 +1300" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.19730814936906457" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.0389305058074451" WEIGHT="34.377883859810034"/>
<DICH_DATA CI_END="2.446293973734077" CI_START="0.14394483609871175" EFFECT_SIZE="0.5934065934065934" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.38850864546356884" LOG_CI_START="-0.8418039104598191" LOG_EFFECT_SIZE="-0.22664763249812508" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66270" O_E="0.0" SE="0.7226916854947705" STUDY_ID="STD-Coroleu-2000" TOTAL_1="182" TOTAL_2="180" VAR="0.5222832722832723" WEIGHT="1.925701922191553"/>
<DICH_DATA CI_END="1.3825596484366258" CI_START="0.2060393355312901" EFFECT_SIZE="0.533724340175953" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" LOG_CI_END="0.14068387735688564" LOG_CI_START="-0.6860498593717316" LOG_EFFECT_SIZE="-0.27268299100742294" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66271" O_E="0.0" SE="0.48562748935238786" STUDY_ID="STD-Coroleu-2002" TOTAL_1="93" TOTAL_2="91" VAR="0.2358340584147036" WEIGHT="4.259062888422773"/>
<DICH_DATA CI_END="1.5528237631413957" CI_START="0.2862169262179011" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.19112216851774488" LOG_CI_START="-0.5433046866291074" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.4314059701848262" STUDY_ID="STD-Davar-2007" TOTAL_1="90" TOTAL_2="90" VAR="0.18611111111111112" WEIGHT="4.5962907417583"/>
<DICH_DATA CI_END="2.034270240801223" CI_START="0.29737360330585955" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.30840864587917793" LOG_CI_START="-0.526697584729314" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66272" O_E="0.0" SE="0.4905455337019395" STUDY_ID="STD-Kosmas-2007" TOTAL_1="150" TOTAL_2="150" VAR="0.24063492063492065" WEIGHT="3.447218056318725"/>
<DICH_DATA CI_END="0.42117578950821327" CI_START="0.007618297466021181" EFFECT_SIZE="0.05664488017429194" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="18" LOG_CI_END="-0.3755366013640058" LOG_CI_START="-2.118142073768881" LOG_EFFECT_SIZE="-1.2468393375664433" MODIFIED="2016-01-27 12:03:21 +1300" MODIFIED_BY="[Empty name]" ORDER="66273" O_E="0.0" SE="1.023615080526831" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="1.0477878330819508" WEIGHT="6.827499839699223"/>
<DICH_DATA CI_END="1.225173768716455" CI_START="0.6652180587437977" EFFECT_SIZE="0.9027777777777778" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="72" LOG_CI_END="0.08819768987820968" LOG_CI_START="-0.17703596945503544" LOG_EFFECT_SIZE="-0.04441913978841288" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66274" O_E="0.0" SE="0.15579956442013654" STUDY_ID="STD-Tang-2001" TOTAL_1="400" TOTAL_2="400" VAR="0.024273504273504276" WEIGHT="27.5777444505498"/>
<DICH_DATA CI_END="3.317730331062353" CI_START="0.8617860007939485" EFFECT_SIZE="1.690909090909091" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="11" LOG_CI_END="0.5208410831678227" LOG_CI_START="-0.06460056504844024" LOG_EFFECT_SIZE="0.22812025905969127" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66276" O_E="0.0" SE="0.34389132214512963" STUDY_ID="STD-Weissman-2003" TOTAL_1="160" TOTAL_2="124" VAR="0.11826124144672531" WEIGHT="4.747342550172892"/>
<DICH_DATA CI_END="2.4607232458377064" CI_START="0.2985682680056561" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.39106277194569794" LOG_CI_START="-0.5249563512069244" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="66275" O_E="0.0" SE="0.5380741673076394" STUDY_ID="STD-Wisanto-1989" TOTAL_1="100" TOTAL_2="100" VAR="0.2895238095238095" WEIGHT="2.6811695993590083"/>
<DICH_DATA CI_END="2.114672373461657" CI_START="0.7798164163747747" EFFECT_SIZE="1.284155844155844" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="25" LOG_CI_END="0.3252430916073326" LOG_CI_START="-0.10800762646281518" LOG_EFFECT_SIZE="0.10861773257225871" MODIFIED="2015-05-02 12:07:02 +1200" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.25449361642004736" STUDY_ID="STD-Zakova-2008" TOTAL_1="308" TOTAL_2="309" VAR="0.0647670007985542" WEIGHT="9.560086091717697"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-02-11 15:39:29 +1300" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Additional analyses - Live birth and type of catheter</NAME>
<DICH_OUTCOME CHI2="32.47070769326644" CI_END="1.799107526612137" CI_START="1.2943207072770608" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.5259823479687125" ESTIMABLE="YES" EVENTS_1="450" EVENTS_2="320" I2="90.76090355547711" I2_Q="96.43653111246104" ID="CMP-002.01" LOG_CI_END="0.25505712044326306" LOG_CI_START="0.11204189931854645" LOG_EFFECT_SIZE="0.18354950988090477" METHOD="MH" MODIFIED="2016-02-11 15:39:29 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="4.16456412688504E-7" P_Q="1.174592760833093E-7" P_Z="4.88083363534715E-7" Q="28.062543312694203" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1574" TOTAL_2="1543" WEIGHT="100.0" Z="5.030939027571497">
<NAME>Type of catheter</NAME>
<GROUP_LABEL_1>UGET</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical touch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CTET</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours UGET</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2468649666796188" CI_START="0.7873215139283462" DF="0" EFFECT_SIZE="0.9907994818480752" ESTIMABLE="YES" EVENTS_1="190" EVENTS_2="187" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.09581942268356734" LOG_CI_START="-0.1038478810961393" LOG_EFFECT_SIZE="-0.004014229206285979" MODIFIED="2015-05-03 09:15:03 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9371849086781805" STUDIES="1" TAU2="0.0" TOTAL_1="834" TOTAL_2="815" WEIGHT="63.31059137080505" Z="0.0788085432223778">
<NAME>Different catheters used between groups</NAME>
<DICH_DATA CI_END="1.2468649666796188" CI_START="0.7873215139283462" EFFECT_SIZE="0.9907994818480752" ESTIMABLE="YES" EVENTS_1="190" EVENTS_2="187" LOG_CI_END="0.09581942268356734" LOG_CI_START="-0.1038478810961393" LOG_EFFECT_SIZE="-0.004014229206285979" MODIFIED="2015-05-03 09:12:10 +1200" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.11728556260929361" STUDY_ID="STD-Drakeley-2008" TOTAL_1="834" TOTAL_2="815" VAR="0.013755903196578531" WEIGHT="63.31059137080505"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.6624074234025805" CI_END="3.124890589440958" CI_START="1.9200588306048876" DF="2" EFFECT_SIZE="2.4494843887908786" ESTIMABLE="YES" EVENTS_1="260" EVENTS_2="133" I2="57.10370591035952" ID="CMP-002.01.02" LOG_CI_END="0.4948348161652522" LOG_CI_START="0.2833145356908635" LOG_EFFECT_SIZE="0.3890746759280579" MODIFIED="2015-11-17 07:45:23 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.09717888592023904" P_Z="5.578993508732231E-13" STUDIES="3" TAU2="0.0" TOTAL_1="740" TOTAL_2="728" WEIGHT="36.68940862919496" Z="7.210394676154189">
<NAME>Same catheter both groups</NAME>
<DICH_DATA CI_END="4.1024571502799905" CI_START="2.2095258631864576" EFFECT_SIZE="3.010728346456693" ESTIMABLE="YES" EVENTS_1="181" EVENTS_2="80" LOG_CI_END="0.6130440535900578" LOG_CI_START="0.34429908947985743" LOG_EFFECT_SIZE="0.4786715715349576" MODIFIED="2015-05-12 11:38:52 +1200" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.15786212222735888" STUDY_ID="STD-Azmy-2009" TOTAL_1="435" TOTAL_2="418" VAR="0.024920449634125593" WEIGHT="20.651149199972394"/>
<DICH_DATA CI_END="3.706965942740529" CI_START="0.7376317208506152" EFFECT_SIZE="1.65359477124183" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.5690185960247616" LOG_CI_START="-0.13216041530832343" LOG_EFFECT_SIZE="0.21842909035821909" MODIFIED="2015-05-12 11:38:59 +1200" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.41187602214913804" STUDY_ID="STD-Martins--2004" TOTAL_1="50" TOTAL_2="50" VAR="0.16964185762139725" WEIGHT="3.979076029929917"/>
<DICH_DATA CI_END="2.7741531374602775" CI_START="1.1051736079393248" EFFECT_SIZE="1.7509771077610274" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="36" LOG_CI_END="0.44313043111300526" LOG_CI_START="0.04343050521373338" LOG_EFFECT_SIZE="0.24328046816336932" MODIFIED="2015-05-12 11:38:59 +1200" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.2347857150197751" STUDY_ID="STD-Matorras-2002" TOTAL_1="255" TOTAL_2="260" VAR="0.05512433197734705" WEIGHT="12.059183399292648"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-03-08 12:18:16 +1300" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-03-04 13:10:57 +1300" MODIFIED_BY="Helen E Nagels" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram for review update 2016.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAkYAAARkCAYAAACXadtrAACAAElEQVR42uydCdxN1f7/f8bMY8ZC
maMU+f2RoRRCAxpUiisKucQ1hqKiEeFySULciyTplyhzyJB5CiFChkKRkKn191nP3ad9znOGfc7z
4Bne79drv3jOntZea33X/uzv+q61/se4+J//+R82tpi3pAZlQv2j/rGl1voHCbBdtxEDJPRFQFqA
Mqf+Uf8g2QsjChRSUuNAfab+Uf+AsocElCMFCSmncaA+A/UPEEeAMAIaBholoP4BwggQRkDDQKME
1D+g/gHCCGgYaJSA+gfUP7g6wujcuXPm6NGjyerBXnzxRTN37txkWSjjx483o0ePThJ5EMs1kvqL
SfX522+/Nfv27TMXL16kFbiM/PDDD+b3339HGF2h9tSLvSantjGx2kKEESSaMBo0aJC55557TJYs
WcyAAQPi7ddvoeZ0uNovnOuvv9689dZbvr8ff/xx8+CDD16WeyX2tRPreoF5cKWukVRfTHv37jV1
69Y1GTJkMNmzZzdp06a1/69WrZrvGOV7YF1W/Xfvz507tzly5IjftdetW2ePPX36tClWrFjY+U5k
U4H3ypkzp3nsscdCvrD0IlVa69SpE3S/rnX33Xdf9vzds2dPvOdJkyZNvOMmT55sypcvbwoUKGCu
ueYa06hRI/Pnn3+mamEUqT29HO1eYrWNl7P9TIr3RRghjELufOSRR8zAgQNt4xbMkL/55hszZMgQ
v61JkyYmf/78MTWCM2fONMOGDbssDcSkSZPMBx98cFkyMbGvjTBK/EZJ3qFcuXKZm266yWzYsMHW
zzNnzlgh0rVrVz+BUblyZbNmzRrfJtETKJyeffbZkMJo06ZNvnNVn/X7J5984vttx44dvmtVqVLF
rFixwgwePNiULFnSiqpgjBgxwl5HYu7gwYNXXRhNnDjRTJs2zW4ff/yx3zG//fabyZo1qxk1apT9
e/v27SZTpkxm3rx5qVoYRWpPr5YwCmy/grXDl7P9RBhBshJGDjfeeKMnQ5aLuHTp0ub999+PKTFt
2rQxd9111xVrIJIqCKPEb5See+45+6V+6NChsOdHEhjanzFjRitQVq9eHVQYuZk9e7b93RFDgdeS
B8thypQp9tiVK1fGO1YCqnr16na/RNTVFkYnTpwIecyqVausF+n48eO+3+Tpeu2111K1MIq2Pb1S
wuhytsMII0j1wuif//yn/doO142mmIMWLVqYa6+91hQsWND3VTl06FDbRaEvzZtvvtk8//zz9vdn
nnnG9O3b13e+rq39c+bM8futR48eplChQuaGG24ww4cPj2f83bt3Nx07dvQ7p3fv3qZw4cI2Hf37
9/eUzmAEXtv5e8mSJfZlVqRIEfPmm2/6naP76wVXrlw5kzlzZlO8eHHfl3dgY5BYeRDpmb1cIzm+
mC5cuGC7cySOIuFFGMlblC9fPitWHM9oYgijBQsW2GOXLVvmd9x3331nf1+6dKmpUKGCqVixYpIW
Rr/++qtJnz69z+tw8uRJkydPHj/PG8IocnsqL+NDDz1kbVVlPnLkyKjtNdq2MVQ7HKz9fOONN+yH
cI4cOUzNmjX9PhS8toORnhFhBMlaGKkxzJs3r228w9G+fXvToEEDs3PnTvsCWL9+vf199+7d5oEH
HjC33XabWbx4sdmyZYv9XX3yrVu39jNIpfmjjz7y/davXz97bxmVztPx+mIN14+uAMQyZcrYl5Gu
pZiTTz/9NGI6vXzV6G81GIqx+Ne//mVefvllm2a9VBwkdNKlS2fjDvTSVJeO88yB10usPIj0zF6u
kRxfTKpb+l2BnF6EkRrxAwcO+LY//vjDb79eNBMmTLDXHDduXKIII3XrNW7c2AouCTk3KjcJZ4kw
dcXoegoej1UYyZOjuhhqCxcY7AgjvfDeffddP6+QG9VrHdehQwf70gx84SGMIgsjiRS1H+qKfOWV
V6y4VzdlNPYabdsYqh0ObJN0XQko1Ud5CLVf6dP50bSDkZ4RYQTJWhgpTqNevXoRr6WXTrNmzYJ6
lYK5cCOJAnXfKXakW7du8dzF7q8Tt4HpRacvIhmlQ8OGDW3wq5d0ehFG+kKWsTtpVODsmDFjfPeX
lyhUIG20wshLHkR6Zq/5mBxfTIsWLbK/exmJEyz42u2Zc4SRUF1VPJ3EQazCSF/yshvVB3kPnTrj
IDGkL33HYyihpm68Xr16xSyM9DLTV36oTWImFL/88osVavfdd58V1nrpBnq4xMaNG623VS86/Xul
vEUpSRi5kVjQtWfNmuXZXmNpG0O1w+5jzp49a9uSTp06+XllVR/0Qem1HYz0jAgjSNbCSF8AirtQ
EGkk1F2kxlJuU3kuEiqMdu3aZf+eOnVqPOMP9VW0detWe06lSpVM7dq17abjq1at6imdXoRRoDGr
gdCXkfv+wWJFYhFGXvIg0jN7zcfk+GJSMLR+//DDDz0JI+XN+fPnfZt7IIFbGClPVe/1gohVGMkT
pK9vdTO4hbmDvtp1vr7K5ZXVVqtWLVO0aNF46boSXWlulDdly5a1z+BG+aIAYz27ugHlfZDwcwtM
hJE3YaTylydFbaOuPX36dM/2Gkvb6EUYbdu2LZ7HWkjgq256bQcjPSPCCJK1MGrZsqW54447PN9U
X5P169e3Ll33dWMRRs5Lb/78+Z6Nf/PmzfYcvZAkgJwtcNRMqHQmVBg59w81P0e0wshLHkR6Zq/5
mBxfTJpHR7/L0+FFGEWKMXKEkVDMluJpnK61WLvSPv/886AvMcWXhRr2rxdKLMJIwd3q6gq1RSNg
nNFyP/74o++3nj17WrtxUJ4oHuvee+9FGHkURhK98lhLdMq7Izt1iwYv9hpL2+hFGGlUp66ruu1G
XcEqZ6/tYKRnRBhBshVG+iJUrEwsQznVHSBDcbqr2rZtG09g6cXxxBNP+P7+6quv/ESBjEuuereh
q9so8LfArjR96YfrMgiXzoQKI8WT6P7qy/dyvcTIg0jP7DUfk+uLSXmobp9wQcOxCCO99GUfCmhP
aPC1yl1pPHz4sK+eaH4jBcw63iJtGlmnbgv3lAHRCCMNx9bHTKjNiZvygryeej73aD91EWveIjfq
ClS3I8LImzBSbI+utXDhQvu3uqHcosGLvcbSNoZqh93H6END3bmBHxqKj2vevLnndjDSMyKMIEkK
IzXyp06dsnOryNOg/6vyulFAnfqNvc5uO3bsWDviSyKjc+fOpkaNGn775HJ3N7IvvfSSbUjkFpaH
Q3EYgW5cdUGUKlXKfhmpy0FfqxqaHa4fXV+1Ch7URHR6ASlOxD2qIlw6EyqMhGKyNLeLgp/VPy+P
jr7Egp2fWHkQ6Zm9XCO5vpjU1SXPjroSnXmM1BUk74k7ViJY8LU2xVUEE0Zu8ZNQYfTTTz/ZeuKI
CnmPZA/BxJw8iIofcQLDQ6XbHTieGGiEmdoBoUDbYKPk9CGhNkF1yHku1atgXYWpSRh5aU8dFJ4g
T7VGw6ocZbu6tkRyNPYaS9sYrB0OPKZVq1b2uhpso7ZfI9SUvuXLl3tuB708I8IIkpwwuu666+K5
793DxoUEgzs2JxJqvPWCUqOuof3uUWzHjh2zsxDLs9GuXTv7m14ot9xyi723JufTaJxAUSCXsQJU
9bu+hmbMmBHRXawXRpcuXWwckQIJ1RDoGC/pTAxhJGEil7XuoU0eAGfkTuD5iZUHkZ7ZyzWS84tp
7dq1Nt5Fx2TLls0K01tvvdU2yG6xEqzbSgHcoYSRePjhhxMsjIQ8rzpeXXP333+/eeqpp4I+i+qj
++s6VLrVRZeYyNuk+qrRjXqpyfblNXajF74zpYEEvTzK8iL9/PPPqVoYeWlP3WiovGxV9bRPnz62
TZTNuru/I9lrLG1jsHY48Bh9VDVt2tR6jiS01L4Fjvr00g5GekaEESQ5YXS5kChwuguCoZl9dYwb
fXVGYv/+/VEvRSKvgb5c9G+06UysvNCszF5mCk+sPAj3zLHmY3J4Mbkbdc1AHWqoOYSvO/JcaqCF
6kk4VIfkqYt0XGoRRrGgOupuC+VZicVeY7HpYO1wIBLBXtuvhDwjwghSvDCCFF+paJSA+gfUP0AY
AfBiAuofUP8AYQTAiwmof9Q/oA4gjAB4MQH1j/oH1AGEEQAvJqD+paD6p3mJvCybc7mvESsaFKAJ
Vx999FG7OO3VyhPaoBQsjJLjMMmUkHZeTAgjoP5dDSJNzeGlXY1leo/EaOM1F5zmaNOEo5oRXvOT
JcZ7ILlNVwKXWRhNmjQpptmskwLJOe28mBBGQP1LisLIS7t6OYSR5s4aNmxY2LRoIWPNqeSeRywx
3gMII4QRAC8moP4hjK7qNQIJtnZbIFp3UpPWJoU8oQ1KwcKoe/fupmPHjvH+XrJkiZ0VWquBR1oq
wjlHs61q2QDNvPrcc8/5lldwHzNlyhS7UveQIUPs75qMTP3FWoOqYMGCpn///r5zNKuulslwo6Ut
br/9dvvFEJh2XUtT1pcuXdrkyJHD1KxZ028pDKHFOt2z0Oqcm2++2W9BTS0R0qJFC/scSpOmsgde
TED9i3TvWNo5Z7+6h7QMkGaE1oKrWhbIa7sW7r6awb1QoUJ2ZmwtwxFJBARrVyNdI9LzRXqvDB06
1HaRSfSoPdZM2YFpkVdI15fHSMcoxihUeiPldbR5QhuUyoRRsGUuZIDly5e3U7prjTSdqxmUQ6Fz
SpYsaQ124sSJtlJrDSW3oNAxJUqUsKsy6xhn6QQFvWnZgQULFtilL7RkhtYVEzpf4sQ9c7MEl2MQ
gWnXukQyroEDB9r1grRf09BrrSeHSCvYi/bt25sGDRqYnTt3Wtft+vXrqUEII6D+Rbx3LO2c0Mea
llQZNGiQPUeBwFp81Wu7Fuq+OlcLFmsZIl1PbZ+WeIkmxsjLNSI9X6T3ip5Fi21rKR/FDjnP7k6L
ZvXu1q2bFY46Rkv/BEtvpLTEkie0QQgju87N9u3b7d9a/FAiZ8yYMWENSWtROYtOClXyJk2a+B0j
Be9e7kJreukLQV8LDg0bNvQtQnn06FF771mzZvmOVwPh/O1Ou7xTupZ7oVAF6skoJHSiEUb6omnW
rFmClsvgxYQwgtQpjKJt57RfL3utMxeI13Yt2H3VdmsNSIkJN/KOhOsFcLerXq4R6fm8vleCdaUF
vp/Ulab1D0MdEyktseYJbRDCKOKCgJGuIV599VWTM2dOn7gIdszWrVtt5dJK6LVr17abKqh7sdr7
7rvPihQh8SLXqBqGwGtu27YtnsAR9erVM7Vq1YpKGMmFrS8ydQvqqwMQRkD98yqMom3nnP3qSgvE
a7sW7L4a1q5zp06dGk8EePUYebmGl3bcy3slMYRRpLTEmie0QQijRBFGAwYMsOLCWXQw2DGbN2+2
lUuuTYkRZ3NWXBaTJ0+2XwC///67FUlupe++5oYNG+y1tMq5m8aNG1v3cjTCSGzcuNHUr1/fulj1
LIAwAupfLMIoUjvn7NdLPxCv7Vqw+27atMmeO3/+/JiFkZdreGnHr5QwipSWWPOENghhlCjCqFGj
RjZALtwxcntmzJjRdOjQIeS1JYgkjN555x2TPn16X99z4DV1nILy1L/sJl++fKZ58+a+v+vWrWue
eOIJ399fffVVUGHk0KtXL/v8dKshjID6F4switTOacV57Vf4QbD2z0u7Fuy++ihVjKb7ha+0BP4W
7hm8XMNLO+7lvdK2bVtzxx13JEgYRUpLrHlCG4QwikkYyVCdkV2fffaZ7cdVtH+464qePXvauCF5
htRAHD9+PN6IC3WlyftUuXLlsGlv1aqVKVWqlFm6dKltUDSSQ8+9fPly3zEa5XbjjTdal6q+JDQK
JFAYjR071o5Mkxjq3LmzqVGjBjUoGQojxRN8++23Zt++fQjbS2gQg2I8Tpw4Qf27gsLISzvXtWtX
kylTJhskrFABeT7kLfLaroW6r2JrdK48JArclhc8S5YsnmOMvF4j0vN5ea+o3VWs1aFDh2IWRl7S
EkueIIwQRjEJIyl99edqOKlGV7Rr185vNFkow5Va79KlixU+8gzJMHSsGwVbK/0jRowIm3YZQNOm
Te0Xliq60j1+/Hi/czRa45ZbbrHXu+mmm+yLM1jwtbxTEncSY2qQIPkIo71791rPoII7FaSq+qD/
V6tWzXfM/fff7xfsqnqkxvTIkSN+11q3bp29l3tCOeEMDAgWMOtc7+677473u+JIlJ5IxyU277//
vk1v/vz5rY3deeedtrvYjbqM9azBtqQoLJOTMIrUzukFrq4ktTvaVG81aspruxbqvuo60pB0pVde
EU2pEu3M116uEen5vLxXjh07Zm1UHh+9P2IVRpHSEkueIIxSmTBKDNwVU6MiTp48GdPXrIZuusVU
rGh0nLwETnxTMNyjN4Khhurw4cPUnGT2YlK5S9BK9OqLW3VAZanhz/oqDyeMdE3NneVFGEmk63e9
rA4ePJjkhZGGNmv5BOWHxJ8EvzwRbr755hs7/41708hSialwtkT9S7x2TnU1VNvlpV0LhYa6J1Tc
erlGYrTjsiflQ2J4SMOlJaF5gjBCGHkWRoAwupr31jxX+qp2u+ODEUwY6UtVosXtdg8ljBT4Ks9i
qNFESU0YBaJuA01wFw51RWruGXmbqH+8FIE6gDCKgrfffjve7KJAw3Cl763YDLnPJY4iEUwYyVuk
WDmJHuerPJgw+u677+xv6mKtUKGCndYhuQkjjfB0zzMTjH/+85/Ws5RU47MQRoAwgiQrjICGISnc
W7Pn6vfA+AuvwkjLBEyYMMFeY9y4cSGFkUYIackGiSfNRqz9ilULFEYSWJpXxb3pHrEKI8WaqGsg
1Ka4p3Coa1jBvZqZXrEcGoAQil9//dXODpyU4+sQRoAwAoQR0DCEufeiRYvs74onilUYCc2lorga
CZFAYSQxpMBNZ729AwcOWKGjaR0ChZHmwFL3nHvTwIRYhZFEmAY3hNrCDZcWGq2jbkbdX9NfqKss
FIrH0iSC1D9eikAdQBjFiL7Sg01QFu0xl+PccOjr38uLFJL+i8mZvO3DDz9MkDCSZ0ciRsswBAoj
rdGkvzXMV14VbZqBuGjRon5BsUm1K01i6Ouvv7bB6e6Zk93I+6TnX7FiBfUvEe59udquq9GGJ8d7
IYzgqgkjLwHYXqYGSMj1YyGWYZpXOx9pGILfW3O86PfAyfCiFUZCq3Nr2LTTteYIo2eeeSbkkHaJ
psspjDSqTIuMhtqcecS8oK5Cpfn777+Pt69ly5bxJtqj/sV+7+Ri01cynSlhwA7CCGF0WYTRpEmT
zAcffIAwchFNnvBiio/mL1JsTKRJDCMJIwkhTQSqhTkdYaQhxFr/TxOXOt4ibRoBp3ln3EP9L4cw
mjlzphUtoTYnLsoLWmIiUMwJBZaruy851MGkWP9URsOGDUMYpZA8QRghjK64MEoKRpvUhBENQ8Lu
ra4veXq0iKQzj5HmMZG3xb1CeSRh5BYPjjDSwpOaLC6Y6NL6e5o/SZPLRSuMNOxfsUruzblOYqGZ
lJ0pDBSErTUDNcFe4LO8/PLLdiJIed+of9Hf28t6X6lNGCXnPEEYpVJh1L17d9OxY0c7+6eGHWsm
UA13Pnv2rO8YdR84waZCw3e1Dprbde9U9HDXCTQG594OWoajRYsW9tyCBQuaUaNGxTt3yZIl9kVS
pEiReFO4K13qAtFXvs4PnEJA+/Xy0/wtCqDVl384YSQPgJYQcaM5bm6//Xb7oox0P+f5pkyZYsqW
LWsnzIv0nIF5ontoCQDNJ6MA25o1a8ZbMsU5J1zepJYXk9Bkhrfddps9RrPkaqmFW2+91QYfRyOM
xMMPP+wTRjrnqaeeCnpPjd7ScdOnT49aGAXrlvv8888TNb/+8Y9/2OtqKQQJR9WRYLF1Wv7GvSo6
Lybv9x46dKidPV2zLat91Og/r21XqLbCi/17aZ81lYXqt9qqYsWK2bZP4ljLcETTxgYSKX0JyZNY
21eEESRYGKmClixZ0lboiRMn2oqrL0b3y9rLivRerhMpxqh9+/amQYMGZufOnWbZsmVm/fr1fsfK
+MqXL2+nkdeXrdKgQFEHxZaUKVPGLFiwwKZN3RsanuygFZfVzaKp9rUYrZ5JI4dCCSOlXeLFPXOq
xN6jjz7q6X5Kc4kSJeywbeWJliPx8pzuPFGa1bBoRJICfrVfc/VoaHo0eZOahJGDRpWtWbPG/gtx
Sy7opaX10sKNSOOLPbZ7yya1EKxEuboonQWvvdhnqLbCi/17aZ/1USCPpoSKBhdIUAS2fbG0I5HS
l5A8ibV9RRhBoggjfU1runkHVWQtBRCtMIp0nUjCSF8OWjA22IRyOlaufzXqQg27hNeYMWPs3+p6
0FeJDN+hYcOGvknsdLwahm7duvldVx6jUF9FznpYWqvNuYcaAf0d6X5OmvW1E7j8SKTndPJE3jbd
w90FpC8/NRASV17zJrUKI0jxjVqSu3eobqNI9hmsrfBq/5HaZ8XGaZoG93WCtX3RtiNe0xdLniSk
faUNgkQRRoF9va+++qoNMnVe3F6FUaTrRBJGWu1eXxvqitNXQqR0uhch1FeQ0qTYEi1mq02G73QL
aDI77VecSGDjEC7GSDMES8QIPa9cujL+SPcLleZonnPbtm3x8llofhn3UOtYFv5FGAHC6MoJo0j2
GewYr/YfqX12Fsp2unlDtX3RtiNe0xdLniSkfaUNgssijLTKtl7czrwssQqjwOt4Ga6vFb/r169v
3bw636shKbhUaZJrV8LD2ebNm2f3O3PczJ8/PyphNHnyZPvlomBUiSTH4xTpfpEM18tzKnhY91AQ
sJvGjRtb9zHCCBBGKVcYebX/SO2zFp7V3xodlpjCyGv6YsmThLavtEGQ6MKoUaNGNlDOQUOgn3ji
Cd/fX331lSdhFHidaOYx0kzCMpRQ3qZAQ5LrVZPShZr9V+JM8ULuhkDnBP4WiASRhJFmClbQqtNH
Hul+Xg033HPq3grUDZyXR+t5NW/eHGEECKMkdu+2bdvGmwMqVmHk1f69tM+K5VEgs4PiGtW9lhBh
5DV9seRJYrWvtEEQszBSRXZGMHz22Wc2FkejFhw0Mktzuqg7Sqq9XLlyQYVRpOtEEkYaIaERWxIJ
nTt3tiNkojFaBRgqBkheHvWrK+jWPUJC/dMalSOvkQIF5bFR4xBp5IW60uT50oKabiLdL5ThRvOc
rVq1smnWqCc1RBoBorxfvnw5wggQRkns3rJtTengTI2QEGHk1f69tM9qqxTDo5G2iglSnKM+CjVK
MiHtiJf0xZonsbavtEGQKMJIal59uBpuqcnd2rVr5zcSS9H+t9xyi60IWkrA6bMOFEYKjgt3HS/B
1/LKSFBJhLgXsPRiSPrK6NKlixUx8vLIGHWeg7rTNExfaVejoKkFvMxjpGBrnTNixAi/3yPdL5Th
RvOcagyaNm1qv8wk4vTMgYukIowAYZQ07q2Rf1qgV94OtX8JFUZe7N9L+6zg5j59+ti2Rx4czXgu
0fHuu+8mqB3xkr5Y8yTW9pU2CBJFGDmVS9H9J0+eDHmRcNH/v/32m29SuJ9//jnsdcKhLwNNQJcQ
JMY07NMtytzs378/6Iiwy3W/xHhOjfZTrIB7PS5eTIAwSpr3PnjwoLXxxMKL/UczOkseHT3DwoUL
r1j6Ys2TWNpX2iBINGEEgDAC6l/Kq3/yHilkQN5pLR2j0V4aFZuUPrSof5BkhNHbb78db0ZRAF5M
QP1LOfVPEyMqVlKCSKETim3UPG1AG4QwAuDFBNQ/6h9QBwBhBLyYgPpH/QPqAHgWRprF1L3ga3JH
cYiRYpsVy6fldSJ1s2tZqXBe51DX0Si4xAzypmGgUQLqH1D/4AoII83CrHXOtNSFUCy2DtdWsqRW
mddMpMnjQUePNqZECWMKFTImUyYNjTcmyCLiZto0Y3LmNKZwYWMKFNAojfjHDBqkWWWNyZJFs3gH
v1+460yaNMlveCkNA40SUP+A+gfJQBgpGM89f4SEkWZ01+zrmixVAqNCheTxoOPGGbNyZdz/NZ+Y
luyRSHKP9JTI0zM5y5TpnFy5NN+G/7UeecSYgQPjBE8wYRTpOhKaWkF6mtQTDQONElD/gPoHSV8Y
aYbqokWL+nWjSRjVrfvXMX/7mzFp08Z1KSU3JkyI83z9dxFnS+fO/s8n5BkLmL/Rx403BhdGXq7z
n//8x84MS8NAoyT27t1rfvzxxyQzTFoT/4UbnaS5YzSBYKT0RroO9Q9o/yDZCCN19WjopptAYdSm
jTGVKv31d/fuxnTsaMyUKcaULWvMkCFxvyuc5o03jCld2pgcOYypWdMY1wzu5tFHjXGtEGK0eoiW
Ulu79q/fNHOAs0KHc58lS+K6xIoU+WufV2bMiBNG+/f/9dsNN8Tdx83TTxtTp050wsjLdfTC0Czg
WoKEhuHy31tzcmmfe9OMvIH7NU1FIM6imDVVcYNcr+Ql1aslFTYH6VeWKNCSC3VCVCINl9ZQ6UyZ
Mtn6oDRpvSqv6U5sBg0aZBcf1T0GhOgnlqczZ86cpnDhwqZAgQJ+yzxEc53UVP+01E+LFi3szPoF
CxY0o0aN8u1TvKGWzJAXWasDqJ65l7gQzzzzjOnbt6/fOVpv0llqKa5d7H6pXex4qf2dcqn9LXup
/R3iO1ZLfGhJEM0SXbx4cbtEiLNPa6WpLJWuwClawqUbEEapThjJQIcNGxZUGOkD8N//jutKutSu
u8RUXByPutsmTowLPBb9+hmTO3dc95N0gI675hpjdu+O2/+Pf8R1bbkFl5LlFjsSIV9++dd9JLLK
lzdGPX0vvxx3/J493h9c19D5fzU0xqRPb8x77/kf98ILcffyKoyiuU6xYsUupf1lGoYrJIy0zMqa
NWt827p16+IJEPfq3w56cQQTRjpWq3prv4RNhSD9ylouRudqaQTN8OtGswJr+YUnn3zSLqGgvydM
mGCXZfCa7sTmkUceuWSnA63gCSZoJP70rAv+20+sSQG1hM2xgP7mSNdJbfWvffv2pkGDBmbnzp1m
2bJlfuJXK8WrHii/9KGkj1Itd7HbaSCNsSKzdevWfsIo2PJLJS41wKqXEy81wDv+2wBLUEl0S6zq
t7lz5/oWvdZCr2XKlLHlqWtlz57dinUv6QaEUaoSRr/++qstXHWnBQojdZ1p02mKnQkUGwo2ds9A
r564rFmN6dTpr98Uy33J/i4ZXdzfs2ebS1/VWpU57m95gHSve++N+3vTprjjnV493SdPnr+6wdSV
p/PHjPH20O+/Hxfz89+2wXLkSNwzffih/7Gvvx7n5fIqjKK5zl133WWeliuJhuGKCKO777475Hna
r/Xx0qRJY5cwcKMuT+0LFEZ1Xe7Tv/3tb1b8nAvoV9ZLSutQKV3uhTnF2rVr7e/ffPNN2HSFS/fl
QouPBhM08iLXDegnlsdsRIj+5lDXSW31T3VAEykGjkZVqILW++rkaiAVgyiB0t5pIKMQRvL8uJcA
0bpi8hIF81hqn+49dOhQ329a11KLakdKNyCMUp0w0peKfl+xYkVQj9GPP8Z5aooVk4vXXxgFriKy
bVucUHDZr6Vevb+8RJc+lE3GjFqUNS5w+dI7yCxaZEy2bHGiR+1q06bh7yOh5GVtVHXzyXvlWp/V
J+AuvRNNwDqHpk8fY4oW9S6MormOvqobN25Mw5BEhJEWstSXuvtFoS9keU/1UgonjNq0aWO7xNx8
9913Nj1abkHeJC214EbdbFo0OJzXMKkJIy22HNjdInEfqqsQYRSHuq5Ut1QHHG9bXPu4LZ7AiWsf
611qH2tFLYwCl3HaunVrUFHu3qd6q0W+tekDoGrVqhHTDQijVCeM5NLX74GjpgJjjBYvjhM9TmhF
MMGyYUPcMfIKuZEecPdaXLJJ26WmBe3bttXXjLn0pRM3zP1//1dD3BMujL74Ik5sKd3ByJcvrrvP
jdJSrZp3YRTNddQAOatK0zBcfmGkr98DBw74Nn0xu/f36NHD/usWQL169bIxFn//+9+DCiOJm3//
+9+2y8jdBSHUTaF4DgUoq5tEadMK54GiQr8rhuTEiRNRpzsQdclpYc1Qm9dA6GCCRi9jCbn3AvqJ
X3jhBRsfgzAKf29Nf1K/fn3rlXTyxIlfmx3QQOqDyd2tG6swUtenjhut+UoCcPapK08CyNnUPRwp
3YAwSnXCSOjLITAQNVAYKaZHp48cGVqwqHtMXW+X3hHxxEPz5n/9reBsBVzfeadGxMX9po/QS+8j
60369deECSOlVV164brbnnzSmCZN/H9THNJLL0UnjLxeRy/Td955h4bhCgmjwCBmd+CqI4w0WlBd
Yoc0p4MxNmZDL61gwkjHadO1xgX0K0sMybviBMxK0OhYCa3A4+Qx0ktHMWeBMRyR0h2IBJg8XKG2
Dh06xCyMjhw5Yu//YUA/8euvv26vjTDydm/VgTyXGiyJm98vNZCqFy8GNJD5LjWQzV0NpET4E088
4fv7q6++8iSMtGp9xksN6AMPPBAvHRLY2ue1TrjTDQijVCmM1Oft/kJxhJG8uz/8EDeqTF4fdRs5
AyiCCRbRqpXiNOK6rySUJIJ0W/dgljVr4n6TR0dda45YUiCzJlN0E4swUlecrq2RbOohdDbnXmLZ
sjgvlRPbqoEbmo8oIOTEnD4dd566EhVYrv+7Q0u8XEdf9noZapg2DcOVEUbqKtAwc2dzDzV3hJG8
Nuo6GHlJ7SsGKG/evPbYUB4jDbHXXF8SNc+4+pUXL15s06JgWsXsaVPXiKbACDbE/euvv7b7NIpL
//ea7stFMEGjeBjV2fEB/cR9+vSxaUcYhb732LFj7QgviQrFadWoUcPVPraycWzqcpVQ0gg1Xcc9
2u+lS19Vystdu3ZZr45GmHkRRqJr1642YF4eTcUvyVMkT5Xo2bOnDfyePHmyFVFql9wj4sKlGxBG
qU4YafSChme6R0a4Z76WEJHY+O+oz7DC6JKt2WPlOdJIY50bGIOjtv7aa42pX/+v3xSTqnv9858J
F0Y33fRX2t3bf9sHH/I4K40ScvoIdkbCubnuuvjXcY2k9XQdDa3VaCQahisnjCLFGEkYOf9X14W6
iBQ7JEIJo0Ah5AzZl0gK9PQ42+IQfbnyyGhYdMuWLT2nO5CVK1fa0UehtnDeJi+CRp6MgQH9xG3b
tjXVQvQ3I4ziUHeouiE1gk+jDJe6ghwlRppeaiDlOZIwllcmUHyqPb7lllvs9W+61JipS9arMJLg
UT3W/bUpsHvkf9388hp16dLFfgwoEFuB2u5Z+cOlGxBGqU4YCQ3rfPjhhxPtZvKsyGuSROawC5tO
CSb3rNiJeR0FPd555522waJhSHrCSDFDehlcd0kBL1y40JMwUvyO7q0XjspV8/wMHz7c5y3Spu45
vZQ051Eo7r33Xj+REa0wmjlzphVWobbALr9ohZHEfJOAfuLy5ctbjwbCKPy9VS8Oh1moUbGdGhEZ
ziPoHnEWLbp/qOvLE6k6fD5Ioxcp3YAwSlXCKM7zMdq6d4N5W9hi3f5tfv75ZxqGKyyMAoOYtTkz
u7uFkdOdVqhQIV88RTBhpK4xdTOo60HBsupm0v+nTp1qv7yDBVOre1pf3/pS13xEmozPCabWuYr5
cMebREp3YnP69Gn7glbXoIJy9X/3FASay0bP5sylpG4dddMETnEQ6TqpURgBwghSiDACSCnCKFi3
1iLNCxEgjIQ8RSudxfVCCCPnGur6UFeIM5vw/fffb5566qmg6VBXhM6ZPn26mT9/vg1alndKIkzC
SucFjpYLl+7ERl6ywHv1Degn1seSunwUF6P0fxmkv9nLdRBGQPsHCCOgYaBRiocC8BWkrRij5II8
QArgPZ/Q/mbqH9D+AcIIaBholID6B9Q/QBgBDQONElD/gPoHCCOgYaBRAuofUP8AYQQ0DDRKQP0D
6h8gjICGgUYJqH9A/QOEEQAvJqD+AfUPEEYAvJiA+kf9o/5RBxBGALyYgPpH/QPqAMIIgBcTUP+o
f0AdQBgB8GIC6h/1D6gDCCMAXkxA/aP+AXUgRZchBQkpqVGgLgN1ECh7SLAwokAhpTQK1GOgHgJl
DokijJyCZWOLdaNxAuoA7SntH6QoYQS8dFNDGZ09e9Zs2bLF/Pjjj+bPP/9MUc8/fvx4M3r0aOoA
kP8ACCMMHsKX0Q8//GDq1KljMmTIYLJnz27Spk1rrrnmGlOjRo0U8/yPP/64efDBB6kDQP4DIIww
eAhdRvv27TO5cuUyZcuWNevXr7eeojNnzpi5c+eabt26IYywUyD/ARBGGHzqKaPnnnvOZMmSxRw6
dChFPz/CCDsl/wEQRhg8hC2jCxcu2C6zdu3ahT23devW8Y7ZunWrqVChgvnll19M9+7dTceOHc2S
JUtM9erVTZEiRcybb77pd/wnn3xiHnroIVOwYEFTsWJFM3LkSL/9Fy9eNL179zaFCxe2x/Tv3z/e
/sGDB5ty5cqZzJkzm+LFi5uPP/7Yt++NN94wpUuXNjly5DA1a9Y0q1evDiuMvJyj/OnRo4dNU7Fi
xczw4cPNPffcY8aOHespX7BTIP8BYYTBQzIqo927d9vfFZgcjnfffddkzJjR72XftWtXc++99/pE
hwRG+fLlzb/+9S/z8ssv2+vu2bPHd/zQoUPtvu3bt5tXXnnFCrLffvvNt//FF180ZcqUMQsWLDAf
ffSRjXX69NNPffv79u1r0qVLZwYNGmR27Nhhu/oUKC769etncufObQYOHGhWrVpl06Pr6/lCCSMv
5/Ts2dN2MyrtEjwSf2nSpDFvvfWWp3zBToH8B4QRBg/JqIwWLVpkf583b17Yc/Xil2hwRnWdO3fO
5M+f30ydOtUnOvLkyWNFj7NfgdxjxowJej0JIt131qxZ9u8//vjDZM2a1QoQh4YNG5rHHnvMt19e
IgWIB6KRdDq3U6dOvt/k6ZGwat++fVBh5OUcxVmpi9F9jLj++ut93rBI+YKdAvkPCCMMHpJRGW3a
tMn+HuxFLm+NupEcHnnkEdvdJGbMmGHy5s1rBUYwb4yQUJKHyM3ixYutt6hNmzb2vtOnT7e/yxuj
vytVqmRq165tNwmQqlWr+u1XV1og27Zts/vkZXJTr149U6tWraDCyMs53377rV8a3cLI8RhFyhfs
FMh/QBhh8JCMyuj333+3v6tbKRDF+xQoUMD392effWa7kTS0/4EHHvDzpEQSRhrp1qxZMxsXJG+L
PFRu0bF582ZfOhQ35GyOJ8vZH2weog0bNth9s2fP9vu9cePGpkqVKkHT6OUcjdbTMTNnzgwrjMLl
C3YK5D8gjDB4SGZlpO4pdf9IJIUTRuomypcvn+nQoYNJnz692bhxo2dhpFgg3X/hwoW+a7mFkbrK
FKujawdD3VraL+ERTNxp3iXFKLlRWps3bx40jV7PUcyU8sFB0xmoe80tjMLlC3YK5D8gjDB4SGZl
tG7dOvtCv+OOO2xQs0OXLl38hJF4/vnn7XUqV67s93skYaQgbHlVRo0aZQ4cOGCDmnUdjfJy0G8K
hp48ebIVQsePH/cbJaag5kyZMtkuPsUDyYskz49o1aqVKVWqlFm6dKkVPRptpusvX748ZBq9nKM0
KVbq2WeftZ4gjbi79tpr43XphcoX7BTIf0AYYfCQDMto7dq1dgi9jtGLXyOxsmXLZurWret3nISK
jgkcau8lxkjiQYHKEjd9+vSxw9wVUO10l8lrJDGmYxQYrX26roPEkmKTJOK0KVDaSYdEVNOmTa0X
SB4d3TtwpF1gGr2cI2+Q0ipB1LZtW/P9999b8abRaF7yBTsF8h8QRhg8JOMyOnHihH3JK14m2Fpp
Cp6WYJGoiAWdJ4HjIO9RIOfPn7ceJv0bDJ2v+J9g6Tt16lTIfaGI5hx5k9xdgomVL9gpNgiAMMLg
IRmWUaNGjcyTTz6ZavJMo9YULK7utnHjxtlRc/KsBYqo5JIv2Cn5D4AwwuAhkcpI3iQJgBUrVqSa
PFM8k0bTSRApBqtz587m6NGjyTZfsFPyHwBhhMEDZQTUAfIfAGGEwQNlBNQB8h8AYYTBQ5IoI80R
pPXMkiIafRZsskjqAJD/AAgjDJ4yuiwEzhAdiIbOK03uTcPmLweBQ/Uj/U0dAPIfAGGEwVNGV1wY
aULENWvW+DZNNplQtITHsGHD/H6bNGmS+eCDD0IKocD9wa5BHQDyHxBGgMFTRpdVGN19992Jfl9N
AnnXXXeFPSaSh8jLNagDQP4Dwggw+BRYRp988ol56KGHTMGCBe0cPYGzN3fv3t107NjRLFmyxM4A
XaRIETu3j5uLFy+aHj16mEKFCpkbbrjBLvWRUGGka2qdssKFC9u09e/fP2i6pkyZYsqWLWuGDBli
hg4damem1szZN998s51t231sKGHk3h/sGq1bt7YzdbvZunWrqVChgvnll1+wUyD/AWEEGHxKKSMJ
AS3dsX37dvPKK6/YJTl+++03PxFRunRpu6Cqjnv55ZfttTQ7tUO/fv1M3rx5rajSgrESElobLSHC
SMHbZcqUMQsWLLATLWoJEM0r5E5XiRIlTJUqVczEiRPtOm+7d++2C83edtttdjZqpSWYEAr3d7Br
aAkQLWLrFkFau+3ee+/FToH8B4QRYPAptYwkiHTcrFmz/ESD1hGTcBJaP0wLq44ZM8b3t9ZW69at
m9+15DEK9CwFCqN06dLZNdmczb1umjw2Em0ODRs2NI899phfuuRN+umnn/yuG6wbLNrg68BrSBBJ
MDoj2fTM+fPnN1OnTsVOgfwHhBFg8CmtjOQZkbdIgkDHTZ8+PaRoEO4FYnft2mXPCRQJXrrS5O2R
R8bZTp48afepm0rX1IzTtWvXtpuuV7Vq1bDpulzCSDzyyCOmZs2a9v8zZsywHrKzZ89ip0D+A8II
MPiUUkZa80tLXhQvXtx6d+SxiVYYbdq0yZ4zf/78qIVRqK60zZs322uqi+7jjz/2bY5H6WoIo88+
+8x2D2qBXXW1derUCTsF8h8QRoDBp6QykpfGvVq8uoiiFUYSV9dee62fCFJXWOBv0Qgjna+Yng4d
OoQ8P5Qwatu2rV3XLCHCKNg1lDf58uWzaUqfPr3ZuHEjdgrkPyCMAINPSWWkAGp5QUaNGmUOHDhg
evbsaY/TqDKvwkgo9qdUqVLWa7Rq1SpTv359O1ljpBijcMHXSotGh02ePNmcOXPGHD9+3KxevTqi
MBo7dqzJnDmzOXToUMzCKNg1hEaoKX80/xJ2CuQ/IIwAg0+BZaSXvQKLM2XKZPr06WOHpUsUON1W
XoSRutM0TF/3kKdIMTgJHa4vr1GXLl1s2hSIrTQpLZGE0bFjx0y1atWsx8kZYh+tMAp2DSFhpmcM
nNIAOwXyHxBGgMGnoDKSN0ZeGQd5j2Jh//79dv6hxOT8+fPWs6V/o+HgwYN+zxQLgddQkLoEmvIL
OwXyHxBGgMFTRqmaRo0amSeffJI6AOQ/IIwAg6eMUjcnTpywwmjFihXUASD/AWEEGDxlBNQBIP8B
YQQYPGUE1AEg/wEQRhh86iqjvXv3mh9//NHOS5SUGT9+vG9pjiuB1mybO3cudgrkP1CHyQIMPjWU
kRZm1dIbGq6vtcs0/9D69euvWLpCDbv3eny050dLpGkHsFMg/wFhBBh8CimjU6dO2UkUNdJKQ9D1
94QJE8z3339/xdI1adIk88EHH8QsjKI9H2EE5D8AwgiDh6BltHbtWvv7N998k2ye43J7iBBGQP4D
IIww+FRaRkePHrXrfr388sshz+vevbvp2LGjnc26YsWKdmbr5557zm9leU3q2Lt3b1O4cGFTsGBB
079/f79raP/gwYNNuXLl7ASJWrRWi8K6r+/wySefmIceesheR/cLnGU6UBgFnq9FXlu0aGHTqWto
uZNo0tmjRw9TqFAhO5O3lkZBGAH5D4AwwuBTURk9/fTTdt8zzzxj5+oJREKkZMmSpmbNmmbixIl2
CZEMGTL4CQ4FKJcpU8YsWLDAfPTRRyZ79uw2dsmhb9++Nn5p0KBBZseOHTaYWQvYBhM6Q4cOtcuN
bN++3bzyyit2SZDffvstpDAK/Lt9+/amQYMGZufOnWbZsmV+8VKR0tmvXz+TN29eK8aUvtatW9u1
5BBGQP4DIIww+FRSRhqFJo+RBECxYsXiBV5LeNx66602/sjhgQceME2aNLH/15pmWstMgsahYcOG
dmFZZ7+8RHXq1Al6/3BdYxJESvesWbM8C6Pq1aubZs2axVuaJFI6z507Z3LlymW6devmd548RuEW
w8VOgfwHhBFg8CmwjL7++mtTtGhROypN/w8nXF599VWTM2dOKz62bt1qr62RbbVr17abxETVqlXt
sc5+daV5FUZak0zeojZt2thzp0+f7lkYqYtOXiZ1w8kz5BApnbt27bL7p06dGk8Y4TEC8h8AYYTB
p8IyOnLkiI3NadmyZVjhMmDAACs+5G3avHmzvba6oSRKnG3evHn2WGd/qLmH3NfX9eTtUQySvDS6
RrTCSGzcuNHUr1/fesGUVnc6QqVz06ZNdv/8+fMRRkD+AyCMMHjKKI57773XVKtWLazw0JphN998
s/2/uqgyZsxoOnToEPR6Wp1e+9X9FkkYKa5H6Vy4cKH9W91bsQgjh169epk8efJYz1akdEqUSRS6
RZDOCfwNOwXyHxBGgMGn0DJat26dmTJlihUAYvXq1VY8KEjZLTzy5ctn5syZY//+7LPPbCyORmw5
9OzZ086HNHnyZCuENCeSruXQtWtXO4GkAp0vXLhgvTcbNmyIJ2z27NljvTwK7D5w4IC9rtLtvlck
YTR27Fg7Mk1iqHPnzqZGjRqe06l4o1KlSlmv0apVq6zXSV2LxBgB+Q+AMMLgU0EZSQDkyJHDDtnX
EHWJkqeeesonlBzhcccdd9iYHB2r0WXt2rUz58+f9/OsdOnSxXavKcBZwdY6z0EiRPFCuo82jQZz
huEHChuNetN1JKT69Olj76XrOV1eXoKvdQ+Jt8qVK5ulS5d6Tqe60zRMX3klT5GmKKArDch/AIQR
Bp/KykjrpMlDohijQNzC46effjInT54MeR2JJXl93KLJjQTSvn37Iq7HJk+OjnWQ9ygadO7hw4dj
Tuf+/fvjjWrDToH8B4QRYPCU0RWfaRqwU/IfAGGEwUOSLaO333473gzRgJ0C+Q8II8DgKSOgDgD5
DwgjwOApI6AOAPkPCCPA4CkjiBEFdmtduEiB5tQBbBAAYYTBQxIqIwVWa582LfOhuXy0yGtikxKC
uDWSzckrZ9MUB4FMmzbN5mXhwoVNgQIFzPLly7FTIP8BYYTBQ3IRRlWqVDErVqyw65mVLFnSLiab
2EyaNMl88MEHno6dOXOmGTZsWJIVRhMnTrTiR5uWFXGjySs1B5OzTtu4cePsnErHjh3DTrFBMgEQ
Rhg8JAdhVLduXd/fmglbx65cufKqpVWTQd51111JVhidOHEi5DGabdudn0Jic8SIEdgpNkgmAMII
g4fkJozk6dCxy5Yt8/2myQ579+5tu4YKFiwYb/i+lvno0aOH3S9vk5bwuOeee+zyHA7du3c3HTt2
9P2tZTtatGhhZ5jWNbUMiBg6dKhdtkMzU2s9Ns2E7SUNzvUl7MqWLWuGDBlyVYSRZs4OTNvTTz9t
6tSpg51ig2QCIIwweEhOwkgzRjdu3NiujSax46C108qUKWNF00cffWSX9NC6Zw5ag0zdRRI1W7du
tQJFsTfupTQCY4zat29vGjRoYHbu3GlF2Pr16+3vu3fvtgvO3nbbbWbx4sV2YVkvadD1S5QoYbsF
1dWlwOdgaFZtCZxQ29GjRyMKIz3fu+++a6/lRuJNy5G89957fr+/8MILpnTp0tgpNkgmAMIIg4fk
IIy0Tlq9evXs2mHlypUz27dv9+3X+mLy3kj0ODRs2NAGaTtiSgutdurUye+6WmPMvfhqsDXNmjVr
FnTpjcCutEhpcK4vb5KWLQnHwIED7ZpvobYOHTqEPPeXX36xAu2+++6zwixv3rx+njUtqaJ8/vDD
D/3Oe/311+21sVNsEABhhMFDMhBGxYsXN/369TNFihTxExtCHiCdW6lSJbuQrDaJnqpVq9r93377
rd0/ffr0eMIonMdIQctazLVixYq+QOVQwihSGoJd/3Kj4fjqslPeOZw9e9Z6ysaPH+93rBbDLVq0
KHaKDZIJgDDC4CE5CCOnK+3zzz+3x02dOtW3X6Os9JuEk8SMszmr3WtRWO3XSLJohJHYuHGjqV+/
vhUTAwYMCCmMIqUhGmGkoPJBgwaF3ObMmeM5TxVQrXT9+OOPvt/UDSmvlJu2bduaatWqYafYIJkA
CCMMHpKTMHIEhrqInNXp1Y2VMWPGsF1M5cuXt4HRDooXUvdaJGHk0KtXL5MnTx5ft5qExB133OHb
7yUNXoWRBFzLli1Dbhpe7xVNb6B8PXTokO+3J5980jRp0iRe/rz00kvYKTZIJgDCCIOH5CaMFKMj
kdKoUSPfbwqu1kixyZMn25giBR2vXr3ab3+GDBnMs88+a2ONFD+k0WYSDqGEi0asaWSaxJCGuNeo
UcNvn+Kd3IIjUhquRFfayZMnzalTp+z/FSReoUIF2xXoRjFHSvu6devs3/JsaV4jedawU2wQAGGE
wUMyE0ZCEzHq+AkTJti/5bHp0qWLjQlSELRe/BIiDufOnbNxNBJE8vZ8//33VsRo5FYo4aJjNYJL
o9kqV65sli5d6tunyRDV9SQvUbt27Tyl4UoII3mblGaNjlP3n2Kcvvvuu3jHjR492nrMSpUqZYOu
v/zyS+wUyH9AGGHwkNLKSAHHGrKuf8OhJTB0v4ULF4Y9Tp4fp8suGAcPHrTHxJKGy4HuuWvXLjtL
+P79+8MeK8/Shg0brko6sVPaSQCEEQYPV7GMNK+QhubL66MYHY0eUxdTUlpAFbBT8h8AYYTBwxUp
I020qDmJJIgUNK2YoXATJQJ2Sv4DIIwweKCMgDpA/gMgjDB4oIyAOgDkPyCMMHigjIA6AOQ/IIww
eKCMgDoA5D8gjDB4oIyAOgDkPyCMMHiyizIC6gCQ/4AwAgyeMgLqAJD/gDACDJ4yAuoAkP+AMAIM
njIC6gCQ/4AwAgyeMgLqAJD/gDACDJ4yAuoAkP+AMAIMnjIC6gCQ/wAIIwyeMgLPHDp0yGzfvt2c
O3cu6P6ffvrJHD58mDqADZIJgDDC4CGpl9GDDz5o97399tvx9m3YsMHuq1mzZrzj3VuWLFmC7k+T
Jo0pUqSIueuuu8y0adPi3ffuu+8Omqb777/f1KlTx+/Y3LlzmyNHjvgdt27dOnuf06dPe0pbYrNt
2zZTrlw5kzdvXpMrVy6TPn168/nnn/v2jx492pQoUcIUKlTIZMqUyVSvXt3MnTsXO8UGARBGGDwk
dWFUpUqVePt69+4dVBhVrlzZrFmzxrdJoATbP2fOHPPuu++aatWqWZE0ePDgmIWR0vHss89GFEbh
0paYHDt2zAqiV155xfz555/m/PnzZsmSJWbnzp2+Y8aNG2dWrlxp/y+vUq1ataxI0rHYKTYIgDDC
4CGJCqPrr7/eCpd9+/b57StVqpTdFyiMQgmaUPv/+OMP07BhQ5MxY0azf//+mISRzk2bNq1ZvXp1
WGEULm2JyZAhQ8wNN9wQ1TkTJkyw6VW3G3aKDQIgjDB4SKLCqF27duaaa64xQ4cO9f2+fv16kyNH
DtO6desECyMhMSDxJQ9LLMJI3qJ8+fJZz5Y8NFdbGCkdzz33XFTnzJgxw6bXEYfYKTYIgDDC4CEJ
CqMePXrYf90CqFevXqZFixbm73//ezxhpFiZAwcO+DZ5hLwIJ8UbPf744zEJI6XR8bioiyqUMAqX
tkCOHz9u9uzZE3I7evRoyHPz589v+vfvb4YNG2a7yBo0aGC++OKLsGWgZy9fvjx2ig0CIIwweEjq
wug///mP7apSLIxQ0PDs2bODCqPAAGfFEnkRRlWrVvXti0UYCQVyS5RI1HgJvnanLZCBAwdar1io
rUOHDkHPO3v2rPV+FS1a1LRs2dIGXDdr1sz+tmjRoqDnvP/++zZAe8uWLdgpNgiAMMLgIakLoxMn
TtjutJEjR5q1a9fawGIFCQcTRrVr17b7nM3p2ookeCS2JCQSIoy2bt1q4406deoUVBiFS1ticeHC
BSsiJfTcKCarUaNG8Y6fMmWKHVW3dOlS7BQbBEAYYfCQHISR8/977rnHvPDCC6ZNmzb2t2DCKJYY
I3VLZciQwbz++usJEkZCo+U0NN7pWos1xkgjxgYNGhRyC+dtKly4sOnatavfb23btjUVK1b0+03d
a9myZTOLFy/GTrFBMgEQRhg8JCdh9O9//9sKjuuuu84sXLgwUYWRxEz27Nl9XXUJEUYSQjfeeKMV
JwkRRjNnzrQerFCbE8sUjMaNG5vbb7/d7zfFGbk9RopTypo1qxkzZgx2CuQ/IIwweEhuwsjpTtNc
OxcvXgwpjAIDnLUp7iZw/969e82CBQvs6C0JLs1pFOk6CpaOJIyE4p+cOKJwwdfutCUmmqhR3Wkr
Vqywf69atcpO4vjJJ5/4jmnatKn1Fml+Ix3nbKdOncJOsUEAhBEGD0ldGAl5ipxJCUMJo8AAZ21O
0LF7v4RD8eLFrRdFwiHwvsGuo0BmL8JIPPzwwxGDr91pS2zeeecdK4YUW5QuXTrTt29fv/033XRT
0PRoRnHsFBsEQBhh8EAZpTjk/dEM2xolRx0A8h8QRoDBU0ZAHQDyHxBGgMFTRkAdAPIfEEaAwVNG
QB0A8h8QRoDBU0ZAHQDyHxBGgMFTRkAdAPIfEEaAwVNGQB0A8h8AYYTBU0ZAHQDyHwBhhMFTRkAd
APIfAGGEwVNGQB0A8h8AYYTBU0ZAHQDyHwBhhMFTRkAdAPIfAGGEwVNGQB0A8h8AYYTBU0ZAHQDy
HwBhhMEDZQTUAfIfAGGEwUMqLaNTp06Zb7/91pw9e5bCx07JfwCEEQYP3srowQcftPu0Zc2a1ZQv
X9689957lzUt999/v6lTp45fGnLnzm2OHDnid9y6detsuk6fPh0vrc6WJUsWv3P27t1r7rzzTpMu
XTqTLVs2kzFjRtOoUSNz9OjRK5LP+/btMzly5DA9evTAToH8B4QRBg/JURhVqVLFrFixwgwdOtRU
qFDBpEmTxmzYsOGKCiOl79lnn40ojCpXrmzWrFnj23SMw4EDB0zevHnt83z//ff2t02bNplSpUqZ
G2+80XqRLjf169e3aUYYAfkPCCMMHpKpMKpbt67v7y+//NIeO2rUqCsqjOTZSZs2rVm9enVYYXT3
3XeHvO7zzz9vcubMaX799Ve/33ft2mU9SIMGDbqsefzBBx+YwoULm4YNG5qePXtip0D+A8IIg4fk
Lox27txpjx0+fLj9+4cffjAtWrQw1157rSlYsKBPMLVu3dq0a9fO71pbt261HqdffvnFXLx40Qwe
PNiUK1fOZM6c2RQvXtx8/PHHIYWRvEX58uWz3p4///wzamF04cIFex+Jo2A0adLElCxZ8rLl78GD
B2134KxZs8xTTz2FMALyHxBGGDykBGHUp08fe+w333xj/27fvr1p0KCBFUzLli0z69evt7+/++67
1ssjEeTQtWtXc++999r/9+3b1+el2bFjh5k7d67ZsmVLSGGkrqcJEybYe48bNy5qYbR792577MSJ
E4PuHzBggPVIhQrGPn78uNmzZ0/ILVKMkuKYWrVqZf+PMALyHxBGGDyZkIyFkQKu5d256667rJhp
27atb3/16tVNs2bNrAfIjQTRNddcY0aPHm3/PnfunMmfP7+ZOnWq+eOPP6z3xi1+3IQSRkJp0HUk
VIIJIyeo2tnmzZtn9y1atMge6/wdiMSW9juxR4EMHDjQBk2H2jp06BAyb6dMmWKKFi1qTpw4gTAC
8h8QRoDBJ3dhpLgcCRJ5PP7v//7Pb7+6vySAKlasaBYsWOC375FHHjE1a9a0/58xY4YNfJZHRl1q
up/EVrTCSOfKE9WpU6egwkhdbfI8OdvJkyftvs2bN9tjp02bFvSeSov2O+Ilsfj5559tN+OwYcPs
9ADa9HzqapSnDDsF8h8QRhg8JDNh5O5KC8bGjRvtaCuNVlOXlMNnn31mf1Mc0gMPPGDFjFukON6k
aISR6N27t0mfPr2va81LV5qOUVpee+21oPsVD6UYplCsXLnSdvuF2ubMmRP0vC+++CLeFALOdv31
12OnQP4DwgiDh5QmjBx69epl8uTJ4+tWU/eZxIa6mSRkJKDEmTNnrNdHYikWYSSRo+H1GuEVzai0
hx56yJQoUSJet5+8Srly5QoZmC1mzpxpWrZsGXJz4p68oPykKw3If0AYYfCQAoXR2LFjrUdIYqNz
586mRo0afvslNnRtzS/kRoHYmTJlMp9++qkdMSYvkjM3UiRhJGbPnu3zvHgVRtu2bbOxTU888YSv
y+zw4cP2HHXzqdvrSoAwAvIfEEYYPJmQQoWRgq/lDZLHReJn6dKlfvs175CuPXLkSL/f5TVq06aN
PVdb9uzZfcd4EUbi4YcfjkoYCQkwTRmgIO3rrrvOjkSrXbu2nRH7SoEwAvIfEEYYPJmQgstIIkee
l2AsXrzYemk0iizUuVomw5mb6Eqh5UU0M7YTnA3YKfkPgDDC4OGyl5Hm73nyySfJYOwUyH9AGAEG
n7rLSHE8EkZaZw2wUyD/AWEEGDxlBNQBIP8BYQQYPGUE1AEg/wFhBBg8ZQTUASD/AWEEGDxlBNQB
IP8BYQQYPGUE1AEg/4E6TBZg8JQRUAeA/AdAGGHwlBFQB4D8B0AYYfCUEVAHgPwHQBhh8JQRUAeA
/AdAGGHwlBFQB4D8B0AYYfCUEVAHgPwHQBhh8JQRUAeA/AdAGGHwlBFQB4D8B0AYYfBAGQF1gPwH
QBhh8EAZAXWA/AdAGGHwQBkBdYD8B0AYYfBAGQF1gPwHQBhh8EAZAXWA/AdAGGHwQBkBdYD8B0AY
YfBAGQF1gPwHQBhh8EAZAXWA/AdAGGHwQBkBdYD8B0AYYfBAGQF1gPwHQBhh8EAZAXWA/AdAGGHw
QBkBdYD8B0AYYfBAGQF1gPwHQBhh8EAZAXWA/AdAGGHwQBkBdYD8B0AYYfBAGQF1gPwHQBhh8EAZ
AXWA/AdAGGHwQBkBdYD8B0AYYfBAGQF1gPwHQBhh8EAZAXUAyH9AGGHwQBkBdQDIf0AYYfBAGQF1
AMh/QBhh8EAZAXUAyH9AGAEGTxkBdQDIf0AYAQZPGQF1AMh/QBgBBk8ZAXUAyH9AGAEGn9rL6NSp
U+bbb781Z8+eTVH5c/78ebN9+3Zz4sSJiMeeO3fOHD16NOT+n376yRw+fBg7BfIfEEYYPCSnMipW
rJj9PdR2zz33+I7du3evufPOO026dOlMtmzZTMaMGU2jRo38BEI01xM6N0OGDKZOnTpB0/zggw+a
u++++7Lnzfvvv2/TkT9/fpM5c2b7nBs3box33KBBg+wzZMmSxQwYMCDe/tGjR5sSJUqYQoUKmUyZ
Mpnq1aubuXPnYqdA/gPCCIOH5FBGmzZtMmvWrLHbsGHD7DGffPKJ77cdO3bY4w4cOGDy5s1rqlSp
Yr7//nvfuaVKlTI33nij9SJFcz2HESNG2GPSpk1rDh48eNWE0dq1a83KlSvNn3/+aY4cOWIqV65s
WrVqFe+4Rx55xAwcONAUKFAgqDAaN26cvY44dOiQqVWrlhVJ8kZhp0D+A8IIg4dkVEazZ8+2xwSK
F/H888+bnDlzml9//dXv9127dlkPkjwp0VzPQUJLXhUdN3jw4KsmjAJ58803raAJhcRgMGEUyIQJ
E+yzqYsOOwXyHxBGGDykAGF04cIF270kcRSMJk2amJIlS0YtjL777ju7f+nSpaZChQqmYsWKSUYY
3Xfffeaxxx5LsDCaMWOGfcb9+/djp0D+A8IIg4eUIIx2795tf584cWLQ8yQQ1BUWGIwdSRi9+OKL
pnjx4rb7St1TOlZB3bEKo+PHj5s9e/aE3MIFSwsFS3/66adWAFarVs16wxIqjB5//HFTvnx57BTI
f0AYYfCQUoTRokWL7O/z5s0Lep7iarTfiT3yIowkhm644QbTt29f+7dimCSuevXqFbMwkrjKkSNH
yK1Dhw5hz+/Zs6cNqlY63nnnHTvyLCHCSAHduXLlMlu2bMFOgfwHhBEGDylFGG3evNn+Pm3atKDn
KTZI+wOHuYcTRosXL7b7Vq1aZeOWtClQuWjRolY0xSKMEgOJoa+//trcdNNNNj2xCqMpU6aY3Llz
225C7BTIf0AYYfCQgoTR6dOnTZo0acxrr70W9Lx27dqZfPnyeb6eeOaZZ0IO6ZdoikUYaTSYgsBD
bXPmzPGcV6G8YF6E0RdffGGnM3A/B3YK5D8gjDB4SCHCSDz00EN2fp6LFy/6/X7y5EnbXRQsMDvU
9c6cOWNHuA0fPtznLdKm4e3Zs2c3zz77bEzCaObMmaZly5YhN4kdrzhpDyVuQgkjxTJlzZrVjBkz
BjsF8h8QRhg8pFRhtG3bNjsy7YknnvB1mSlYWaJF8xv9/PPPnq83depUe61gM0y3bt3aCq0//vjD
J4w0nF8xSO7N2Z9YqLtQwsx5Lk3imCdPnnhplPdMczZpIst+/frZ/7tjkZo2bWq9RUuWLDErVqzw
bc48T9gpNgiAMMLgIQUII0c8aFi95i267rrrbJBy7dq17YzY0Vzv/vvvN0899VTQcxSTo3OmT5/u
E0bButs+//zzRM2bf/zjH/a6mrAyffr0pkiRIkFnrNZzB6bFCSAXik0Klt4NGzZgp0D+A8IIg4eU
WEaaGVqzWKsbLSVx7Ngxs3r1ajsZY7gRadQBIP8BYQQYPGUE1AEg/wFhBBg8ZQTUASD/ARBGGDxl
BNQBIP8BEEYYPGUE1AEg/wEQRhg8ZQTUASD/ARBGGDxlBNQBIP8BEEYYPGUE1AEg/wEQRhg8ZQTU
ASD/ARBGGDxlBNQBIP8BEEYYPFBGQB0g/wEQRhg8UEZAHSD/ARBGGDxQRkAdIP8BEEYYPFBGQB0g
/wEQRhg8UEZAHSD/ARBGGDxQTkDZUwYACCMMHigroMwpBwCEEQYPCS4vttSzAe0kAMIIgwegngL1
DwBhhMEDUE+B+geAMMLgAainQP0DQBhh8ADUU6D+ASCMMHgA6ilQ/wAQRhg8APUUqH8ACCMMHoB6
CtQ/AIQRBg9APQXqHwDCCIMHoJ4C9Q8AYYTBA1BPgfoHgDDC4AGop0D9A0AYYfAA1FOg/gEgjDB4
AOopUP8AEEYYPAD1FKh/AAgjDB6AegrUPwCEEQYPQD0F6h8AwgiDB6CeAvUPAGGEwQNQTwGof4Aw
wuABqKcA1D9AGGHwANRTAOofIIwweIAkX0/Z2K7mBoAwQhgBAHYOAAgjGkwAwM4BAGFEgwkA2DkA
IIxoMAEAOwcAhBHQYAJg5wCAMAIaTADsHAAQRkCDCYCdAwDCCGgwAbBzAEAYAQ0mAHZOJgAgjIAG
EwCwcwCgBaDBBADsHAAQRjSYAOBv36z5BQBYPsIIABBGAIAwQhgBQGhxBAAII0AYASCMEEYACCNA
GAEAwggAEEYIIwBAGAEAwghhBADYOQAgjGgwAQA7BwCEEQ0mJL36xMbG5m0DQBghjIC6BADYDCCM
MEygHgEAtgMII4wSqEMAgA0BwgiDBOoQAGBDgDDCIIE6BADYECCMMEigDgEANgQIIwwSqENh+Omn
n8zhw4cTfMzJkyfNtm3bzMWLF1NEvr344otm7ty5l+36u3btMr179zaPPvqo+eSTT1LM840fP96M
Hj2adhgAYYRBQvKqQ3p5lShRwhQqVMhkypTJVK9ePd6L0ssxf/75p3nhhRdM2rRp7XG5cuUys2bN
Svb5dv3115u33nrrslz7woULJnfu3Gbw4MFm8eLFZuXKlSnm+R5//HHz4IMPhvybdhgAYYRBQpKs
Q+PGjfO9kA8dOmRq1aplhc358+ejOmbatGkmR44cZuHChfbvYcOGmQwZMpi9e/cijEKwbNkyKyRP
nz7t+23mzJk271KaMJo0aZL54IMPEuXaVzqPaIcBYYQwglRchyZMmGCP3b59e1TH1K1b1zRq1Mj3
t0RT1qxZzcsvv4wwCoE8ccojN23atDF33XVXihNGicmVziPaYUAYIYwgFdehGTNm2GP3798f1THF
ihUzr732mt9xEkvyLoWie/fupmPHjmbKlCmmbNmyZsiQIfZ3xScp7qZw4cKmYMGCpn///n7nab+6
n8qVK2cyZ85sihcvbj7++GPfvjfeeMOULl3aerBq1qxpVq9e7fm+PXr0sN6wG264wQwfPjyecPjh
hx9MixYtzLXXXmvTNmrUqJDPp5ihhx56yB5XsWJFM3LkSN8+eU/0fPIY3XzzzTbGaOjQobZrTWJJ
vz3//POe8iPU8wTi5fmeeeYZ07dvX79zlJY5c+bEu5/qgZ5LefHcc8+Zs2fPhhRGzjleyjBcvsWa
R9GUG+0wIIwQRkAd8nuhlS9fPupj9JJ67LHH/H6rX7++jU0Kdx3tr1Klipk4caLZsWOH/V0BwWXK
lDELFiwwH330kcmePbv59NNPfefpxZ0uXTozaNAge47inbZs2WL39evXz744Bw4caFatWmXvcc01
15jdu3dHvK/OzZs3r30R63qtW7c2adKk8RMO7du3Nw0aNDA7d+60XWHr168P+Xx6if/rX/+ynrVX
XnnFpuO3336z+yQqu3XrZkWB4ovWrl1r0/jAAw+Y2267zf7mPFOk/Aj1PIF4eb577rnH/u4WMKo7
uq/7fiVLlrSiU/eTOFG3qVtsRIoxCleG4fIt1jyKptxohwFhhDAC6pDl/ffft0HTzssmmmP0YtJL
d8OGDfbvRYsWWW9IgQIFwgojfeFrtJvDH3/8Yb0Bejk6NGzY0Ce6tF9iok6dOvGuJ4+Fzu3UqZPv
NwU46yWpF2O4+547d84+l8SKG3lU3nzzTd/fCjxv1qxZ1KPu9GJXGbgD0tWVli1bNr/jAruJIuVH
qOcJxOvzeRVGt956qzl16pTvN4mVJk2aeBJG4crQS77FkkexlhvtMCCMEEaQSuuQumHkaVm6dGlM
xyiAWC9HeSDkvbjjjjvMww8/bCpVqhRWGAXGoWzdutWmVefVrl3bbnp5V61a1W+/umEC0TQBgS9x
Ua9ePb8uvWD31bB5nTt16tR4wsHtUVF3jzwY6uKRdyIS8mrI66GXua4/ffr0qIRRpPwI9TyBeH0+
r8Io8H6vvvqqyZkzp094hBNG4crQS77FkkfRlhvtMCCMEEaQiuvQF198YV/Qehkl5Bjx3XffmU2b
Ntnh+/pqlziKRhht3rzZplXdPnqZOdu8efP89gebI0feKu2bPXu23++NGze23Uzh7qs069z58+eH
FQ5i48aNtptQInDAgAFBn03PLw+FYmfkkVH6YxFGkfLDqzDy+nyxCiPlg4SHnjuSMApXhl7yLZY8
8lputMOAMEIYQSqvQ3v27LHdEGPGjAl5rpdjAjl+/LjtLgk3aWGwF6y6RTJmzGg6dOgQ9JwzZ87Y
/fJOBfL777/b7jt167nJly+fad68edj76oWswFy3SFBaAn9z06tXL5MnT56g3TPqalSeO9MXqCvL
izBq27at9bZ5zQ+vwsjr8ylg/oknnvD9/dVXX3kSRhqRqDizUMe4/w5Xhl7yLZY88lputMOAMEIY
QSqvQ02bNrUv5yVLlpgVK1b4Nnf8iJdjjhw5Yk6cOGH/r6H6+uqvUKFC2JdPqBd6z549bZfd5MmT
7UtUIss9sqxr1652okkF1yqGSB4DJ7apVatWplSpUra7T0JJI9T07MuXL494X8Wk6Fx5VRS4Le9C
lixZ/GJwxo4da0c46bk6d+5satSoEVJMyjOhgOQDBw7YZ1I6NBIsnDDS9SUoNV+U1/zwOjTey/O9
9NJL5sYbb7Rdb/K6aNRYMGEksemMVPvss89s/JL72SIFX4cqQy/5FkseeS032mFAGCGMIJXXoZtu
usnuC9wcoeH1GHmT5K3RyCC9JBVYe+zYsbBpCvVClwegS5cutmtGniq9BHWs22uk7pT06dPbTcHV
zpBuvRAl5JQWvfTlGdDyFF7uq+4mDWPXs8mTouHogV1NCuLVPfWMlStXDhuTpdFaegYJgD59+ph2
7drZZ3G6eIIJI+VZtWrVrAdEx3vJD6/CyMvzaYTYLbfcYo9RuX/77bdBhZE8Norl0ZQIGl2mtLon
/IwkjMKVYaR8iyWPoik32mFAGCGMgDqUKBw9etR+pf/yyy+Jcj29aOVBcL9w3ejlum/fPl9cixt5
s0Lti4SG0ofzdOm+kdaMc5BQ0/EO8oJ44eDBg37necmPxHo+EW6Em1vk6DitjxcrocrQS75Fm0fR
lBvtMCCMeKkBdQjAEylh3TNsCBBGGCRQh8gESBTefvvteDNLY0MACCMMEqhDANgQAMIIgwTqEAA2
BIAwwiCBOpTs0JxGWocLABsChBEGCZDq61CwmasBsCFAGGGQQB1CGAFgQ4AwwiABEEYII8CGAGGE
QQJ4qEPdu3c3HTt2NFOmTDFly5Y1Q4YMsb9rAsDevXubwoULm4IFC8Ybnu2cp9mI/9//+3/muuuu
s8s2aGK99u3bm/z585v77rvP7Ny503eOrqklOkqXLm1nTK5Zs6bfsg3PPvusXZLCjfbffvvt5vTp
0xHTpP09evQwhQoVsjM8Kz0II6AdBoQRBgnguQ5psr4SJUrY1ecnTpxol4QQClrW8h4LFiywy0Fo
yQata+U+T+tu/e///q/drwU8teTC/fffb5577jkzc+ZMu+aW1sRy0OrnWs9q4MCBdq0uXUNLOOze
vdvu1/pYWqrCPWuxrvXoo496SpOunzdvXru0hBYj1SrxWncLYQS0w4AwwiABPAsjeWDcS0Bo3Smt
NzV06FDfbw0bNrSLkLrPK1asmG+JBS06qnu88MILvmPkOZJwEmfPnrXX7NSpk2+/Fg+VuNFxQkuK
ZMiQwcyaNcuXDgkp/R0pTVqFXetgdevWze/55DFyL5IKQDsMCCMMEiCsMApc3mHr1q32+EqVKtmF
QrVJYFStWjXkeVq3SucsWrTI95u8RRUrVrT/37ZtW7zFSEW9evVMrVq1fH+r+61Zs2b2/zpWXWYS
UJHS5AizqVOnxhNGeIyAdhgQRhgkQMzCaPPmzfZ4dU19/PHHvs1Z3TwWYbRhwwa7f/bs2X73aty4
se3Gc5g8ebL1DP3+++9WJDkeoEhp0srx2j9//nyEEdAOA8IIgwRIPGGkbquMGTPauKFQRCuMJHTS
pk1r44Tc5MuXzzRv3tz3t46TMHrnnXdszJJihbykSauzKz7JLYJ0TuBvALTDgDDCIAGiEkaiZ8+e
Nr5HHpwzZ86Y48eP+40gi1YYiVatWtmA7aVLl1oBpBFqOmf58uV+91ZXmoKyK1euHFWaFG+k68tr
pODu+vXrmyxZshBjBLTDgDDCIAESJozkbenSpYsVKPLgZM6c2R6bEGEkIdO0aVPrOZJgyZMnjxk/
fny8eyvYWtcaMWJEVGlSd5qG6etceYpmzJhBVxrQDgPCCIMESLw6pKHze/bs8RtCn1BOnTpl9u3b
Z7u/Lkea9u/fb+c0AqAdBoQRBglAHQLAhgBhhEECUIcAsCFAGGGQANQhAGwIEEYYJAB1CAAbAoQR
BglAHQLAhgBhhEECUIcAsCFAGJFZGCRQhwCwIUAYAQYJ1CEAbAgQRoBBAnUIABsChBFgkEAdAsCG
AGEEGCRQhwCwIUAYAQYJ1CEAbAgQRoBBAnUIABsCQBhhkEAdAsCGABBGGCRQjwCwHQCEEUYJ1CUA
bAYAYYRhQpKsT2xsbN42AIQRwggAsHMAQBjRYAIAdg4ACCMaTADAzgEAYUSDCQDYOQAgjGgwAQA7
BwCEEQ0mAGDnAIAwosEEAOwcABBGNJgAgJ0DAMKIBhMAsHMAQBjRYAIAdg4ACCMaTADAzgEAYUSD
CQDYOQAgjGgwAQA7BwCEEQ0mAGDnAIAwosEEAOwcABBGNJgAgJ0DAMIIaDABsHMAQBgBDSYAdg4A
CCOgwQTAzgEAYQQ0mADYOQAgjIAGEwA7JxMAEEZAgwkA2DkA0ALQYAIAdg4ACCMaTADAzgEAYUSD
CQDYOQAgjGgwAQA7BwCEEQ0mAGDnAIAwosEEAOwcABBGNJgAgJ0DAMKIBhMAsHMAQBjRYAIAdg4A
CCMaTADAzgEAYUSDCQDYOQAgjGgwAQA7BwCEEQ0mAGDnAIAwosEEAOwcABBGNJgAgJ0DAMKIBhMA
sHMAQBjRYAIAdg4ACCMaTADAzgEAYUSDCQDYOSSZ8mdLPRvCiAYTALBzoOwhTJlTCzAaAMDOKXfK
nbJHGGE4AICdA2UO/nWA2oDxAAB2TpkDdQBhhPEAAHYOlDkgjDAeAMDOgTIHhBHGAwDYOURb5j/9
9JM5fPhwgo85f/682bFjh/nzzz9TRL69+OKLZu7cuQgjjAcAsHNIDWU+evRoU6JECVOoUCGTKVMm
U7169XhCwMsxYtq0aSZnzpymcOHCpkCBAmb58uXJPt+uv/5689ZbbyGMMB4AwM4hNZT5uHHjzMqV
K+3/Dx06ZGrVqmUFkDw/0RyzefNmK5oWLFjgOydXrlzm2LFjCCOEEQ0mAGDnkDzLfMKECfbY7du3
R3VM586dTd26df2OK1mypBkxYgTCCGFEgwkA2DkkzzKfMWOGPXb//v1RHXPDDTeY/v37+x339NNP
mzp16oS8Tvfu3U3Hjh3NlClTTNmyZc2QIUPs7xcvXjS9e/e2XXIFCxaMd13tHzx4sClXrpzJnDmz
KV68uPn44499+9544w1TunRpkyNHDlOzZk2zevVqz/ft0aOH9YbpeYYPHx5PGP3www+mRYsW5tpr
r7VpGzVqFMII4wEA7BxSapk//vjjpnz58lEdI0GRPn1689577/kd98ILL1iBEu46il2qUqWKmThx
og3aFgp4LlOmjO2W++ijj0z27NnNp59+6juvb9++Jl26dGbQoEH2HMU7bdmyxe7r16+fyZ07txk4
cKBZtWqVvcc111xjdu/eHfG+Ojdv3rxm5MiR9nqtW7c2adKk8RNG7du3Nw0aNDA7d+40y5YtM+vX
r0cYYTwAgJ1DSizz999/38YFOSLD6zFHjhyx1//www/9jn399det1yacMJJXSKPdHP744w+TNWtW
M3ToUN9vDRs2NI899phvv7xEwTxRZ8+eted26tTJ99uFCxessJKgCXffc+fO2efq1q2b3zXlMXrz
zTd9fyvwvFmzZlYMJuc6QAtAgwkA2DllHgZ1K8nTsnTp0qiPkSCRZ2X8+PF+v/fp08cULVo0rDB6
8MEH/X7bunWrTWulSpVM7dq17SZxUrVqVb/96koLZNu2bXafvExu6tWrZwPGw913165d9typU6fG
E0Zuj5G67OSBqlixoi/QHGFEgwkA2DmkoDL/4osvTLZs2czixYtjPiZfvny2+8pN27ZtTbVq1aIS
RhrdprSqW0sixNnmzZvnt19TCASyYcMGu2/27Nl+vzdu3Nh2m4W776ZNm+y58+fPDyuMxMaNG039
+vWtGBwwYADCiAYTALBzSCllvmfPHtv9NGbMmJDnejnmySefNE2aNPH7TXFIL730UlTCSF1lGTNm
NB06dAh6zpkzZ+z+Bx54IN6+33//3aRNm9bGKAWKtubNm4e9ryakVEC1WwQpLYG/uenVq5fJkydP
sulWQxjRYAIAdg4Ryrxp06bWE7RkyRKzYsUK33bq1KmojlEgsmJ/1q1bZ/+Wl0fzGu3bty8qYSR6
9uxpu+wmT55shdDx48f9RpZ17drVXlsB2YohkhdJ3iLRqlUrU6pUKdvdJ6GkEWp6dvdkk6Huqzgm
nSuvkQK35RXKkiWLX4zR2LFj7cg0iSFNUVCjRo1kWQdoAWgwAQA7p8yDcNNNN9l9gZsjNLweI9S9
JSEhcaGg6y+//DJsmkIJFHlqunTpYmN55KmS4NKxDhJLbdq0sSPhtCm4WiPJhESUhJw8R0qLPDqB
sU+h7qvuNA3T17PJU6RpCQK70hR8rXsqULty5cphY7IQRjSYAICdQyovc3mRJJjcs2LHiq6hbrxQ
15JAkkcq2LpsSkeofZHQ/Ezhusd030hrxiGMMB4AwM6BMgeEEcYDANg5UOaAMMJ4AAA7B8ocEEYY
DwBg50CZA8II4wEA7Bwo86jQiLBgkzFGi+Ym0ppoV/saCCOMBwCwc6DMYybU0PhoCTYD9dW4BsII
4wEA7Bwoc4QRwgjjAQDsHChzhBHCCOOhwQTAziHVlLkmMuzdu7cpXLiwKViwoOnfv79v3y+//GLu
uOMO89prr/l+0xIcWqfMPZu0rqHV7suVK2dnqS5evLhdEiSYMHrmmWdM3759/c69+eabzZw5c/x+
69GjhylUqJCdiXr48OHxRE24dHu9BsIIaDABADunzP1QQHKZMmXMggULzEcffWSX19AaZA7/+c9/
7PIaixcvtn9LAJUtW9Yu2+EgoZMuXTozaNAgs2PHDhvgvGXLlqDC6J577jGtW7f2EzBKm+7t0K9f
P5M3b167zIeuo+O1kr1b1ERKt5drIIyABhMAsHPK3IfEjdYiGzp0qO+3hg0b2sVU3Tz11FOmSJEi
diFXLSb79ddf+11DXqI6deoEvW+0wujcuXN2HbJu3br5XUfeHmcx10jp9nINhBHQYAIAdk6Z+7F1
61b7e6VKlUzt2rXtJvFQtWpVv+N+++032z2WMWNG8/e//3/2zgRIqurs38UqwYjKkowTURHZBBQJ
CYvAX6IgS4xIogRUKlHC5rB8wzIBZHOw1IBhCCJahEgoGYIRUPlAEQZZBA2EAA6MBAwohC2RRUQM
Szz/+r1Vt7/unu6+t2djGJ6nqgv6Luee0+e85/7mPcv7RMw05EkqCmH0ySef2PeFCxfmEzWet8cv
30HSQBgBHSYAYOfUeQS5ubl2XMNOmhPkfVauXBlx3YkTJ8xjpKGoF154IWYa8fYqSlYYKcK9vq9a
tSquqPHLd5A0EEZAhwkA2Dl1HoGGpOQFSktLS3hv7969Xbdu3WwYSsNmO3fuDJ1TpHmloQnZQYRR
x44dXa9evULf16xZEyGMvvnmG1ezZs0IAaN8hh/zy3eQNBBGQIcJANg5dZ6PjIwMd+2117rs7GwT
OSdPnrS5RB4LFixwtWrVckeOHDHBoblETZs2tWs9hg8f7qpUqWKTn7VqTR6dbdu2xRRG48aNc3Xq
1LHhLnl5tJItevK15grVq1fPPD6bNm1ynTt3dlWrVo2YH+SX7yBpIIyADhMAsHPqPAJ5UtLT090V
V1xhE5rlEZKYEQcOHDDx8eabb4auP3z4sAmlgQMHho5JmPTr189VrFjRPlohptVgsYSRVq1JWCk/
jRo1Mu9TtDDSUJiW2Ou4vDxLlizJNwyWKN9B00AYAR0mAGDn1HlMzp8/7/bt22f/FhQJpP3795tn
yY+jR4/6XiNhpjlIhcl3kDQQRkCHCYCd8yNQ54AwAowHALBz6hxoA7QGjAcAsHPqHGgDCCOMBwCw
c6DOAWGE8QAAdg7UOSCMMB4AwM6BOgeEEcYDANg5UOeAMMJ4AAA7B+ocEEYYDwBg50CdA8II4wEA
7Byoc0AYYTwAgJ0DdQ4II4wHALBzoM4BYYTxAAB2DtQ5IIwwHgDAzoE6B4QRxgMA2DlchDo/d+6c
+/zzzwv9rMOHD7tdu3ZZeqWBJ5980r377ru0AYQRHSYAYOfgX+dTp051d999t6tataqbPHlyvvM6
pvtjff773/+Grvv444/drbfe6mrUqOGuueYaV7FiRfe///u/F73s119/vXvuuedC33/+85+7n/zk
JwgjoMMEAOycOs/Pz372MzdlyhT33e9+N6Yw+stf/uKmTZsW8XnggQfcd77zHffNN9/YNceOHTNB
NGnSJDt2/vx5t27dOrdnz54C5Xfp0qVu+vTpxSKM5s+f7+bOnYswAjpMAMDOqfP41KlTJ6YwikZD
ZPXr13e///3vQ8cklm666aYiy2+/fv3cXXfdVSzCiDaAMKLDBADsnDovMmH0u9/9zrVo0SJiGK1l
y5Zu4MCBSeXp008/dX369HE1a9Z0KSkpbtasWXY8KyvLXXvtte7KK690TZo0cUOGDLHjffv2dePH
jw/dr+fr/IoVKyKOjRo1yl133XUm1GbMmJFPGI0cOdINHjw44p4xY8a41NRUy0dmZmagfCKMMB4A
wM7hMhdGJ06csCGz9evXRxzXsJoEhYa/2rdv77p06eLefvvthGkNGjTIrtNw24YNG9zWrVvt+N69
e919993nmjVr5tauXet27NhhxzUP6vHHH48QNCrXa6+9Fjo2YcIEy9+LL75o9+n6cuXKJZxjpMnZ
DRo0cDk5OZbWVVdd5d544w3ffCKMMB4AwM7hMhdGw4cPd506dYo4dvbsWRMfN9xwg/vFL35hE657
9+5tx9577724ad155512XbjnySPWUJqfMNIQnyZ9jxgxIuI+eYyeffbZmMLoP//5j3mm5KXy6Nq1
q+vZs2egfCKMMB4AwM7hMhVG+/btc5UrV3YffPBBxPELFy648uXLu1atWkUcr1evnrv//vvjpvf6
66+7K664wt1xxx3mrSmsMPrkk0/s+8KFC/MJo3geo7y8PLunefPmrkOHDvbR9eFlSZRPhBHGAwDY
OVymwkjeoDZt2sQ8p/k58iaF079/fxMTidi+fbvr3LmzeZfCn10QYfTRRx/Z91WrVgUWRrm5uXaP
huAkgLzPypUrA+UTYYTxAAB2DpehMPr73//uKlSoEHeZe/fu3d33v//9iGOal5PIYxTO6NGjXfXq
1UPDVRJV0SKsY8eOrlevXqHva9asiRBG2iZAE6TDRZCGyqKPRQ+lyQuWlpZWoHwijDAeAMDOoYzV
+ZkzZ9xXX33lbrzxRvOc6P/Ru1ZPnDjRVapUyZ0+fTpmGtpZWsNp3jDbpk2bXJUqVdzixYvjPnfO
nDm24ksiY9iwYa5t27YR5771rW/ZLtoe48aNM/GmITN5dbSZZPTka80N0hCevEbKg7w82rgy3hwj
kZGRYavgsrOz3ddff+1OnjzpNm/eHCifCCM6TADAzqGM1fn3vve9fDtahy+LFxID0XOIovntb39r
YkjCRN6l6DSi0aRm7Y6tCdNa/h++0k0bRrZu3dq8OQMGDLBju3fvdk2bNrX8NWrUyO3cuTOfMNJw
mpbp67g8RUuWLPHd+Vpeo/T0dJtHpInYEmS6Jkg+EUZ0mACAnQN1Hhd5m/7617+a1yUI8tAcOXIk
7vlDhw7ZNeEcPXrUN90DBw4kPdyl3bo1wVz/JptPhBHGAwDYOVDngDDCeAAAOwfqHBBGGA8AYOdA
nQPCCOMBAOwcqHNAGPHDAQB2DpdhnSt2mJbfl2aKIo+XQjkRRnSYAICdw0Wuc7/l7aWB6DxerDQQ
RhgPAGDncJkJo/nz58fd8RphhDDCeAAAO4fLShiVRhBGCCM6TADAzqHI61ybII4aNcpdd911tmP0
jBkz8gmGkSNHusGDB4e+KzxGnz59bGfplJQUN2vWrIj0nn/+eQvXoR2kb775ZgvfIRQepEePHnaP
gsu++OKLEXnxnrNgwQLXsGFDN23atMB51DVjxoyxYLZKPzMzM+lyRuOX30S/A8KIDhMAsHO4BOtc
sdFq1KhhL/0dO3ZY9HpFkE80x2jQoEEWIHbPnj1uw4YNbuvWraFzCgOicCBTp061EB6a3Kx0RVZW
lps5c6bbtWuXmzRpkoXgOHXqVMRz6tat61q2bOnmzZtn9wfNoyZSN2jQwOXk5FiIkKuuusq98cYb
SZUzGr/8JvodEEZ0mACAncMlVucKFKv4XyNGjIg4Lk9KoqCrih3Wu3fvfCE3FHNMXqJ77rnHNz8S
GMrTsmXLIp4jj094yI8gedRzFeNMQsaja9euFlA2mXImm994vwPCiA4TALBzuATrXFHqdXzhwoX5
BEMij5GGxuQ90fCSPDQeeXl5lp6G0uKxdu1a877069fPrl20aFHc5wTNo/fc5s2buw4dOthH572g
t0HLmWx+4/0OCCM6TADAzuESrHNFotfxVatWJSWMxPbt213nzp1tOGry5Ml2LDc319J7+eWX8z3r
m2++Me+K5hzJS7Ny5cpAwihIHr3narhMYsX76BnJlDPZ/Mb7HRBGdJgAgJ3DJVjnevlr4nC4ONCw
VPSxRPsYjR492lWvXt2GkxSBvnLlyu6+++7Ld53m9SgPq1evtu8a3goijILkUd/13LS0tLgiJ0g5
k81vvN8BYUSHCQDYOVyida55OPXq1TNvyqZNm8z7UbVq1YRzjObMmWMrsiQChg0b5tq2bRs6N3z4
cFelShWb+HzhwgXz5mzbts3t27fPvCpauXXw4EGXkZFhedLqMD8BFiSPSu/aa6912dnZJtBOnjzp
Nm/enFQa4QTJb6LfAWFEhwkA2DlcgnWuYSYtX9d5eVCWLFniO5SmSccVK1a0Cc0tWrRw69evD52T
KNF8HJ3XR6vDvGXuQ4YMsTk5Ek5jx451AwYMsMna3pBXPGEUJI/yAKWnp1v6moitdJVeMmlE45ff
RL8DwogOEwCwc7iE6/zAgQNJDQNJAB05ciTh+f3799swVjjy5Oich7wxQQmSx/Pnz5u3R/8WRTn9
8uv3OyCM6DABADsH6hwQRhgPAGDnQJ0DwgjjAQDsHKhzQBhhPACAnQN1DggjjAcAsHO4DOr8lVde
iblZY1FTUs8pa3lDGNFhAgB2DiVY54k2dixKCvOc4s5jSf0GCCM6TADAzgFhVOjnzJ8/382dO/ey
EUZLly5106dPRxjRYQIAdg4Io5KntOVNm2feddddCCM6TADAzqE46lybHT7//PPu1ltvtV2dFTRV
AVhjiQJdO2bMGJeamupSUlJcZmZmRFqLFy92PXr0sHOKOO/teO0xcuRIN3jwYLdgwQLXsGFDN23a
tHzPefzxx22H6XDy8vLcbbfd5o4fP54v/16afs+Id9yvTMn8Br/61a/cuHHjIu5XWJLvf//77syZ
M4F/n3Xr1tmu2rVr144IWZKVlWVhT7Szd5MmTWxnboQRHSYAYOdQhHU+fvx4V6FCBTd16lS3e/du
9+6771oA1Vii4Mknn3QNGjRwOTk57rXXXrNwH4qJFv7injlzptu1a5ebNGmShdM4depUhMioW7eu
a9mypZs3b549L/o5L730kgWEDRdBir927733BvLoJHpGrON+ZUrmN1BcNYUbCd91e+DAge7BBx8M
/PvUr1/fNW7c2K6bOHGi1Zt28hZ79+61AL3NmjVza9euDdUTwogOEwCwcyiCOld8MXmJ7rnnHl/R
oWvlqdDL3aNr164WnDUWeuHrmcuWLYtIT56Wo0ePxn2OBJEEg7cSTFHtv/Od77iFCxcGFkbxnhF9
PEiZkvkNPv/8c1epUqVQmXW9PDzhv4Hf71O9enUTTl7Zld7s2bND1zCURocJANg5FFOda4hKxzWU
5ic6vGubN2/uOnToYB8FYW3VqlXEPfJkyBuiF7iuX7RoUVwRE+/4z372M9euXTv7v4K91qhRw509
ezawMAryjKBlSvY36Natm+vdu7f9Xx4lDZtduHChwL+PhJK8RwgjOkwAwM6hmOs8NzfXjsfbpyf8
Re1dO2HCBJuD5H28SPMKFitBoDlKmhej4wUVRm+99ZYrV66c+/TTT23oaOjQoXHLVRhh5FemZH8D
kZ2dbV6l06dPm0gaMWJEoX4fhBEdJgBg51BCda7I8JrPI/HhJzo0LKRr09LSYl6r+S56xurVq+27
hoEKKox0b61atexZFStWdNu3by8WYeRXpmR/AyFBJGH029/+1vLuzQMq6O8TLYz69+/v2rRpgzCi
wwQA7ByKo841sblKlSo2gVhDPvKKbNu2LeaLOiMjw+bMyCsiUXXy5ElbdSU0QVheHk1APnjwoF2r
Z86YMaNAokUrrnR/ixYtEparMMLIr0zJ/gYe8gxpnlR43gv6+0QLozlz5ti8sMOHDyOM6DABADuH
oq5zvdw1PCPvhj5aZeUtI49+Uctjkp6ebi99eUX0gtY14WJG5yS0xo4da8vudY031JSMaJHYUJ6j
l7QXtTDyK1Oyv4HQhGrl/YUXXsgn9pL9faKF0bFjx1zr1q3NcxW9rQHCiA4TALBzKKI6l0Dav3+/
zYXxQ8vR5QEJX5buIQ+K0vKQd6QgaJKyRIPSKwkSlakori/q3+fQoUMR6SCM6DABADuHMlzn999/
v3v44YepuGJqA/QAdJgAgJ1T55cIX3zxhQmjDz74gIpDGGE8AICdA3UOCCOMBwCwc6DOAWGE8QAA
dg7UOSCMMB4AwM6BOgeEEcYDANg5UOeAMMJ4AAA7B+ocEEYYDwBg50CdA8II4wEA7Byoc0AYYTwA
gJ0DdQ4II4wHALBzoM4BYYTxAAB2DtQ5IIwwHgDAzoE6B4QRxgMA2DlQ55crr7zyinv55ZfjfkcY
YTwAgJ3DJVzn+/fvd9WqVXOjRo0q1DWXKj//+c/dT37ykwJfn+z9CCM6TADAzqEU13nnzp3tukSi
J8g1RcnSpUvd9OnTSyTd+fPnu7lz5yKMgA4TADuHy73OJQhSU1Nd165dXUZGRoGvKWr69evn7rrr
rlKZLsII4wEA7BzKYJ0fOnTIXXvttW7ZsmXukUceiSl6glwTzsiRI93gwYPdkiVL3B133OFq1qzp
Bg4c6M6ePRu65r///a975plnXP369W14rl27dm7z5s2h81lZWfbMK6+80jVp0sQNGTIkdN+YMWNM
pKWkpLjMzMyYz163bp278847Xe3atd2zzz7rm653n8fixYtdjx497Bkqw4svvhhYGD3++ONuwIAB
Edfn5eW52267zR0/fhxhRIcJANg5lNY6v//++91jjz1m/48neoJcEy0abrnlFhM78+bNM/FRqVIl
N2vWrNA1EyZMMIEyZcoUt2nTJrvniiuucHv37rXz+ve+++5zzZo1c2vXrnU7duyw408++aRr0KCB
y8nJca+99pq76qqr3BtvvBHxbImtxo0bu5kzZ7qJEyda+fft25cw3WihIwGl+3ft2uUmTZpkeTt1
6lQgYfTSSy+5ypUrR4ig4cOHu3vvvRePER0mAGDnUFrrfMGCBe6GG25wX3zxRVzRE+SaWMLo9ttv
d1999VXomMTIAw88YP+X50gem6FDh4bOX7hwwUTOoEGDQseih7z+85//2H0SLR4a2uvZs2fEs6tX
r26CRpw7d85E2ezZs+OmG0vohCNBpN9QHrMgwkiCSELKW6WmPHznO99xCxcuRBjRYQIAdg6lsc7/
9a9/2RCXJiHv3LnTPj/+8Y9tGGj37t2Br4knjKJFxlNPPeWuvvpqGwr7+OOPLU/y+ITTqVMn1759
+7gCRsNRuq958+auQ4cO9rn++utdq1atEj5bQknen2SFkTxK8hbpej130aJFgYSR+NnPfmYeM6Eh
xRo1akQMJSKM6DABADuHUlTnb7/9th2P9ZHYCHpNUGE0efJk86J88803btu2bZbG8uXLI67p3r27
a9myZVwBk5uba/dpGO71118PfVauXFmkwkh57N27t7v55pttfpLST1YYvfXWW65cuXLu008/NW9Z
uHcMYUSHCQDYOVwCdd6xY0ffYbIg18QSJ5qnpMnO4vTp0658+fI2XyicWrVquUcffTT0vX///q5N
mzah7xpK09ydtLS0pJ4dLYyi042+T/OO9JutXr3avmsoLFlhpHtUHuW1YsWKbvv27QgjOkwAwM7h
chVGEgUrVqyw7/KeXHPNNW7GjBmhazSZu169em79+vUmlLRCTfncuHFj6Jo5c+a4b33rW+7w4cOh
Y3q2Jm1nZ2e7r7/+2p08eTJiNVsQYRQr3fD7NFFb3h5NFj948KA9U3kLz3+Q5fqadK77WrRoUara
AD0AHSYAYOfUeQkLI3lkNAdIS/ErVKhgy9fPnz8fukaC5qGHHjLPUdWqVU28KKxGOMeOHXOtW7c2
L5G3/F1eo/T0dBuW00RsCRw9LxlhFCvd6PskavSMKlWquLFjx9p1epY3bBdEGEmw6bePXuqPMKLD
BADsHC6jOg8XCUePHnVffvll3Gu1ck2hRjSvJx7aR0neoXAksuTZCRdbyRIr3XAk3sLPy3uUDJq8
LTGldBBGGA8AYOeAMLqs0byqhx9+uNS1AXoAOkwAwM6p8xLkN7/5Tb4dqS83tO+ThNEHH3yAMMJ4
AAA7B+ocSmsboDVgPACAnVPnQBtAGGE8AICdQ8HrXKvEvLAWRUWQNIvjucWB9mF69913EUYYDwBg
53A51HmQJenFkcalMnlbu38/99xzl0S+EUZ0mACAnUMRC6P58+e7uXPnJpVG9D0XWxgtXbrUYr8V
hzAqyO+DMKLDBADsHC5RYVQUXGxhFCtOWlEJo0ulDdAD0GECAHZOncdAke7HjBnjUlNTXUpKSr4l
9tECZeTIkW7w4MGh7xcuXHCjRo2y+2+88UYLmXH33XdbyI1493hpKuL8HXfc4WrWrOkGDhwYEXk+
+rl++YxGgVv79Oljaet6hfYQWVlZFk5EO2Yrbpt2txZ9+/Z148ePj3ieznshTbxjKut1113nbrrp
JitrtDCKLqtfvuPlE2FEhwkA2DlchDrX5OEGDRq4nJwc99prr7mrrrrKvfHGG3EFSvR3hQZRDDQJ
jry8PBMFijGWaN6Nvt9yyy2uXbt2bt68eSZOKlWqFCEKou/xy2c0gwYNcl26dHF79uxxGzZscFu3
brXje/futUj3zZo1s12pFSxWSMw9/vjjEYJGv5me5TFhwgRXo0YNC++h+3S9X1n98h0vnwgjOkwA
wM6hhOtcMcfkOZGo8ejatavr2bNnIGGkUBmKcTZ06NCIdOVFefbZZxOmcfvtt1soEA+JlQceeCDm
PUHyGc2dd97pevfubQInmlhDaX7C6Ny5cyYAR4wYEbisQfKdKJ8IIzpMAMDOoQTrXB4eHW/evLkF
e9VHL/pWrVoFEkY7d+60+xctWpRPLPh5jKLnDz311FPu6quvDgmE8GuC5DOa119/3QLAaqhO3prC
CqNPPvnEvi9cuDBwWYPkO1E+EUZ0mACAnUMJ1nlubq4d1xCRXtDex4se7ydqFPhV92uVV2GF0eTJ
k00geIFkw68Jks9YbN++3XXu3NmGu5R+YYTRRx99ZN9XrVoVuKxB8x0vnwgjOkwAwM6hBOtcQz2V
K1d2aWlpce/zEzWNGze2ycUemiOj4bVkhZFiimmyc6xrguQzEaNHj3bVq1cPeaP69+/v2rRpE3FN
x44dXa9evULf16xZEyGMJNg0QTq8XMpX9LHC5Ds6nwgjOkwAwM6hhOtck6e1Sis7O9vmDJ08edJt
3rw5sKjR/Zo4/atf/crmGmnOjMTC888/nzCNWrVqhVZ8vfXWWzZ/R6u8Ej0nUT6j0ao4rfiSyBg2
bJhr27ZtxLlvfetb7vDhw6Fj48aNc3Xq1LEhM3l1br311nyTrzU3qF69euY12rRpk3l5JAITzafy
y3eifCKM6DABADuHEq5zeTXS09NtGEsThSUY9HIPKow0KXns2LEmiOSJ+cc//mFC4KWXXkqYhiYh
a85NtWrVXIUKFdyAAQPc+fPn497jl89olJ+KFSua4GrRooVbv3596NyxY8dc69atzZuj54rdu3e7
pk2b2u/UqFGj0PypcGGk4TQt09dxiT9tN+A3bOiX70T5RBjRYQIAdg4Xqc4lSvbt2xchTgrCxo0b
7VmrV6+Oe82pU6fc6dOn7f//+te/3Jdffhk4/WTyKQ/NkQ0XwwkAAIAASURBVCNH4p4/dOiQXRPO
0aNHfdM9cOBA0sNdifLtl0+EER0mAGDncInUuTwqGkqSp+MPf/iDrcDSCitvEjWUzjZAD0CHCQDY
OXVeDGizQu3DI0GkCc2aJ/P555/zgyOMMB4AwM6BOgeEEcYDANg5UOeAMMJ4AAA7B+o8Ma+88op7
+eWXC52OYo69++67Fz0NhBHGAwDYOVDnBSbWZo4FIXpZ/MVKA2GE8QAAdg7UOcIIYYTxAAB2DtQ5
wghhhPHQYQJg53DZ1Lk2KlSss9TUVJeSkuIyMzND544fP25L8J9++unQsQsXLrj77rvP5g6Fp6EQ
IAqjoZ2db775ZgurEUsY9e3b140fPz7iXsVI88KDeMdGjRrlrrvuOttpWqFCokVNonwHTUP7Lt1z
zz1xfzOF6ujTp4/tcq1nzJo1K6nnJzqPMKLDBADsHEphnWtCcoMGDVxOTo5t1njVVVfZ3kQer776
qitfvrxbu3atfZcAatiwoYW68JDQUViPqVOnWmgNTXDesWNHTGHkF8VeKBp9jRo13Isvvmjp6HpF
ng8XNX75DpLGO++8Y+IpHoMGDXJdunRxe/bscRs2bLAAuUGf73ceYUSHCQDYOZSyOpe4UfyurKys
0DHFMFOw1HAeeeQRV7t2bQt++u1vf9u9//77EWnISxTP85KsMFLsNcUNGzFiREQ68vZ4wVr98h0k
jSAojpk2r4wO/+H3/KC/K8KIDhMAsHMoRXWel5dnx7VrtQK66iPx0KpVq4jrFNtMw2MKuvrEE0/E
TEOepKIQRopur+8LFy7MJ2o8b49fvoOkEQQNByr4q0KcyPMT9HcL+rsijOgwAQA7h1JU57m5uXZc
w04SAd5n5cqVEdedOHHCPEYainrhhRdiphFvr6JkhZEi2Ov7qlWr4ooav3wHSSMo27dvd507d7ay
T548OdDzg/6uCCM6TADAzqEU1bmGfOQFSktLS3ivhpO6detmw1AaNtu5c2fonCLDKw1NyA4ijDp2
7Oh69eoV+r5mzZoIYaTgs5rsHC5glM/wY375DpJGsowePdpVr17dhJzf84P+rggjOkwAwM6hlNV5
RkaGu/baa112draJnJMnT9pcIo8FCxa4WrVquSNHjpjg0Fyipk2b2rUew4cPd1WqVLHJxVq1Jo/J
tm3bYgqjcePGuTp16thwl7woWskWPflac3Hq1atnHp9NmzaZx6Zq1aoR84P88h0kDXmDdH885syZ
YyvTJIYUHLdt27aBn+93HmFEhwkA2DmUwjqXdyM9Pd3m0mjCsDxCEjPiwIED9nJ/8803Q9cfPnzY
hNLAgQNDx/Ti79evn6tYsaJ9tAJLq8FiCSOtWpOwUn4aNWpk3qdoYaShMC2x13F5eZYsWZJvGCxR
voOmof/fcMMNcX8zTb5WeTSRu0WLFm79+vWBn+93HmFEhwkA2DmU4jo/f/6827dvn/1bUCSQ9u/f
b54lP44ePep7jYRZ9IqwZPOdKI2zZ88m3MfIK5O8ZQV9flH8rggjOkwAwM6BOi92li9f7ubNm3dZ
tgFaA8YDANg5dQ4RyGN0ubYBWgPGAwDYOXUOtAGEEcYDANg5UOeAMMJ4AAA7h6TqXKE0tEpME6ij
JywraGy8TRwBYUSHCQDYOZSZOv/ss89s48VKlSrZUnsFjdX/W7duHbometl9WaSwZSztvxHCiA4T
ALBz8KlzeYe0T4/2FNKmjFpqryXq7777rm3cWNpf+kuXLnXTp08vkrTmz5/v5s6dW+DnJnM/wogO
EwCwcyiFda6NGrUjtDZuTERpFUbaWPKuu+66bJ6LMKLDBADsHIqpzhW+Qzszh+9i7SeM1q1bZztC
K6hseHgNsXjxYtejRw+XkpJiEem93a89Ro4c6QYPHmxhRho2bOimTZsW6D7Nd3r++ectfIh2kL75
5pstnEhWVpbtzK2dpZs0aeKGDBkSun7MmDEuNTXV0szMzAyUD++4h8KB9OnTx3bOVjqzZs2y4/Ge
G31/vHwnShthRIcJANg5XKQ637t3rx3XxOogwqh+/fqucePGbubMmW7ixIl2r3Z19pBg0Lldu3a5
SZMmmeg6depURBp169Z1LVu2tI0VFR4kyH3jx493FSpUcFOnTrV7NMy3Y8cOy7+C1zZr1sytXbvW
joknn3zSNWjQwOXk5FioEc2bUhw3v3xEe8UGDRrkunTp4vbs2eM2bNjgtm7dGvrdYj03+v54+U6U
NsKIDhMAsHO4SHX+3nvv2XG9sIMII0WXl3gRWsGmCdqzZ8+Oeb2EjdJetmxZRBry4iQKBxJ9n2KO
ydsSL3RH9JCWrpcnR2LLo2vXrhZU1i8f0cJGnrHevXvHDCkSaygt/H6/fCdKG2FEhwkA2DlchDpX
oFUd/9Of/hRIGEXPMZJQkqcnHHlQ5PWRcFDaixYtSpiG3315eXn2XUNSQYSRd33z5s1dhw4d7KPg
sa1atfLNR/RxDXvJe6XhPXmfkhFGfvlOlDbCiA4TALBzuAh1fvr0aTuuoafCCiOtZpMHRPNoNPdo
5cqVgYSR3325ubn2Pd4eStECxbt+woQJJj68j9JNVhiJ7du3u86dO7ty5cq5yZMnBxZGfvlOlDbC
iA4TALBzuEh1rv2LatSo4b744otCCSPNndEzVq9ebd811BZEGPndp60DKleubHN6YtG/f3/Xpk2b
0HcNYen6tLS0pMqS6LgYPXq0ldcb+op+bvT9fvlOlDbCiA4TALBzuEh1/re//c1VrFjRhp68fYzO
nz/vPvzwQzd06NDAwkiTsOX50OqqgwcPuoyMDHvmjBkzEqYR5D7tp1SlShWbQK2VdPLGKK9izpw5
NpcnfLsBpaFVY9nZ2SZQTp486TZv3py0MFLaWj0mwTJs2DDXtm3biHPRz42+3y/f8dJGGNFhAgB2
Dhexzrds2WIrrHTNt7/9bXuZ33777SYwggojoWXrmjej+8eOHesGDBhg4sEbxoonSPzuk7jR0JUE
nD5aZeYt6T927Jjt0C3vjO7zvEbp6emWpiZiKy09O1lhpAnSep42wGzRooVbv3596Fys50bfnyjf
idJGGNFhAgB2DqWgzuVZ+etf/2r/FhTdK0HgIS9QUd2n89qpW16taA4dOhRxv5DnSx4p/VtQlOaR
I0fino/13KD59ksbYUSHCQDYOVDngDDCeAAAOwfqHBBGGA8AYOdAnQPCCOMBAOwcqHNAGGE8AICd
wyVY55988okFZn3wwQct6GtJo3huiTZLDIo2swwSAqW400AY0WECAHYOl2idaw8e7Quk8BYK3aE9
jqLRMnU9I/xTtWrVIst/os0Xk0HhQZ577rmLngbCiA4TAEqJfUd/gL7dD0V/L1++vDtz5kzcayRa
tB+Plvt7H20eiTBCGCGMAABhBGWqb9cQljZKTIREy49+9KNiyz/CCGGEMAKAYhdHQN+ukBTPPPOM
q1+/vqtWrZpr165dRPiMuXPnutTUVPMYNWnSxOYYJSuMjh8/bnHFnn766dAxDc8pjpjmDoXnRcN1
t956q+1WrcCyCgAbSxj17dvXjR8/PuJe5W/FihURx0aNGuWuu+46d9NNN1mYkWhRo2s0d0plTElJ
cZmZmfl+H780EEYIIwBAGEEZ6dsVhV7zh6ZMmeI2bdpkAkShNPbu3WvnDxw44EaMGGFCRfOLFD4k
njBSmAvtWO19FJrD49VXXzVxpTSEBFDDhg0jrpHQqVChgps6darbvXu3TXBWkNlYwujuu+92jz/+
eISAURlfe+21iLIpQK7CcCgdXa+4bOGiRhOpGzRo4HJycuxehe1QbLNk0kAYIYwAAGEEZaBvP3v2
rA2RhQeLlSdH4mDQoEGhYxpKUwy1RMSafB3uvRGPPPKIq127tnmklN77778fOieBJPF1zz33xEw/
WWF07tw5i0MmUReOvD3PPvts6Jkqf1ZWVuh8165dXc+ePQOngTBCGAEAwgjKSN/+8ccf5/OyiE6d
Orn27dsnLYw6dOhgccm8T3RssFOnTtnwmAKvPvHEExHn8vLyLC/yJBWFMNL2Avq+cOHCfKLG8/Z4
z2zevLnlXR+db9WqVeA0EEYIIwDAzqGM1Pm2bdvs+PLlyyOOd+/e3bVs2TJpYeQ3+frEiRPmMdJQ
1AsvvBBxLjc31/ISb6+iZIXRRx99ZN9XrVoVV9R4z9RwmeYyeZ+VK1cGTgNhRIcJANg5lJE6P336
tM370TybcGrVquUeffTRIhdGvXv3dt26dbNhKA2b7dy5M3ROkeblSdKE7CDCqGPHjq5Xr16h72vW
rIkQRvJW1axZM0LAaOgs/Ji+65lpaWkxnxkkDYQRHSZAmWvvfC6fD317fh577DFXr149t379ehNK
WqGmazdu3Ji0MIqefK2P5jGJBQsWmOA6cuSICQ7NJWratKkJIo/hw4e7KlWq2ORnzXWSR0derVjC
aNy4ca5OnTo23CUvj1ayRQ8Laq6QyiaPjyaWd+7c2TadDJ8flJGRYZPPs7OzLS8nT56MWJUXJA2E
EcIIgLYO1HkZKbuEwEMPPWSeI73wq1evHrGEPhlhFEuMvvfee7ayTeLjzTffDF1/+PBhE0oDBw6M
8Br169fPVaxY0T6aBK7VYLGEkVatSVjpGY0aNTLvU7Qw0lCYltjruLw8S5YsyTcMJg9Qenq6rcTT
RGx5svSsZNJAGNFxANDOgbovY+X+6quv3P79+/NNmL4YSCAFzcvRo0d9r5Ew0xykRGiy+L59++zf
gqaBMKLTAKCNA22AMgPCCOMBoI0DbYAyA8II4wGgjQNtgDIDwgjjAaCNA22AMgPCiA4D4LJr45rM
qSXFhb3myy+/tJ2FL/UJmx7a60axq+jnymaZP/vsM/fPf/6zWCdfl/Y2pNV48TaYTOYaP7TFgALX
KiDv4sWLEUZ0GACls42rs6tbt65F0dZeKtqTJboTD3KNXiy//vWvbfmzrlOspWXLll3yv9ulukSZ
fi5xmbVnkEJiqD0rgKuW7G/durVE2lD0EvyLTZD8FDbP2p9JWxco9IkC6n744YcIIzoMgNLZxv/w
hz+EOintsaJYURI24ct3g1zz5z//2VWrVs2tXr3avk+fPt1VqlTJ/iJHGNHPlaYya4m+XtIPP/yw
7Wek73/84x/dP/7xj9A1S5cutTZcHG1o/vz5bu7cucVS3oLkuySE0YYNG+yPpjNnzlzUNsCbng4D
IOk2rheErt21a1dS1yhUwf333x/6LtGkjeMmTpyIMKKfK1Vl3rJlix3/y1/+Evc+bbh41113XXJt
qCD5LglhJK+z+oOL3QZ409NhACTdxrXDra7Vxm7JXHPjjTe6p59+OuI6iaXwaOXRjBw50g0ePNjC
JjRs2NBNmzbNjmt+kuYipKamupSUFJeZmRlxn87LJa9wCNqxV5HLFR7BO6fwDvXr1zcPVrt27SJC
Hfg9d9SoUeYN066/M2bMyPdS+/TTT12fPn1sN2DlbdasWfRzl1iZP//8c9thOp5oz8rKMo+SXuRN
mjRxQ4YMseN9+/Z148ePj2iHOr9ixYqIY35tyGt/4fckau9B21y8fGs+T48ePezeO+64I7SrdrTo
kV3rvJ6jnbm9sCaxhJFfnsORd0zXyWOkfGmOUWFtFWFEhwFQYm1cHWDjxo2TvkYdnuIrhaP4Spqb
lCgdnVdE83nz5lm4A6HJqg0aNHA5OTkW6kAhEjQnxEMvJ80LmTp1qt2j+U47duywc4oYrpfDlClT
LMaTnqGwB3v37vV9ru6tUaOGvTiUnqKYKyJ6+Ett0KBBrkuXLm7Pnj02PFBc81Lo54q3zL/85S/t
nMTOF198EXFObUVBXZs1a2bzYby25RfZPmgbihYZfu09aJuLl28JppkzZ5qHd9KkSWYPp06disjP
LbfcYsJE9iBBpWHwcAGWbJ7D0R9QI0aMsD9ilC957AprqwgjOgyAEmnjv//9723StNehJnONOkq9
ELzgl4oVpb8Qv/vd7yYURvpLMjy8gWI46S9edeYeXbt2DYkunVcHq2Cc0egvXN07dOjQ0DFN+lSn
rZdLoueeO3fOyqUOPBz9tR8eOFMTzxUt/VJcdYcw+j+0WEAeI4kWeTujxUasISk/YRS0DYWLDL/2
nmyb8xtKkyBSnsMXRig/t99+u8218pDAeuCBBwqc52ii484VxlYRRnQYACXSxuWq1l9vijZekGs0
qVKdqV40+guvTZs27qc//amt/EkkjKLnLeTl5VledV+HDh3soxdLq1atIs5rKC0abRMQ/Re86NSp
U8SQXqznaimx7l24cGG+l1r4X/sastNftRpy0F/L9HOXdpnff/99d8MNN9iqNP2/MMIoaBsKb39+
7T3ZNhdPGMlTI2+Rzut5ixYtSmgPTz31lLv66qtDYizZPPsJo8LYKsKIDgOg2Nv422+/bZ2WOs/C
XCP+/ve/W2Ru/UWuvyIljpIRRrm5uZZXudn1QvA+K1eujDgfa08Veat0bvny5RHHu3fvbq74RM9V
nnXvqlWrEr7UxPbt222YUCJw8uTJ9HOXeJn//e9/27yaX/ziF4USRkHbUHj782vvyba56HzLDuVt
0jw8ea2UbhBhpGdIjHn7OxUkz4mEUWFsFWFEhwFQrG1ckbXl0p49e3bce4NcE42WQWvIK9FGbrE6
PbnpK1eu7NLS0mLeowjkOi/vVDSnT5+24TsN64VTq1Yt9+ijjyZ8rl4AejmGv8CUl+hj4YwePdpV
r179khlWQxjF595773WtW7cOfe/fv795PcPRYoJevXqFvq9ZsyZCGAVtQ9HDUonae7JtLjrfGvJW
Hr1tNDTcF0QYaYWp5g0WRZ5jCaPC2CrCiA4DoFjb+EMPPWQd1rp169wHH3wQ+oTPNwhyjf7q9iax
aqm+/kq97bbbEoqGeJ1eRkaGDdllZ2ebEJLICl+tMnz4cNuYT5M9NS9Bf8F6c5see+wxV69ePRvu
U+erVS8q+8aNG32fqzkSuld/8WsyqP5C1xBL+PyQOXPm2CohlWvYsGGubdu29HOXWJn/9re/2bCw
XvBCbUsv+vCXtOpZwl77dnmMGzfO1alTx4bM5CHRqsjo4aAgbSi6/fm192TaXHS+9UeNvEyaSH3w
4EF7lvKs1XLh+ZEg8VbXvfXWWzZXKvqaZPLsJ4wKa6sIIzoMgGJr440aNbJz0R9PaAS9Rt4k/QWo
lSrqVDU5+tixYwnzFK/T0wsrPT3dXPnyVKmj17XhXiMNGWjJtT6asOktQVYHLSGnvOiFpL+uFc4g
yHM1FKIl1iqb/srX8uXoYRBNhNUzVcYWLVoknJNFP1c6yyzRouXhqkctq5dweOSRR0JCSajtyoMk
wTRgwAA7phVRTZs2tTRlEzt37swnjIK0oej259fek2lzsfKtVWZKW39MjB071o7rGd7Ql56lYW/N
FdLvohWfuiZ8A9dk8xxEGBXGVhFGdBgAl0Qb1/4w+qvx+PHjRZKeOmb9xRveQYcjgbR///6Yca7k
zYp3zg8tL07k6dJz/WLG0c+V/jJrV3Z5deTtjMehQ4esvsMJskLKrw0l296TbXPR+ZYICf8u75GH
VqrJYyP+9a9/WbzDorLRIBTGVhFGdBgAtHGgDVBmQBhhPAC0caANUGZAGGE8ALRxoA1QZkAYYTwA
tHGgDVBmQBhhPAC08WJAS7EVU402QJlLUxvRKqxYm5UCwogOA4A2XqzE2sGaNlA2ypSoXMmUuSTa
SPTy86JYjg4IIzoMANo4wog2ECGMoj8lIYyWLl3qpk+fnlR+58+f7+bOnYswQhjRYQDQxhFGpaUN
xBMTZfVTXG3EL5J9EBBGCCNeGgClrI0r1ECfPn1sl96UlBQLHeChDeoUxV6hD7SzrQJRKhSCGDly
pBs8eLCFVmjYsKGbNm1a6J4xY8a41NRUSy8zMzPieX7nvXQVfkQ7/tauXTsinELQZ4waNcp2NdYu
xAptgDDCY5RsG0nUzrKysiwkhnZ9Vkwx7S4tFBuwR48edv0dd9wR2pE9un3HE0aJ7BEQRnQYACXQ
xgcNGuS6dOni9uzZ4zZs2OC2bt0aOjd+/HgLDzB16lQLh6CJqQpK6XXodevWtUjY8+bNs/NCE1gV
FiQnJ8dCJShch2KaefidV7r169d3jRs3djNnznQTJ060vGt33aBpKOp3jRo17KWk/CoiusI+IIyY
Y5RMG0nUzvbu3WuBjJs1a+bWrl0bsgsJJrXbXbt2uUmTJlnIDO0sHU8IRX9PZI+AMKLDACiBNi6v
jAK+RocvUCwkeYkU8ywW6tD1l3R4eATdo7+g9XLwUAwmBdYMct5LVzGT9GIRigZeqVIli8UWJA1d
r5hSI0aMiMivvAHRnifawOVZ5iBtJEhb9RtKkyDS85ctWxZYGMWzR0AY0WEAlFAb19CY/qqV219/
GXvk5eXZPRpKiyeMoudGePc0b97cAlLqo5dNq1atAp2Pl66Ekv4KD5KGIp/r/MKFC/O99PAYIYyC
tpEgbTWeMJIHSd4inVcaixYtCiyM4tkjIIzoMABKsI1v377dde7c2YYSJk+ebMdyc3Ptnnh7rMQS
MN49GqZQB+99vCjefueDCCO/NBTdXOcVQR1hRD8Xq8xB2kiQthotjBQEVd4ezcWT50nXJiuM4tkj
IIzoMAAuQhsfPXq0iRC58RWJu3LlyjaPIqgw0vCD7klLS4t5j9/5IMLILw29nDRxNVwE6Z7oY7SB
y7fMQdpIkLbav39/16ZNm9B3zTPS81avXm3fNWRXEGEUyx4BYUSHAVBCbXzOnDm2Ekad77Bhw1zb
tm1D54YPH+6qVKliE04vXLhgf0Vv27YtYYeekZFhq3Wys7NNXJ08edJt3rw58Hk/YRQkDc0DqVev
nnkENm3aZH99V61alTlGCKOk2ohfO5PtaB7e4cOH7bsWCMjLo5VkBw8etPv1fK14CyqMEtkjIIzo
MABKoI1rsmfFihVtMmqLFi3c+vXrQ+f0MtBwgc7ro1U53vLjeMJIf2mnp6fbPAlNXtWLQ9cGPR9E
GPmloaESLcFWmeUFWLJkCUNpCKMIgrQRv3Z27Ngx17p1a/MsDRgwwI5p2b6u1x8UY8eOteO6zxuC
CzL5Op49AsKIDgOghNq4BNCRI0cSnt+/f78NQQTl/Pnz9he0/i3I+aJ4xoEDBxiGQBglPB+kjfi1
s0OHDpmNeMizFP5d3qNk8LNHQBjRYQDQxoE2QJkBYYTxANDGgTZAmQFhhPEA0MaBNkCZAWGE8QDQ
xoE2QJkBYYTxANDGgTZAmQFhhPEA0MaBNkCZAWGE8QDQxoE2QJkBYYTxANDGgTZAmQFhhPEA0MaB
NkCZAWGE8QDQxoE2QJkBYYTxANDGgTZAmQFhhPEA0MaBNkCZAWGE8QDQxoE2QJkBYYTxANDGgTZA
mQFhhPEA0M6BuqfscAnUPS0BwwGgrQN1zm9AnSOMMBoAv/bO5/L5AO2edo8wQhgBAHYOAAgjOkwA
wM4BAGFEhwkA2DkAIIzoMAEAOwcAhBEdJgBg5wCAMKLDBADsHAAQRnSYAICdAwDCiA4TALBzAEAY
0WECAHYOAAgjOkwAwM4BAGFEhwkA2DkAIIzoMAEAOwcAhBEdJgBg5wCAMKLDBADsHAAQRnSYAICd
AwDCiA4TALBzAEAY0WECAHYOAAgjOkwAwM4BAGFEhwkA2DkAIIzoMAEAOwcAhBEdJgBg5wCAMKLD
BADsHAAQRnSYAICdAwDCiA4TALBzAEAY0WECAHYOAAgjOkwAwM4BAGFEhwkA2DkAIIzoMAEAOwcA
hBEdJgBg5wCAMKLDBADsHAAQRkCHCYCdAwDCCOgwAbBzAEAYAR0mAHYOAAgjoMMEwM4BAGEEdJgA
2Dk/AgDCCOgwAQA7BwB6ADpMAMDOAQBhRIcJANg5ACCM6DABADsHAIQRHSYAYOcAgDCiwwQA7BwC
1j+fy+eDMKLDBADsHKh7SFDntAKMBgCwc+qdeqfuEUYYDgBg50CdQ2QboDVgPACAnVPnQBtAGGE8
AICdA3UOCCOMBwCwc6DOAWGE8QAAdg4lUeeffPKJGzNmjHvwwQfd4sWLizz9V155xb388stUHsKI
DhMAsHMo2Tr//PPPXaVKldw999wTKL0LFy64a6+91j3//PNu7dq17sMPPyzyPP/85z93P/nJT0rk
99m3b1++/X/KlSuHMAI6TADsHC7HOn/hhRfsmvLly7tDhw75prdhwwa79syZM0WSv6VLl7rp06df
dGE0b9489+c//9k+r7/+OsII6DABsHO4HOu8ZcuW7s4777Tr5AXyQ0NcV155ZZHlr1+/fu6uu+66
6MLoiy++uCzaAD0AHSYAYOfUeRz+/ve/2/n169e72267zd1xxx0J05o7d65LTU01j1GTJk1sjpHo
27evGz9+fOi6//73v3Z+xYoVoWMjR450gwcPdgsWLHANGzZ006ZNc1lZWTYsJ6Gl64cMGRIhjNat
W2eirXbt2u7ZZ5+NyIueoXlOyk9KSorLzMyMOB/reQgjhBEdJgBg59R53HNPPvmku/nmm90333zj
pkyZYtfu3Lkz7vUHDhxwI0aMcN/61rdsftGWLVvs+N133+0ef/zxCNGitF577bXQMYmdunXrmodK
w1a7d+92e/fudffdd59r1qyZpbdjx47QtfXr13eNGzd2M2fOdBMnTrT0JGLC896gQQOXk5Njz7nq
qqvcG2+8kfB5iYSRRNRLL73kTp48iTACOkwA7BwutzqXGLrppptCnp6DBw+aJ2j06NEJ09NQ2re/
/e2IY0GFkbw7R48ejbg33lBa9erV3a5du+z7uXPnbIL47Nmz7ft//vMf8zLJ4+TRtWtX17NnT9/n
RXP8+HETWd26dTNxVaNGDZtHhTACOkwA7BwuozqXh0bnNm3a5E6cOGGf9u3buxtuuMFEU3EIo1jz
hoLOMZJQkvdI5OXlWfrNmzd3HTp0sM/111/vWrVq5fu8RJw/f96G3eRFQxgBHSYAdg6XUZ1rXlD0
MnXvI9FUmoVRbm6upT9hwgRbQeZ9Vq5cWShhJLxVev/85z8RRhgPPxcAdg6XQ51//fXX7uqrr3Yz
ZswIeYv0OXz4sA0n/epXv0pKGHXs2NH16tUr9H3NmjWBhVH//v1dmzZtkhJGGkqrXLmyS0tLi5vP
ggojrcxT3vVbIIwwHn4EAOwcLoM6X7hwoU2gjrUSS56fa665xsRHUGE0btw4V6dOHdsRW56bW2+9
NbAwmjNnjuUlXIj4CSORkZFhK9qys7NN6GnS9ObNm5MWRl9++aX76quv7P+aDB5kdR7CiA4TALBz
KEN1/uMf/9g98sgjMa/X0n3ds2jRosDCSCu+mjZtavc1atTIVrYFFUbHjh1zrVu3Ng/QgAEDAgsj
Cbf09HR3xRVX2ERsiSvdl6ww0gaTFStWtBVu2vFa85S0jQHCCOgwAbBzoM4Lhd8KsERo1215fpJF
E6a15F7/FgTdJ0/XBx98YNsRlPU2QA9AhwkA2Dl1DrQBhBHGAwDYOVDngDDCeAAAOwfqHBBGGA8A
YOdAnQPCCOMBAOwcClDnmnSsQKwKBrt48eJA6b3yyiu2Mi3ed/D/zRBGdJgAgJ1DKavzCxcu2D5A
2tBQO11/+OGHgdKLXgZf0I0UL3WSKffF/o0QRnSYAICdg0+dK1CqgsaeOXOmUIIg2Ze+9g2aPn16
kZezuNKNl/b8+fPd3LlzEUZ0mACAnUNZqHMN7WhjxGQprDCKFRutKCiudIsibYQRHSYAYOdQiutc
no7U1FTzGDVp0sTmGAkFlh0/fnzoOgWD1fkVK1YUiTDKysqy4TsJMqU7ZMiQ0HM010l5SklJcZmZ
maF7jh8/brHUnn766dAxDQPed999NncnUbrRaB5Vjx497BkK+/Hiiy9GnB85cqQbPHiwW7BggWvY
sKGbNm1a3LS9a8N/Kw1LKhyKduG++eabLTxKrN8oUXnFp59+6vr06eNq1qxp52fNmoUwosMEAOwc
iqvOtcPziBEj7AWu+UVbtmyx43fffbfFSgt/gfuF9khGGCkWmQRNs2bN7Lk7duyw408++aSF5MjJ
ybFnKZDtG2+8Ebrv1VdfNRGne4QEiISLF88tXrqxhJnCiuzatctNmjTJwomcOnUqoix169Z1LVu2
dPPmzbNQJ/HSji63BGWFChXc1KlT7b5333037rV+5R00aJDr0qWL27Nnjw15bt26FWFEhwkA2DkU
Z53HinlW3MJIRA9LSdzIGyPR4tG1a1fXs2fPiPsU26127doWKFb5fv/99xOm64cEkcq2bNmyiLLI
ixMd2iRW2uHlVhkkMu+5556Yz4q+1q+8d955p+vdu7f9/kXdBugB6DABADunzktQGCkI6w9/+MN8
nxMnTsQUGXl5efaM5s2buw4dOtjn+uuvt3SihYyGpxRs9oknnvAVXPGQ10feIl0fHSw3nsjzE0Ze
GeTJ8hNGQcqrITh5szTcJ68SwogOEwCwc7hEhdE777zj3n777Xyfc+fOxRQZubm59owJEyaYIPA+
K1eujMibhJU8RuXKlXMvvPBC0sLom2++MS+MxNWzzz5r6ReVMPLKEG+voljX+pV3+/btrnPnzlbe
yZMnI4zoMAEAO4eSFkYdO3Z0vXr1Cn1fs2ZNkQ+l9e/f3yZTe2hoSV6gtLS0hPdJ1HTr1s1EjYat
du7cmTDdaDTfR2VZvXq1fZdQCyqMYqUdfu3XX39tZdBcJD9hFLS8HqNHj3bVq1cv1LAawogOEwCw
cyiAMBo3bpyrU6eO7YgtL4ZWWBW1MJozZ44Jm8OHD4eOZWRk2Mqv7OxsExknT560uUQeWiVWq1Yt
d+TIEfP8aC5P06ZN7dpE6Yazb98+875ohdfBgwftmSrbjBkzfMsSK+3oa4cPH+6qVKlik6i1ak6e
oW3btsW81q+8ep5WpkkMDRs2zLVt27bI2gA9AB0mAGDn1HlAYaTVVBIcuqdRo0bmlSlqYXTs2DHX
unVr85oMGDAg5EVJT0+3eTWamCwRonSFVtBJRLz55puhNCRQJJQGDhyYMN1otNRez5CAGTt2rF2n
Z3nDWPHKEivt6GslcDTkVrFiRftopZm3HUD0tYnKKzT5Wmlcc801rkWLFm79+vUIIzpMAMDO4WLV
efSqrOLg0KFDER4fcf78efPs6N+iTDcceWfCz8t7VFRpewJp//795tnyI1F5lY48ZEXdBugB6DAB
ADunzoE2gDDCeAAAOwfqHBBGGA8AYOdAnQPCCOMBAOwcqHNAGGE8AICdQymrcwV4jbfhYTIorpji
jhV3GtqiQIFdFVBXwWYRRkCHCYCdA3VeZCS7jD8eCpfx3HPPFWsa2ndIWwIopIdChnz44YcII6DD
BMDOgTq/PIWRItiXL1/enTlzpsy3AXoAOkwAwM6pc4RRwjQ05KeNFi+HNkAPQIcJANg5dR4DhZvQ
nJrU1FSXkpLiMjMzQ+eOHz9uscGefvrp0DENNykWmOYOhaeh4SeFDtHuzQrQqlAisYRR37593fjx
4yPubdKkiVuxYkXEsVGjRrnrrrvO3XTTTRauI1rUJMp30DTCmTt3rqUlj5HyozlGXjrPPPOMq1+/
vqtWrZpr165dRNgOMXLkSDd48GALWdKwYUM3bdo0hBEdJgBg53Ap1rkmJDdo0MDl5ORYyA+FsFCc
L49XX33VxILm3AgJIL38Fc7CQ0KnQoUKburUqRZORBOcFaw1ljC6++673eOPPx4hYKLDjSjifI0a
NSyUhtLR9YpvFi5q/PIdJI1wFHJkxIgRJuxU1i1btoTS0byjKVOmuE2bNll5FMJj7969oXt1rG7d
uq5ly5Zu3rx59hsgjOgwAQA7h0usziVuNHSUlZUVOta1a1fXs2fPiOseeeQRV7t2bfOUKK7a+++/
H5GGxIQCusYiWWGkaPeKDSaREo68Pc8++2ygfAdJIxbRcePOnj1rzxk6dGjomDxmEmGDBg2KKKO8
TSURQgVhRIcJANg5FFOd5+Xl2fHmzZu7Dh062EfioVWrVhHXnTp1yobHFDz1iSeeiJmGPElFIYy0
XF7fFy5cmE/UeN4ev3wHSSOIMPr444/zebNEp06dXPv27eOWEWFEhwkA2DlcgnWem5trxzVcpDlB
3seLMu9x4sQJ8xhpKOqFF16ImUa8vYqSFUYfffSRfV+1alVcUeOX7yBpBBFG27Zts3SWL18ecV33
7t1t2AxhRIcJANg5lKE615CUvEBpaWkJ7+3du7fr1q2bDUNp2Gznzp2hc4r+rjQ0ITuIMOrYsaPr
1atX6PuaNWsihJGi0desWTNCwCif4cf88h0kjSDC6PTp0za/SvOZwqlVq5Z79NFHEUZ0mACAnUNZ
q/OMjAybXJydnW0i5+TJkxGrrrTSSkLgyJEjJjg0l6hp06Z2rcfw4cNdlSpVbPKz5uDIoyNvSyzR
MG7cOFenTh0b7pKXRyvZooerNFeoXr165vHRhOfOnTu7qlWrRswP8st3kDT8hJF47LHHLJ3169eb
UNIKNeV348aNCCM6TADAzqGs1bk8Kenp6bbSShON5RHSi15opZbEx5tvvhm6/vDhwyaUBg4cGDom
YdKvXz9XsWJF+2hyslaDxRINWrElYaX8NGrUyLxP0cJIQ2FaYq/j8vIsWbIk3zBYonwHTSOIMJLg
euihh8xzJGFVvXr1iK0KEEZ0mACAnUMZrPPz58+7ffv22b8FRQJp//795lnyI8gKLgkzzUEqTL6D
pBGEr776KnDZEEZ0mACAnQN1DggjjAcAsHOgzgFhhPEAAHYO1DkgjDAeAMDOgToHhBHGAwDYOVDn
gDDCeAAAOwfqHBBG/HAAgJ0DdQ4II344fi4A7Byoc0AYAcYDgJ3DZVTnDz74oJsxY0bo+4oVK1yT
Jk3cli1bQscyMzNDYTRGjhzpBg8ebGFCGjZs6KZNm2bHtYGiQmXUr1/fVatWzbVr1y4iPEf4vevW
rXN33nmnBaWNDs+hcCKjRo1yqamp7sYbb7S8KejsnDlzqECEER0mAGDnULx1/j//8z+uffv2oe8K
66HrwgWL4pq988479n+Fvqhbt65Flp83b56F9xCKcq/QIVOmTLG4ZLpOoTr27t0bSkfHJJwaN27s
Zs6c6SZOnGjP0q7VHop/ds0117isrCyXl5dnQqpcuXIJw3gAwogOEwCwcyiSOl++fLmrVKmSBUcV
8uIo5te9995r3xVvTHHPzp49GxI38uaEh/PQOcUqGzp0aOiYPD+6b9CgQRHCSHHGdu3aZd/PnTtn
z549e7Z9VzgRxSILT0covlmiwK+AMKLDBADsHIqkzhX/q3Llym7ZsmUuNzfXRMh7771ngVQlXCZP
nmwBVMPFTXSw1I8//jhfEFjRqVOnCG9UrHsllOQ9El4w2UWLFuUTRniMEEZ0mACAnUOJ1HmHDh1s
SE3io3///ha1XpHqN27c6H7wgx+4+fPnJxQ327Zts7TlfQqne/fuNuQWVBgpQKvSWbp0KcIIYUSH
CQDYOVycOtekaU24/n//7/+5t956y47dc8897oknnjBv0okTJxKKGw3DlS9f3j355JMRx2vVquUe
ffTRwMJIaP7RmDFjQt+3bt1qw2sII4QRHSYAYOdQInX+17/+1c5p+ExDa55Yqlixoq0ICyeWuBGP
PfaYq1evnlu/fr0JJd2vNOV1SkYYafK15h396le/srlGWr1Ws2ZN9/zzz1OBCCM6TADAzqH46/yb
b74x8dG5c+fQsb/85S92/e9+97tAwujkyZM2F0meI3l4JHheeeUV33ujhZHmNY0dO9YEkYb1/vGP
f9hqt5deeokKRBjRYQIAdg6XVp3L46S5QhJbRYE8Tsr36tWrqUCEER0mAGDncHnVuVa2aWm+huT+
8Ic/uObNm7s77rijyIQWbQBhRIcJANg5XDJ1/sYbb7jevXubIGrTpo0bNmyY+/zzz6k8hBHGAwDY
OVDngDDCeAAAOwfqHBBGGA8AYOdAnQPCCOMBAOwcqPMiI96WAoAwwngAADuHy67OFcJk7ty5VDjC
COMBAOwcqHNAGGE8AICdQ4Hr/L///a+F3Lj11lsteOzNN9/sXn/99dA5hfeoX7++q1atmmvXrp3b
vHlzxP0jR450gwcPditXrnQ//OEP3fe+9z03Y8YMd/78eTdo0CD3ne98x3Xr1s3t2bMn3z1Lliyx
fYq08/bAgQPd2bNnQ9csXrzY9ejRw6WkpNg1L774YsznLliwwDVs2NBNmzYt4rjHp59+6vr06WPP
UFqzZs2KKHvQ8q1bt8525K5du7bttRSO9lxSfLl4+OVB8eFSU1PtXGZmZr76SXQeYUSHCQDYORRh
nY8fP95VqFDBTZ061e3evdu9++67bseOHXZuwoQJFpJjypQpbtOmTTZ/54orrnB79+4N3a9jipP2
gx/8wDZoTEtLszhrP/7xj03sLF261NWpU8cNHz484p5bbrnFhMi8efPckCFDLEZauGDIysqycCG7
du1ykyZNsueeOnUqIo26deu6li1bWhrKu3c8fI6RxFmXLl1MmG3YsMEC03oELZ+EkwLcKj8TJ060
33Lfvn2ha9555x03atSouL99ojwo+G6DBg1cTk6O/X5XXXWV7ecU9DzCiA4TALBzKKI6/89//mNe
oljeDnlvrrzySgvm6nHhwgV7MetFHy4cbrzxRnfkyBH7/sknn9izfv3rX0cIAwmn8Htuv/32UNBa
cd9997kHHnggZt4liJTmsmXLItKQF+Xo0aMR10YLI3l5tGmkPC8FLZ9iukmgCcVzk4ibPXt24N8+
Xh70+ysPEoEeXbt2dT179gx0HmFEhwkA2DkUYZ3n5eXZ8VjR6z/++GM7Jy9FOJ06dXLt27ePK0QO
HTpk97333nuhY/IWaTgs3j3iqaeecldffXWEeFi7dq15i/r162dpLlq0KGEasY5rWFBeID1fXpfC
lk9EB7/1I14evN9fO3136NDBPtdff71r1apVoPMIIzpMAMDOoQjrPDc3146//PLL+c5t27bNzi1f
vjziePfu3W34qqiF0eTJk008KC6aPvKwaL6T5vNo/lJBhZHYvn2769y5sytXrpw9pzDlK4gwipcH
7/fXkJ7Ek/dReYOcRxjRYQIAdg5FWOdff/21q1y5sg1jRXP69GlXvnx5m+MSTq1atdyjjz5a5MLo
/vvvd02aNLH/a46T0li9erV91/BVYYSRx+jRo03UyCtV0PIVVBjFyoOGyvT7a15WLPzOI4zoMAEA
O4cirnOJlipVqtiEXs2xkZdC3hTx2GOP2cRqRbuXkNAKLqWzcePGQgsjCZAVK1bY97feestdc801
tppNaGKzPCuajH3w4EGXkZFhaXrnkxFGc+bMsVVhEiIKStu2bdvQuYKUL5YwkjcoOzs77m+fKA8q
myaA634J1ZMnT0asjPM7jzCiwwQA7ByKsM71stUcHq0k00eTj72l8XoJP/TQQ+ZZqVq1qgmCV155
JaEQCSqM2rRpY3NmtExeq+IGDBhgS/w9tFJNQ2sSbWPHjrXzmijuDSMFFUaa+KxySXi1aNHCRJBH
QcoXSxg999xz7oYbboj72yfKg7xC6enpVlZNtFYZ9cyg5xFGdJgAgJ1DMdS5BNL+/fttfk80Wj0W
71xBCBcbWlX25ZdfxrxOwkX58pD3qCAoDW/VXCwKWz6tcEu0j1GQPEgUylMWLg6TOY8wosMEAOwc
LtE6L2vxzDSBW3spXUptgB6ADhMAsHPqvJTwm9/8plA7OJc2wnfsRhhhPACAnQN1DggjjAcAsHOg
zgFhhPEAAHYOZbLOtV/Qzp07bSJydPgKrdaKtREkIIwwHgDAzqFM1flnn33mOnbsaDHAtFxfy9f1
/9atW4euKWsTpmNR2DKW9t8IYUSHCQAx7Dv6A5d33y7vkPbXadSokW3sqCXrWlr+7rvv2v5Dpf2l
v3TpUjd9+vQiSWv+/Plu7ty5BX5uMvcjjBBGAIAwglLYtw8cONA2Nzx8+HDC+0urMNLmlHfddddl
81yEEcIIAIpRHMHl3bcrBIh2VJY48sMTRuvWrbOdnGvXrm0BXsNZvHix69Gjh0tJSbGdrr0dtD1G
jhzpBg8e7BYsWOAaNmzopk2bFug+zXd6/vnn3a233mo7Pyu4rIKpZmVlWbgM7QitOGvaLdu7fsyY
MS41NdXSjN4aIF4+vOMeCuPRp08fV7NmTUtHIUpEvOdG3x8v34nSRhghjAAAYQQXqW/fu3evHY8O
gxFPGNWvX981btzYwmFMnDjR7tVuzB4SDDq3a9cuN2nSJBNdp06dikijbt26Fr1eGyLu3r070H3j
x4+3sCFTp061ezTMp0Czyr8C4DZr1sytXbvWjgkFhm3QoIHLyclxr732ms2bUiw4v3xEe8UGDRrk
unTp4vbs2eM2bNjgtm7dGvrdYj03+v54+U6UNsIIYQQACCO4SH274pnpuF7YQYSRYoRJvAitYNME
7dmzZ8e8XsJGaS9btiwiDXlxFAYkHtH3KVaYvC3xQm5ED2npenlyJLY8unbt6nr27Ombj1hx1nr3
7p1vhV6s50bf75fvRGkjjBBGAIAwgovQt3/00Ud2/E9/+lMgYeQXTFXIgyKvj4SD0l60aFHCNPzu
y8vLs+8akgoijLzrmzdvbkFq9bn++utdq1atfPMRfVzDXvJeaXhP3qdkhJFfvhOljTBCGAEAdg4X
oc5Pnz5txzX0VFhhpNVs8oBoHo3mHq1cuTKQMPK7Lzc3177H20MpWqB410+YMMHEh/dRuskKI7F9
+3bXuXNnV65cOTd58uTAwsgv34nSRhjRYQIAdg4Xqc61f1GNGjXcF198UShhpLkzesbq1avtu4ba
gggjv/u0dUDlypVtTk8s+vfv79q0aRP6riEsXZ+WlpZUWRIdF6NHj7byekNf0c+Nvt8v34nSRhjR
YQJc1PbO5/L50Lfn529/+5urWLGiDT15+xidP3/effjhh27o0KGBhZEmYcvzodVVBw8edBkZGfbM
GTNmJEwjyH3aT6lKlSo2gVor6eSNUV7FnDlzbC5P+HYDSkOrxrKzs02gnDx50m3evDlpYaS0tXpM
gmXYsGGubdu2Eeeinxt9v1++46WNMEIYAdDWgTq/iGXfsmWLrbDSNd/+9rftZX777bebwAgqjISW
rWvejO4fO3asGzBggIkHbxgrniDxu0/iRkNXEnD6aJWZt6T/2LFjtkO3vDO6z/MapaenW5qaiK20
9OxkhZEmSOt52gCzRYsWbv369aFzsZ4bfX+ifCdKG2FExwFAOwfqvhSUW56Vv/71r/ZvQdG9EgQe
8gIV1X06r5265dWK5tChQxH3C3m+5JHSvwVFaR45ciTu+VjPDZpvv7QRRnQaALRxoA1QZkAYYTwA
tHGgDVBmQBhhPAC0caANUGZAGGE8ALRxoA1QZkAYYTwApb6Nf/nll+7jjz8OvKfIJ598YgErH3zw
QQuGGQTFpgrf+C36O9DPlbYyF6SdFyVFZSPazDJICJTiTgNhRIcBUOrbuFaM/PrXv3bly5d31113
nS2jDY/zFAvtTaL9UrTtv0IaaO+XIEQv6020sRzQz13sMgdp52q/0ftGVa1atcjyX1Q2ovAgzz33
3EVPA2FEhwFQ6tv4n//8Z1etWrXQDrzTp0+3IJmfffZZ3LQUFVtC6syZM4Xq5JPt9JcuXWr5K2qK
K136uUu7zEHaudqv9uPRcn/vo80jEUYIIzoMgEu0jSs0wv333x/6rr1PtDncxIkT46Yl176uKWwn
n2ynHytOU1FQXOnSz13aZQ7SztV+f/SjHxVb/hFGCCM6DIASbuM33nije/rpp/OJpfbt28e8fu7c
uS41NdX+km7SpInNvRB9+/Z148ePD12nuUo6v2LFiiIRRllZWTasoReV0tWuwd5zNAdEeUpJSXGZ
mZmhe44fP25xncLLp+ERxXHS3I1E6dLPle0yq90888wzrn79+uYxbdeuXUT4jHjtPBlhFKT9eXnR
cN2tt95qu1UrsKwCwMaykSB2pmOjRo2yofGbbrrJwoxEi5pEdhM0DYQRwgigTLZxdao9e/aMOKbI
13Xr1o15/YEDB9yIESOsA9e8C4VVEHfffbd7/PHHIzpWPfO1114rEmG0d+9ee6EohIOeqyCcQhNC
GzRo4HJycuxZCj+gGE0er776qr3cdI/QC6hhw4YWPiFRuvRzZbvMikIvQTxlyhS3adMma4sKpaH2
kKidxxJGCnOhHau9j9e2grQ/IaFToUIFN3XqVLd7926b4Oy1w2gbCWJnKpsC5CoMh9LR9YrLFi5q
/OwmSBoII4QRQJls4+og1QF6QR7fe+8968i/+93vxk1LQwyKLRVOcQsjET3kpZeLPD3y+nh07do1
n9B75JFHXO3atc0joHy///77CdOlnyvbZT579qy1m/BgsfLkSBwMGjQoYTuPJYyiJ1+He2/82p/a
sMTXPffcEzP9ZIXRuXPnbAGFRF048vY8++yzgewmSBoII4QRQJlt45pYKo+J/hqUl0iu/5/+9KcW
dbykhVGrVq3cD3/4w3yfEydOxBQweXl59gzltUOHDvZR5610wjl16pQNTyjw5RNPPOEruOjnynaZ
tS1FdNsUnTp1ihhCDiqM1O40N8/7RMcGS9T+vDYsT1JRCCNtL6DvCxcuzCdqPG+Pn90ESQNhhDAC
KPNt/O9//7v76KOPrFPXX48SRyUtjN555x339ttv5/voL9hYAiY3N9eeIbe/5mR4Hy86uYeElf5i
l/h74YUXEEaXebuXd1THly9fHnG8e/furmXLlkkLI7/J14nan9eG4+1VlKwwkg3r+6pVq+KKGj+7
CZIGwoiXBsBl08YV7Vuu/USb2cV6YWjCdq9evULf16xZU+RDaf379zePloeGBPRXeFpaWsL7evfu
7bp162bDACrbzp07E6ZLP1e2y3z69GkbLtYwcji1atVyjz76aJELo0TtT5Hm1YbltQ0ijPzsTH/Y
1KxZM0LAyE7Cj/nZTZA0EEa8NADKbBv/97//7b744gv7v4YB1InfdtttCXfAjvXCGDdunKtTp465
4fXXp1bYFLUwmjNnjr1YDh8+HDqWkZFhk2izs7PtJSNhF766aMGCBfbCO3LkiHX4msvRtGlTuzZR
uvRzZbvMjz32mKtXr55bv369CSWtUNO1GzduTFoYRU++1kfzmIK2v+HDh7sqVarY5GfNdZJHx5vz
F20jQexMc4VUNnl8NLFciym06WT4/CA/uwmSBsIIYQRQJtv47Nmz7a9nrVDRhEt13MeOHUuYVqwX
hlbTqMPXcxo1amR/FRe1MFK+WrdubX/tDhgwIPSXbHp6uq0o0oRSCRylK7SySJ3/m2++GUpD4kcv
qoEDByZMl36ubJdZQuChhx6ytq8XfvXq1SOW0CcjjKInX+ujRQxB25+EiYZzK1asaB9NAtdqsFg2
EsTONBSmJfY6Li/PkiVL8g2DJbKboGkgjBBGAGW2jX/++ef216L2XSksR48eLfayHDp0KOIvbs/b
tW/fPvu3KNOlnyvbZf7qq6/c/v37802Yvhio7QXNSxA7kzDzi33oZzdB0kAY0WEA0MaBNkCZAWGE
8QDQxoE2QJkBYYTxANDGgTZAmQFhhPEA0MaBNkCZAWFEhwFAGy9mtAIo3qZ24I/24FFMLfq5wpX5
s88+c//85z+LdfJ1QeqqtNliUdirthhQ4FoF5E20TxrCiJcGQJlp48ksv092qT5EUpCl0wij/0N7
BikkhvYPUgBXLdnfunVridRVaWv7QfJT2DxrfyZtXaDQJwqo++GHHyKMeGkAlK02vnTpUjd9+vSI
Y/Pnz3dz585FGCGMSnW71xJ9vaQffvhh289I3//4xz+6f/zjHwnbd1HVVTJ2UhR2WRqE0YYNG2zP
KMVmvJhtgDc9HQZAsbXxwsYXQxghjC5Wu9+yZYsd/8tf/lJs7buwdVWSdlkSwkjDcNpI8mK3Ad70
dBgAvm1cY/09evRwKSkp7o477gjtuOsxcuRIN3jwYAtt0LBhQzdt2jSXlZVlf3Gro2vSpIkbMmRI
xLUe2hhOrnOFLdDOuoowrjAGsTpaXav5B6mpqZaXzMzMiHx8+umnrk+fPrYLr87PmjUrbln9ypQo
rUTnCpPHwqSr86NGjXLXXXed7UY8Y8YMhFEhyqwNTbXD9MSJE2PeE6999+3b140fPz6iXnR+xYoV
SdVVLDspirYfL99+9uDZona31nk9Rztze2FNCmKv4cg7puvkMVK+NMfIS0OhWOrXr++qVavm2rVr
FxGWJF7/gzBCGAEUaxtXZzpz5ky3a9cuN2nSJAsRcOrUqYgOsW7duhZ1fN68eRaSYO/evRb0slmz
ZjZfYMeOHTE7T71ENH9j6tSpdp8moMa7VhNUFZYkJyfHwhsoLILmgXgMGjTIdenSxe3Zs8fc8onm
g/iVKVFaic4VJo+FSVdR0GvUqGEvNP1+iq6uSO0Io4KX+Ze//KWdk9jxYgV6xGvffpHtg9ZVcbX9
ePkOYuO33HKLCRPZuARVpUqVIgRYsnkOR7tnjxgxwv44Ur7ksfN+Kwm5KVOmWDw2PUN5UzkS9T8I
I4QRQIm1cXWWum7ZsmURHZP+2osOQRDLZR/eeSoWkzpCxV6LRfS1+itXHbhH165dLZClhwJ1KsBt
suEJYpUpUVrxzhU2jwVN99y5cxbDTi+WcOSFSDagJ8Lo/9AqNHmMJFpuvPHGfGIjVvv2E0ZB66o4
277fUFo8G7/99tttrpWHBNYDDzxQ4DxHEx13Tt4opTF06NDQMU3QlsCSEPTrfxBGCCOAYm3j+itO
f0mqU9V1ixYtivuXYlBhlJeXZ2lpKM1PGHnXapVQhw4d7KOXSatWrULXawhOf03K1a+/Uv1IVKZE
acU7V9g8FjRdLXHW+YULF+Z72eIxKnyZ33//fXfDDTfYqjT9vzDCKGhdFWfbjyeMkrXxp556yl19
9dUhMZZsnv2E0ccff5zP2yY6derk2rdv79v/IIwQRgDF0sb1V7P+EtXcH/1Fu3LlyiITRrm5uZZW
vL1PYl0r17peAt5H+Qln+/btrnPnzvZX/uTJk+N6AvzK5JdWrHNFkceCpKso5zq/atUqhFEx9e3/
/ve/bV7NL37xi0IJo6B1VVxtP1a+C2rjeobEmLe/U0HynEgYbdu2zdJYvnx5xHXdu3e3YTOEEcII
4KK0cc1B0PHVq1fbdw0FBBVG/fv3d23atIkrdhQpvHLlyuaS9xNGcs3r2rS0tEBlGT16tKtevXrM
oYUgZQqaVvi5osxjMunqxaSXdviLVfdEH7tc+zmVKVG5gpb53nvvda1bt07Yvjt27Oh69eoV+r5m
zZoIYRS0roqr7cfKd0Ft/P7777eJ0kWR51jC6PTp0zYZW3OVwqlVq5Z79NFHEUYII4CL08b37dtn
f4FqkuXBgwddRkaGXaeVNH4d05w5c2wO0eHDh+NeO3z4cNtAT5MyNX9Af2nqL8VY1+rZmoiZnZ1t
okr7y4SvUNHztDpHL4Rhw4a5tm3bxixnkDIlSivRucLksTDpau5GvXr1zBOhSaryHGjohzlG/yeM
oj+Jyvy3v/3NVjnpBS/0W+tFH/6SjtW+x40b5+rUqWNDZvKQaLVl9HBQkLoqrrYfK99BbVyCxFtd
99Zbb9lcqUT9gF+e/YSReOyxx+y3Wr9+vQklrVBT3jZu3IgwQhgBXLw2rhUocplLwIwdO9YNGDDA
OlbPLR6vYzp27Jj9ha0Xiu6Jda06TLn2tTRaH02s9JYKR1+rl1R6errlRZMylQdd46EJqEpDHXaL
Fi2sM42HX5kSpZXoXGHyWJh0NUSjpd+qQ3kftKy6MENp8cREWf1EI9Gi5eGqDy2rl3B45JFHQkIp
XvvWiqimTZtamo0aNXI7d+7MJ4yC1FVxtv1Y+Q5i45o8rblC+l20klTXnD9/vsB5DiKMJKYeeugh
8xxJPMoTptAj8TzLCCOEEUCJtXF1UBIxHvrLMiiHDh2KuDcWOr9///5A8ajUGeuv3PBOOTydI0eO
BMqXX5kSpeX3nILmsTDpCi17TnZVHh6j+GVWnDR5dTTHKJn2HWSFVEHqqqjafqx8J7IHrVSTx0b8
61//cl9++WWR5DkoWg0XtH9AGCGMAGjjQBsIIIxo94AwosMAoI0DbYAyA8II4wGgjQNtgDIDwgjj
AaCNA22AMgPCCOMBKN42ruXHCgip4I4KOFmSaBVKvE0gSzLN4sgH/dylVWYt11c8v0u9/QPCiA4D
oBBtXPsLaT8She5Q2IAPP/ywRPMVvRy3IMtzC5KG3z1FsUyYfu7SKnNBtkC4GO0dEEZ0GADF2MYV
rVv7iJw5c+ai5Cv6xTB//nw3d+7cpNKIvifIy8bvnujzS5cuddOnT6efQxgVqk0UpK0CwogOA6AE
27jc+Nqg7WJRHC+GovA6ReMXtZx+7vITRkXRJhBGCCM6DIBS1Mb1l2tqaqp5jBQXSXOMhDam0/b8
9evXt51w27Vrl2+7/5EjR7rBgwdbaIWGDRu6adOmxXyu0tL8JT0nJSXFZWZmJnwxeOl6aKhv1KhR
dv+NN95oYQoUzFOhD+Ld46WpXYcVkVw7EA8cONCdPXvW955Y57Oysmy4UQJSv5N2ElYwUW9nYQ9F
Hb/tttvc8ePH6edKeZnVLtWutPO1dqpWu4oWRonabqw2ITRHr0ePHna92p6303vQdqfQH3369LE2
qzQUygMQRnQYACXUxrU774gRI2w7f80v2rJlix1X1Gx1+lOmTLGdgdV5a+v/vXv3RnTodevWtUjY
8+bNs3AJsdCE1gYNGricnBwLnaCwIIqdFu/FECsmk0Ih6EUk4aGXikI4JAqxoO//v70zAbKiuvd/
RRgDRDQRQcDgggKPTccR4oCIoQQZUAP6BANGKiEYFkFwZBEExEBifG6gcUkQwfceQ8aIUhAEZJGl
QEUMICKU5KEPijWig0EIajz/9/1V9f337bm3u+/MHZiBz6fqFtN9+5w+59yzfPmd5XfZZZeZoFPa
NGjl5OQkDTKZrDFSvuUMNzc318pJjjmff/55c7vgF0HyDSdnpPRzlT/PquN16tQx4aLfU0I3WK/C
6m6qOuEJpmeeecZt377dPfTQQ9ZudLJ03Ho3ZMgQ161bN7djxw6b5t64cSOdF8KIDgPgRNbxoA8j
WVX0v+Dhw4cnWW00KKjT9nfo+p90mHsE+VNSXBosPOSTSY424wwUcmEgH0r+tAj9zz7MKaeur7ji
CnM14KFB7JZbbimTMBLBaRMJIg163o4ieS2vV6+eKy4upp+r5HnWbyWxrf8UpKtXcepu1FSaBJHe
v3Dhwtj1TH7R+vbtWy7XL4AwosMAyKIw2rZtWynHmOKGG25wHTt2TNuhp0IWHsWVl5dnDir10eCT
n58fa6DwnHTOnTu31AAWZTEKpu3Xv/61O+eccxIDTnmFkbjtttvMKiU0bScLhH+6jn6ucuZZx1Po
flDE+utVnLqbThjJgiRrkb4P1t+oevbKK6+Y4NY0nCxVgDCiwwA4ycJo06ZN9uzrr7+e9FzPnj1t
2iwTYbRlyxaLS9MW6vC9j+fVO2qgkGNJhdfun/IKoylTptiA4zmqzIYwmj9/vk2/aF2ILFJByxb9
XOXM8/vvv2/3ly1blrZexam7wTqhuiVrT+PGjc3ypGczFUZi8+bNrqCgwOqW6i0gjOgwAE6iMJKX
bS3G1voKP3Xr1nV33nlnRsJI0xFahzN06NC0z0QNFC1btrQFsB5ac6HptUyFUY8ePWyRbNwwweuB
Awe69u3bJ8WpKRmVi/JXvXp1G9Do5yp/niVgtLjZX4dUV/334tTdYJ3QOiO9b8WKFYn6URZh5DF2
7Fh37rnnMq2GMKLDADiZwkj079/fNWnSxK1Zs8aEknaoKfy6desyEkZCi6e1kLuoqMjWDJWUlCTt
cIuz+FoLp++66y6zyGgNhgYwHUgZFocEy5IlSxKWHa0p0c6jsgoj7YLTIvV9+/Yl5U8Lu1U2bdq0
oZ+rQnnWWiHVcVmNtMFAFhoJbv/atai6G6wTH3/8sVl5tMh/z549Fl7vz6TeKU5ZICWGRowY4Tp0
6EDnhTCiwwA42cJIA0Dv3r3NcqTBQv9rleuCMEtPmNWosLDQprG0mFUDicLGHSj0v+4HHnjABJH+
h/4///M/NlhpV1hYHFooq3UhOm6gWrVqtrX+66+/LrMwOnTokGvXrp1ZEfzb9DVQqmyD27Lp5yp3
njWdpm36+l5CW2vEglO0UXU3VZ2QUNbzNWrUsHqr+wrnTcHFWXwt66OEvMS2/nMCCCM6DIBKUse1
q0vrfLx1OeVBokT/o/aLk7Igq5V/uiIV2g0kS5c4ePCg+8c//pG1cty7d69ZDzy00FYDn8Qk/VzV
y7OOrIiaqoqqu8E6obrgv5b1KBMUdv/+/XRaCCM6DADqeGm0O07TG/qf84svvmi7hLRjJxtiLRto
7dIdd9xBHSDPgDCi8QBQxyseHainnT4SRFroqnUXn376aaVI2+HDh00YvfXWW9QB8gwIIxoPAHUc
qAPkGRBGNB4A6jhQB8gzIIxoPADUcaAOkGdAGNF4AKjjQB0gz4AwovEAUMeBOkCeAWFE4wGgjgN1
gDwDwoiCA6COA3WAPAPCiIKjEIA6DtQB8gwII6DxAHUcqAPkGRBGQOMB6jhQB8gzIIyAxgPUcaAO
kGdAGAGNB6jjQB0gz4AwAhoPAPWc3568w+n921MTaDgA1HXgN6cM+M0RRjQagKj6zuf0+QD1nnqP
MEIYAQDtHAAQRnSYAEA7BwCEER0mANDOAQBhRIcJALRzAEAY0WECAO0cABBGdJgAQDsHAIQRHSYA
0M4BAGFEhwkAtHMAQBjRYQIA7RwAEEZ0mABAOwcAhBEdJgDQzgEAYUSHCQC0cwBAGNFhAgDtHAAQ
RnSYAEA7BwCEER0mANDOAQBhRIcJALRzAEAY0WECAO0cABBGdJgAQDsHAIQRHSYA0M4BAGFEhwkA
tHMAQBjRYQIA7RwAEEZ0mABAOwcAhBEdJgDQzgEAYUSHCQC0cwBAGNFhAgDtHAAQRnSYAEA7BwCE
ER0mANDOAQBhRIcJALRzAEAY0WECAO0cABBGdJgAQDsHAIQR0GEC0M4BAGEEdJgAtHMAQBgBHSbA
adW+gx8AQBgBwggAYYQwAkAYAcIIgDaOKAJAGAHCCAAQRgCAMEIYAQDCCAAQRggjAEAYAQDCCGEE
ALRzAEAY0WECAO0cABBGdJhwOtVPPnwqywcAYYQwAqBuAlAnAWFEQwegXgJQNwFhRCMHoE4CUEcB
YUQDB6BOAlBHAWFEA6cQgDoJQB0FhBHQwIE6CUAdBYQR0MCBOnlKMX78ePfGG29QENRRAIQRDRxO
xzq5a9cud/bZZ7vRo0dTYP/HD3/4Q/fII48krn/605+6n/zkJxQM/SYAwogGDqdDnSwoKLDnqrIw
WrBggZs2bVqFCKPZs2e7WbNmUZnoNwEQRjRwONXrpAb8hg0buu7du7sxY8ZU2Xz+6le/cj/+8Y8r
RBgB/SYAwogGDqdBndy7d6/7wQ9+4BYuXOh+9rOfRQqjUaNGuWHDhrnVq1e7a665xjVq1Mj97ne/
S3rmX//6lxs3bpyJrfr167vJkycnvuvVq5d7+umnE9dLlixxrVq1cu+9917inp4PxunxySefuH79
+rnzzjvP4n7uuefs/tSpUy0f3/ve9yy+e+65x+4PGDDATZw4MSlt+l7v9d+TpaxBgwbu4osvtvQF
hZGX7zh5DEsn0G8CwogGDlCJ62SPHj1c//797e84wkhrbZo2bepatmzpnnnmGTdp0iSL/+OPP048
o4XLzZo1c8uXL3cvv/yyq127tps3b559d++997qOHTsmnpWVR+H9QuiSSy5xixcvTvn+IUOGuG7d
urkdO3a4tWvXuo0bN9r9nTt3uptvvtnl5ua6VatWuQ8++MDuX3/99e6Xv/xlkqDR+5QujwcffNDV
qVPHPfvssxZOz3/nO98JXWMUlsewdAL9JiCMaOAAlbROzpkzx1144YXu8OHDGQmjc889123fvt2u
v/rqK5eTk+OmT59u1//85z/NaiMLjoem6G6//Xb7+/XXX7fnjxw5YteyOElwdO3a1a7ff/99ExnH
jx9P+X5Zqfr27WsCJ0iqqbQoYaT0f//733cjR45MCieLkV+s+YVRVB6j0gn0m4AwooEDVLI6efDg
QZvm0WLlrVu32uemm24yEfHRRx+FCqPg7iwJJVmPxIcffmjvy8vLc506dbKPREZ+fr59/+WXX7oz
zzzTpu62bNli37355pvurLPOMpEyZcoU17t377Tvf+WVV9x3v/tdd+WVV5q1przC6G9/+5tdFxcX
lxJG6SxGUXmMSifQbwLCiAYOUMnq5KJFi+x+qo8G+bIKI4kdxaHpKYkD77N06dLE8xISmlKT8Bg4
cKBZYGrWrOnWrVvn2rZtazvAwti8ebPtotN0l4RUeYSRLFS6XrZsWWxhFCePYekE+k1AGNHAAapA
nezSpUusqbQwYSSRI4vQ0KFD08bx8MMP2wLo6667zs2fP9/ude7c2d19990W9vPPP4+V3rFjx9q7
vekqiaz27duXylOfPn0S1ytXrkwSRt9++61ZzvwiSHkI3gtOpUXlMSydQL8JCCMaOMBpIoyE4tAO
saKiInfs2DFXUlLi3n333cT3GzZssDRp+kxTa55Yql69ull4wpgxY4bt+JLIGDFihOvQoUPSd7I8
7du3L3FvwoQJtphbU2ay6rRo0aLU4mutDWrSpIlZjdavX29Wnlq1aqVdYxQnj2HpBPpNQBjRwAFO
I2Eki0phYaGtsdEiZYkVhfPwrDQSIB7vvPOOpfOpp54Kfb8WNUtAacF0mzZt3Jo1axLfHTp0yLVr
186sOYMGDbJ7Wi/VunVri7t58+a2lioojDSdpm36uq90vfbaa5EnX0flMSydQL8JCCMaOMBpWCe/
/vpr28avf7OJLDT79+9P+73OZtIzfg4cOBAZ7+7duzOe7grLY1Q6gX4TEEY0cADqJAB1FBBGNHAA
6iQAdRQQRjRwAOokAHUUEEY0cADqJAB1FBBGFBYNHE7TOjlz5kz3hz/8odzxyA/ZG2+8cdLjqCxk
q1ypowAIIxo4QEidTLX1vjxkK77gVvmKiCPbea9IgmmtqLSfzDKh3wSEEcII4KTXSbnemDVr1mkp
jLKd9xMpjIJpX7Bggfm8y4RUYU5mmdBvAsIIYQRwytXJqiSMqhJR5ZrKR1wUZQlDvwmAMKKBwyld
J0eNGuWGDRtW6nr16tV2cnOjRo2S3GIIHYD4+OOPm2sNnfbcuHFjc7WRagAfMGCAmzhxYlJY+Uhb
smRJ0r3Ro0e7Bg0a2OnTTz/9dClRo2fGjRvnGjZs6OrXr+8mT55cKk1RcWQj70FSvVcuTeQOJJMy
ePXVV92tt95qebvyyivds88+GyqM/GmfOnWquSbR6duK95577omMM10Yf7x33XWXuVPxI5cnV111
lTt69Gjkb0K/CQgjoIFDlauTqdauNG3a1LVs2dJcfEyaNMnC6mRnDw3y1apVc4899pi529AC5w8+
+CBlfFGe7YU81NepU8cGbsWj5+WN3i9qtJC6WbNmbvny5Ra2du3abt68eRnFkY28B4nz3jhlIKGi
d27fvt099NBD5mbkiy++CE2rd71z50538803u9zcXLdq1arEbxEWZ7ow/nife+45c4/iP9F78ODB
rlevXrF+E/pNQBgBDRxOCWEkv2caTMVXX33lcnJy3PTp0+1a/sFkJercuXOs+KJEgeKXL7GRI0cm
xSNrj2et0Ttl2dBA79G9e3dz/Bo3jmzkPUjc98YRRn4kXvT9woULYwkjETUtlirOVGH88X766aeW
fy+MfgdZmXQd9ZvQbwLCCGjgcMoIozAHsR9++KHFpam0bAgjebzXdXFxcSlx4VldvHfm5eW5Tp06
2Uff5+fnx44jG3kPEve9cYWRLDey7Eiw6Pu5c+eWWxiFxRkljMSNN97o+vbta38rvZoy++abbyJ/
E/pNQBgBDRxOC2G0ZcsWiyvdmTqZCiN5tdf1smXL0ooL752attJaJu+zdOnS2HFUhDCK+96oMvj2
229NfGitlixNyld5hVGcOOMIo6KiIrMMHTlyxESSZx2L+k3oNwFhBDRwOC2EkbzFn3nmmbY+JU58
Xbp0cX369Elcr1y5spQo0DoWv5DQNI3/nq71zqFDh6Z8Z5w4KkIYxX1vVBlofY+uV6xYYdeaostU
GA0cONC1b98+cR0nzmCYVPFKEEkYPfHEE6569eqJtUhRvwn9JiCMgAYOp4UwEvfdd5+rUaOGLbTV
tIqsB5s2bUoZXruaLrnkEpt2kkVBO9mC00hal9KkSROzvKxfv94VFBS4WrVqJa3TGTNmjK1vkQVD
4qykpMR2SGUSR7aFUdz3RpWBFndrwbYWO+/Zs8fyqu+1wy1uWrULTmu/9u3bFzvOYJh0ZSDLkxZu
t2nTJul+1G9CvwkII6CBw2khjDQIahpGFgR9tBvJ2woeDK9da61bt7b3N2/e3G3durWUMNKUlLa6
676sLa+99lqp6ShZKAoLC22AlgVDA7relUkcFSGM4rw3Thlou7zyJsH5wAMPuEGDBlkevampqLQe
OnTItWvXzqw4ChsnzlRhUpWBFlsrvb///e+T7kf9JvSbgDACGjicVnVSAmnXrl02pRTFgQMHIp/Z
vXu3rb8JQ1vHZQ3xbyHPNI6KwP/edIIsqgxkcVGZesjSkyl79+5NiiNOnMEwmRL1m9BvAsIIaOBA
nTyNOZVO3KaOAiCMaOBAnYRy8fOf/zxxEjhQRwFhBDRwoE4CUEcBYQQ0cKBOAlBHAWEENHCgTsZk
5syZaQ+HPJXQQuv9+/eHPqPFytqxFrV4XWcQyT1HGNpyL1cmepY6CoAwooEDVJE6mWo7eGWJPxtp
k+i79NJLXYMGDWyb/DXXXGNOdoP8+c9/duecc455pj///PPdunXrSj0jJ706NVvnIk2ZMiXl+7Zt
22bnIsmRrfy26fiEv/zlL9RRAIQRDRygstXJBQsWuGnTpp1QYTR79mw3a9asEx7W48UXX3Rvv/22
/S0rTseOHU0k+bey60BMiSZ5pffCSNToXCE/t912m3v00UdNOKUSRnpegki+0GR10jtWr17tduzY
QR0FQBjRwAEqW52M44vrVOell16ystc0l8eIESPMTYifyy67rNQBih46NTuVMHryySftcEnqKADC
iAYOkKU6+cknn7h+/frZqc3ynC4XEkJOT73TkD3kUf3yyy93n332mRs1apQbNmyYWSg0XdSoUaMk
NxhTp041dxE6EblVq1Z2CrNfGKULJ3RQ4rhx42yaSWmaPHlyrDQLL11xng0SDBuVxzjoJGyVvQ6A
9JCYCebpF7/4hevcuXNGwujqq692gwcPpt8EQBjRwAGyVSeHDBniunXrZtMva9eudRs3brT7zz//
vLmKkAjykI+0rl27JgRO06ZNXcuWLc1lxqRJk+wdOgFZ7Ny50xzN5ubmulWrViWcj0aFE+PHj3fN
mjWzqSa5zZDLEflli0qzX3jFeTZIKrcbUWmNQnEovF/0aR3QH//4x6Tn7r//fntXJsKoXr16JrA0
XakpO+Vz0aJF9JsACCMaOEBZ66QsIXISGnSjIUEkH1jeDjLtdtJAXFxcnBjw5UfMmyLS9zk5OW76
9OmJONJNpYWFk/8tWZlkcfLo3r27OWuNSnMqcRP2bBxhFJXHMF544QVbO+SJQvH3v//dfos//elP
Sc/+9re/dWeffXZsYXT8+HFzEnvhhRfagZJacK186t6bb75JvwmAMKKBA5SlTuqEZgmgK6+8MrEY
2EOLf6+99lr7W1NCWuirATmViBBBh6tx1xj5w2m6TmnNy8tznTp1so9cbOTn58dKczD+sGfjCKNM
ncp6zJkzx6YS16xZk1LQ6NgCP3LyKpETVxh988037owzzkgqF9GkSRPXo0cP+k0AhBENHKCsdXLz
5s2uoKDABmz/ADx//ny7p3U6mhYbPnx4RqKhLMJIO7aU1gcffNBEjffxPMJHpTlV/OmerShhpOms
s846y6YQU1G3bl3bbeZn4MCB5uk+rjASWoOl6c1gPBKB9JsACCMaOEA56+TYsWNt4PemnTR1pEF8
6NChti5GAiMT0aBBun379hkJI02laW2T3hmHYJrDdr0Fn60IYaT1R5oKDJtuu+OOO9wtt9ySdE/r
kCZMmJCRMOrZs6e76qqrku5pnREWIwCEEQ0coIx1csaMGWYRkljQNvIOHTokfa/dZArbpk2bjASO
F3fNmjXtPJ9Mwo0ZM8amoYqKityxY8dcSUmJe/fdd2OlORh/VP6yLYx69+5t1iLtZHvrrbcSny+/
/DLxjBaBq1z++te/2rUsYjrXaNeuXUlxHT161MJddNFFZkHT3/6TrXVwpKbTFL9Yv369xfPqq6/S
bwIgjGjgAGWpk1qcLGuQFglL/ATXxEiQKOyzzz6bsTDSAYSaHpIFyNv6HyecrEaFhYW2NkjWF4kI
hYuT5lSLr8Pyl21h1Lx5cyuv4GfTpk1Jz2lRu0601pogLbpevHhxqbguuOCCUvFMnDgx6ZknnnjC
xJDiqVatWqnv6TcBEEY0cIAM66SsMun8emmdjISJrDZlZe/evfaOTNFJzpqa8p8aHSfN5Xn2RCIL
kARTqvxlGs+GDRvK9RvRbwIgjGjgQJ2MgdaraE0MAP0mAMKIBg6ndZ08fPiwCSNvDQsA/SYAwogG
DtRJAOooAMKIBg7USQDqKADCiAYO1EkA6igAwogGDtRJAOooAMKIBg7USQDqKADCiAYO1EkA6igA
wogGDtRJAOooAMKIBg7USQDqKADCiAYO1EkA6igAwogGDkCdBOooAMKIBg5AnQTqKADCiAYOQJ0E
6igAwogGDkC9BOomAMKIRg5A3QTqJADCiIYOUKb6yYdPZfkAIIwQRgBAOwcAhBEdJgDQzgEAYUSH
CQC0cwBAGNFhAgDtHAAQRnSYFAIA7RwAEEZAhwlAOwcAhBHQYQLQzgEAYQR0mAC0cwBAGAEdJgDt
HAAQRkCHCQC0cwCEEdBhAgDtHAAQRnSYAEA7BwCEER0mANDOAQBhRIcJALRzAEAY0WECAO0cABBG
dJgAQDsHAIQRHSYA0M4BAGFEhwkAtHMAQBjRYQIA7RwAEEZ0mABAOwcAhNEJ7zD58OFz6n8AAGEE
AFgPAADo9ykCAIQRAAAgjAAQRgAAgDACQBgBAADCCABhBAAACCMAhBEAACCMABBGAACAMAJAGAEA
AMIIAGEEAAAIIwCEEQAAIIwAEEYAAIAwAqhIQYT/LAAAhBEAIIwAABBGAJBeHAEAAMIIAGGEMAIA
QBgBAMIIAABhBAAIIwAAhBEApBNHAACAMAIAhBEAAMIIKv9AzYfPqfoBAEAYAdYLAOo4ACCMgAED
gLoOAAgjYKAAoM4DAMIIGCQAqPMAgDACBgkA6jwAIIyAQQKAOg8ACCNgkDipjB8/3r3xxhtVMu0z
Z850f/jDHypFGZyscqTOAwDCCMo1SOzatcudffbZbvTo0RTY//HDH/7QPfLII4nrn/70p+4nP/lJ
hbwr23FnK75gGVREHBVVrggjAEAYQbkGiYKCAnuuKgujBQsWuGnTplWIMJo9e7abNWtWhaQ723FX
JWFUUeWKMAIAhBGUeZDQwNSwYUPXvXt3N2bMmCqbz1/96lfuxz/+cYUIo6pEVRJGJ/M/AwAACCOE
USn27t3rfvCDH7iFCxe6n/3sZ5HCaNSoUW7YsGFu9erV7pprrnGNGjVyv/vd75Ke+de//uXGjRtn
Yqt+/fpu8uTJie969erlnn766cT1kiVLXKtWrdx7772XuKfng3F6fPLJJ65fv37uvPPOs7ife+45
uz916lTLx/e+9z2L75577rH7AwYMcBMnTkxKm77Xe/33ZClr0KCBu/jiiy19wQHdy3ecPIalM6xM
My3jxx9/3LVo0cLVrFnTNW7c2L3yyisphVG2yiAqz3HiyEbeEUYAgDCCChNGPXr0cP3797e/4wgj
DbpNmzZ1LVu2dM8884ybNGmSxf/xxx8nntGC22bNmrnly5e7l19+2dWuXdvNmzfPvrv33ntdx44d
k6w8Cu8f/C655BK3ePHilO8fMmSI69atm9uxY4dbu3at27hxo93fuXOnu/nmm11ubq5btWqV++CD
D+z+9ddf7375y18mDd56n9Ll8eCDD7o6deq4Z5991sLp+e985zuha4zC8hiWzjgWnjhlLKFTrVo1
99hjj7mPPvrIFjh7eQ7Gl60yiMpznDiykXeEEQAgjKBChNGcOXPchRde6A4fPpyRMDr33HPd9u3b
7fqrr75yOTk5bvr06Xb9z3/+06w2suB4aIru9ttvt79ff/11e/7IkSN2LYuABsauXbva9fvvv28D
7vHjx1O+X1aEvn372uAeJNVUWpQoUPq///3vu5EjRyaFk6XDL9b8A3hUHqPSGUccRJWxrESdO3eO
FV82yiAqz3HLsbx5RxgBAMIIKkQYHTx40KZ5tFh569at9rnppptsAJUFIu5AJjSQ6X/34sMPP7T3
5eXluU6dOtlHg2N+fr59/+WXX7ozzzzTpu62bNli37355pvurLPOskFwypQprnfv3mnfr+mi7373
u+7KK680y0V5hdHf/vY3uy4uLi41oKezGEXlMSqdccRBnDLWVFo2hFGcMojKc9xyLG/eEUYAgDCC
ChFGixYtsvupPhrMyiqMJHYUh6ZVJA68z9KlSxPPa1DVlJoGzIEDByYsIOvWrXNt27a1nUphbN68
2XbRaZpGQqo8wkgWKl0vW7YstjCKk8ewdJZXHHjvT3dWUabCKE4ZROU5bjkijAAAYQSVUhilokuX
LrGm0sIGLokcWYSGDh2aNo6HH37YFv9ed911bv78+XZP00J33323hf38889jpXfs2LH2bm+6SiKr
ffv2pfLUp0+fxPXKlSuTRMG3335rljP/4K08BO8Fp9Ki8hiWzvKKg2PHjtn7taYqTnzZKIOoPMct
R4QRACCM4LQSRkJxaIdYUVGRDeIlJSXu3XffTXy/YcMGS5OmzzS15oml6tWrm3UjjBkzZtiOL4mM
ESNGuA4dOiR9J8vTvn37EvcmTJhgi7k11SMLh3ZxBRcea51MkyZNzNqxfv16s/LUqlUr7RqjOHkM
S2c2xMF9993natSoYYufv/nmG7PobNq0KWX4bJVBVJ7jxIEwAgCEEZx2wkiWgsLCQltjowW7EisK
F7QuaOD0eOeddyydTz31VOj7tahZAkoLfdu0aePWrFmT+O7QoUOuXbt2ZtkYNGiQ3dN6qdatW1vc
zZs3t7VUQVGgaSBtL9d9peu1116LPPk6Ko9h6cyGOJAw0dSh3qGPFqxrN1iq8Nkqg6g8x4kDYQQA
CCOoMsIo23z99de2zVr/ZhOJgv3796f9Xmcz6Rk/Bw4ciIx39+7dsXaRxc1jVDqzVRZy5yKxGUW2
yiDqdy1LOZ4qdR4AgN4HYQRAnQcAQBgxSABQ5wEAEEYMEgDUeQAAhBGDBAB1HgAAYcQgAZWUmTNn
pj3okToPAIAwglNokEi1dbsyx3sqlVFVLyuEEQAgjKBKDxILFiwwv21+5Bpk1qxZoc9kI96qQqq8
VLRwqaplhTACAIQRVOlBIpWfs7I8k40wVamMTiXrF8IIABBGcFIHCR3CN3r0aNegQQM7sfjpp582
lxxyZ+ExYMAAN3HixKQw8nO2ZMmSxL1XX33V3Xrrra5+/frmTd47gdlj1KhRbtiwYW716tV2InSj
Ro2S3ERMnTrVXE3oNGXFfc899ySFC3sm7N1x4r3rrrvMZYYfubm46qqr3NGjRy2/48aNcw0bNrR3
TJ48ObSs5QakX79+dvKznn/uuefsvpy4eqdxe8hj/eWXX+4+++yzMpeRJ4zShfN+s7A8pEtzsKyi
nkUYAQAgjKq0MJKn9Dp16piY+OCDD2zwlid4vwuHKM/s3qAtlw3bt293Dz30kLmM+OKLL5KsGk2b
NnUtW7a05yZNmmRx6PRksXPnTnOImpub61atWmVpCVpD0j0T9u448Wpg1yDvP8V58ODBrlevXvb3
+PHjXbNmzdzy5cstz3K9If9k6RgyZIjr1q2b27Fjh1u7dq3buHGj3X/++efNVYlEkIf8nXXt2rXc
ZRQWLk4e0qU5lUUq7FmEEQAAwqjKCqOvvvrK/HiNHDky6b58W/ktDnGEkR+JEn2/cOHCpMFV/q4k
Xrx35+TkuOnTpyeeiTNNFDUtlurdUfF++umnlhYvjPyByTKja/0tC43El0f37t3NWWo6ZLXp27dv
KZcYEkQSbd4OMpVBvXr1XHFxcbnLKCxcnDykS3Oq3yDsWYQRAADCqMoKI3la131vYPYLo0wtRkJW
DFlsNHjr+7lz56YdXEXQMWh5hFHYu+PEe+ONN9pgL5QvTRHJY72muhRfXl6e69Spk31UPvn5+WnL
Wt7rJYA0rScLjZ/bbrvNXXvttfa3HKzKWnf8+PGsllEwXJw8hKU5GH/YswgjAACEUZUVRvKErvvL
li0rlzCS81KJisaNG5ulaenSpSdMGMV5d5x4i4qKzKpy5MgRE0meFW3Lli0Wn6YcJQi8j94TxubN
m11BQYFNS06ZMiVxf/78+XZP63Q0LTZ8+PCsl1EwXNw8pEtzqvjTPYswAgBAGFVZYSRRobU1fhGk
aZfgvS5durg+ffokrleuXJkkjLTWRdcrVqywa03llEUYDRw40LVv3z500A8+E+fdceKVIJIweuKJ
J1z16tUT63dUHloXNHTo0DKV+9ixYy2f3rST0le3bl2LT++RwMh2GQXDZZqHYJrDdr0Fn0UYAQAg
jKqsMBJaZ9KkSROzGq1fv96sALVq1UpaY6QdW5dccolNvcnS0KJFiyRhpEW+shxoEfOePXvcmDFj
7HvtcMtk0NdOuJo1a7p9+/alDRd8Js6748QrZHnSFFGbNm2S7itOrTmSVenYsWOupKTEdq2lQ++T
RUhiYcSIEa5Dhw5J32s3mdIYfE+2yihVuKg8hKU51W8Qlj+EEQAgjKDKCiNNp2mbvr6XpUjrXoJT
aR999JFr3bq1PdO8eXO3devWUmuMNNhLVNSoUcM98MADti1dA7g3XRNn8D506JBr166dWTe8be3B
cKmeiXp3nHiFFlsrX7///e+T7sviUlhYaO+QVUlxK3w6tDhZ1iAtbJf4WbNmTdL3EiR6T/BIg2yV
UapwUXkIS3Oqxddh+UMYAQDCCKqsMPLYvXt3YjokKIw8Dhw4EBqHrBCyRnjIglMW9u7dmxRPnGfi
vDtOvGFoO78sVP5t/enQe/bv35/yOy0UlzBRmstKWfMSloewNJfnWYQRACCMoEoPEumEEWSHHj16
uDvuuIOCQBgBAMIIqsIg8fOf/9zWEkH2OXz4sAmjt956i8JAGAEAwggYJACo8wCAMAIGCQDqPAAg
jKBqDBLbtm1LnMAM/5+ZM2cmXHicCLRL8ESfCaRF9VELqbVYW7sTdfZVGDqnSS5WwtBRA3JfomcR
RgCAMIJKJ4x0yOAVV1xhLjAgmbDDDSsintmzZ4ceBZDNdEnwXXrppa5BgwZ21IG24b/xxhulnvvz
n//szjnnHNewYUN3/vnnu3Xr1pV65rHHHrMT0nUGVrqTsCW+dQaW3KBoq7+2/P/lL39BGAEAwggq
lzDSScr+M28qggULFrhp06adtsJIgmfWrFmRz0mcNm3a1MRINuIL48UXX3Rvv/22/S0rTseOHU0k
+bfyy52IRJPnE01hJGp0npIf+YB79NFHTTilEkZ6XoJI/uxkddI7Vq9e7Xbs2IEwAgCEEVQeYSTf
XRdeeGGFT6Olc/56ugijTPjv//5vO438RPPSSy9ZPdE0l4dOtpZLGD+XXXZZqUMwPXRCeiph9OST
T9pBopXlPwMAAAgjhFHagV+Dn59Ro0a5YcOG2cnRP/rRj9wFF1xgLjb0v/whQ4a4evXqmaNV///2
tS5m3LhxNt0iz/STJ09OfDd16lRzR6ETl1u1amUnVYtXX33V3Xrrrfa8PLUHT4KOIiq8lw9ZJjRN
1KhRoyRXJ3Hi8AsjOdL1Tpv2kOf6yy+/3H322WfmJqNfv352grjik5uSYFo8wp7V2ptq1aqZi5Z0
BOOLk9codOq56okO+/SQmPH/luIXv/iF69y5c0bC6Oqrr3aDBw9GGAEAwggqtzA6++yzS01xSQzI
YtG2bVtz++E5PL3ppptscNO0mAbA++67LxFm/PjxrlmzZjblojC1a9d28+bNs+927txpnuRzc3Pt
1GfPQasEk6bwZKHQFIvcVXzxxRex8xQVXvnQtFTLli3tuUmTJlk56OTnTOLwhNHzzz9vrjgkgjxU
Bl27drW/JRq7detmgnHt2rVu48aNaS1PYc+Kiy66yNIb15IVJ69RKA6F94td/e5//OMfk567//77
7V2ZCCOJaQks1TVN2SnvixYtQhgBAMIIKo8w+vzzz+2+ptOCA6QGZm+nkpzH6jkNiP6BXcJJyA+X
rEESGR7du3c3B7UeUVNpEiN6h/yVlYVU4ZUP+QzzpoZkicnJyXHTp0/PKA5PgEgQSTh5u9QUnwb8
4uJiu5alRo5oU+0qS+VvLN2zQmUly0wmwiiTvAZ54YUXbO2QJ1rF3//+dyuPP/3pT0nP/va3vzVB
HVcYaZpWjn41ZavDQ7XgWnnXvTfffBNhBAAII6gcwkiWHN0PnsIcHHTll0vP+QcxWUo09SQ0naTv
8/LyXKdOnewjtyL5+fmRwkgWJFlq9L3imDt3buI7hddUXvAjQRcnfBznqpnGoUXG1157rf2tqSct
KPbWZ+m0cAknlYu3WDldPGHPeu/p2bNnRsIoTl5TMWfOHJvqDDqD9QSNjizwI0e9EjlxhZEWlJ9x
xhlJ9UHIKqlTwBFGAIAwgkohjL788ku7H9wBlakw0s4lff/ggw/agO99PO/2qYSRdibJatC4cWNb
C6Nng6Jk8eLFNt0S/MgaEid8lFgoSxyyrkksaI2QpgeHDx+eFL+OPigoKLBn/AIhVVrSPeuJwuB6
pooQRirPs846y8RhKurWrWu7zfwMHDjQtWvXLrYwElp75p969eLx6hDCCAAQRnDShZGQZec//uM/
yiWMNJWmtTdai5QODYI6FsBDUzaKc8WKFXYtsRMUJWHECR8lFsoSh56RWPDWXUncpGLs2LH2Lm+q
LGx3W/BZoW3vTzzxRIUKI60/0hRo2HSbnN3ecsstSfe0DmnChAkZCSNZv6666qqke1pnhMUIABBG
UKmEkSwe2m1VHmEkxowZY9MxRUVF7tixY66kpMS9++67ie9nzJjhatasaefleIOyLCXajbVnzx4L
r3do91sc4oSPEgtljUO76vRcmzZtku4rj7IkSeBop1+HDh3SxhP2rMpO6frf//3fChVGvXv3NmuR
drJpOtX7yJLooYXh+t3++te/2rUsgTrXaNeuXUlxHT161MJpbZosh/rbf7K1Do7UdJo3basdd4pH
uwI9fvOb39jCbP/7EUYAgDCCEyqM5OZB28W13qg8wkhWo8LCQls3IyuEBlP/Cc464E/TL7IseVNE
Ehh6XgOk1q3ovsL5p+DCiAofRyyUJQ4JPpVHcGu/FlTLiqRFzBJN/jU7qRZfp3tWW+9lqQkjG8Ko
efPmlo/gZ9OmTUnPabG5TrTWmiAtutYUZxAd6RCMZ+LEiUnPyAKmclY8Oo4g+L2OL1C4w4cPI4wA
AGEEJ0cYef+b//d///esvEdnHckS4z892Y9ElixKfuuI/1qWm0wob/iyxKH1OBJPChdE8UT5HQt7
VgvZr7vuuqT0VAZkxZFgSve7ZhLPhg0bUpbdiazzAAAII4RR6PeyChw5coSCioHWxURZdMrKf/3X
f7mDBw9SyAgjAEAYAYNE5UfTPBJGwSMOgDoPAIAwYpAAoM4DACCMGCQAqPMAAAgjBoksohOVPfca
pC0auWaRo95evXolbXOv7GUgP3pa4H+i40AYAQDCCDIaJHTmTKrt2t7n+uuvr9A0hR16eLKpbGmT
Ww2dE/X444/brri33367wtOcrfh0iOgjjzxywuNAGAEAwggyGiTef/992zqtj7ye6xlZIrx7OuMo
LgsWLLA4EEYVgw5a1AGJOkgxHbNnz3azZs1CGCGMAABhBOUdJF5//XV7JhMx5Cedk1iEUXbQlJYO
zqyKZYAwAgCEEZxSwkhuKx5++GHXtGlTO/lY3uX97j6mTp1q0zwauFu1amWnSQtZn2699VY7WVun
ZAdPio4aeHUC9LBhw8xlhU6KbtSokTl79TNgwICkE5SVVqVhyZIlpeLRadY/+tGP7JRmuf3QYYVD
hgxx9erVczfeeKPbsWNHqbS99tprlvbzzjvPDR482DzO+9+lNT9ykKo8Tp48OWX65b3+3/7t39yT
Tz6ZMp9R5SsrkN4hi5HypjVGYeWVSfnp3Zqea9GihR1aKYe6cvuR6veJU9a6N3r0aNegQQN38cUX
WzkHRU1UucWJA2EEAAgjOGnCSL6vJHzkZV0+rjRgyo2G50ZE/8rTfG5urq1/kXNWTzDJJcX27dvd
Qw89ZGG++OKL2MJI30ssyGmp4pk0aZKlUSdre2gdlN/XmwZVPfPyyy8nxSM3FG3btrX7ngPYm266
ycSOpgHl/NTv/V1hLrvsMhMp//mf/2liLycnx/yqeWhBcLNmzdzy5cst3tq1a7t58+YlxXHppZe6
q6++2uJIZ42LKt/du3e7kSNHmnBR+b733nuxLDxxyk9CR+45HnvsMUufFjh7v18wvjhlrbzUqVPH
RLDi0fPy++YXNVHlFicOhBEAIIzgpAgjWUhkCZKzWQ8tBNZgJmuLR9RUmgSR4l+4cGFGwkj+viSs
hJySSpz4vcHHFUZaaO6539DuLj1z//33J55RXiSc/GGuuOKKJIemEn+ep3n5hlO5SPx5dO/e3d1+
++1JccgqcuDAgbR5jFu+mkqTw9cwUgmjsPJTHiS2OnfuHCu+qLJW/PL9JhHnR9Yez1IVVW5x4kAY
AQDCCE6aMNq2bVspoSFuuOEG84QeJYxk4ZC1SN8rnrlz52YkjKIco8YVRpk6xU317l//+tfunHPO
sXfIp5niyMvLc506dbKPBu/8/PzY+cukfMsqjMLKz8uDptKyIYw8wVlcXFxK1HjWnqhyixMHwggA
EEZw0oSRHIfqvr7307NnT5siSieMvv32W9e3b19bs6L/6Wt9T1UXRlOmTLEpLuVty5YtFoemfbQm
x/son5kIo7jlWxHCyMtDurOKMhVG2uWo62XLlqUVNVHlFicOhBEAIIzgpAkjOZbVol+tC/FTt25d
d+eddyauBw4c6Nq3b5+41toQxbdixQq71hRJRQijLl26uD59+iSuV65cWWHCSD7StNhYaErozDPP
tPVKmaQ/SNzyrQhhdOzYMcuDpgjjxBdV1hKMWqTuFzAqJ/+9qHKLEwfCCAAQRnDShJHo37+/LV5e
s2aNDeTaQaVn161bl3hmxowZtl5l3759dq0Fvlowq8XKe/bscWPGjLEw2mGUTWE0YcIEWzitKRhZ
HrS7KlvCSOLE23E1f/58W/viT7/ypEXTRUVFJjJKSkqSdpPF3e4ep3wrQhh5+a5Ro4YtftbaJll0
ZMVKFT5OWWutkPIii48WkhcUFLhatWolrQ+KKrc4cSCMAABhBCdNGGng6t27t1k2NEBpcJW7CD+H
Dh1y7dq1M2vAoEGD7J52cmnqSQPvAw88YPclnrxpk2wII6W3devWlvbmzZu7rVu3Zk0YaVGw1sBo
C712bin92uLvt2QUFhZaHrWgWHlTuEyFUZzyrShhJGGiaVDt0tNHi769YxWC4eOUtabCtMVe92Xl
0XEHwWmwqHKLEwfCCAAQRlChwigO2qG1a9cum+5Ih0SHBlv/oO+/lvWoIgjb+VUWtItO1htx8OBB
949//CPtsxJLspD5RVNFlW9Fod8o7rvjlLWOGNAapDCiyi1OHAgjAEAYAYMEAHUeABBGwCABQJ0H
AIQRMEgAUOcBAGEEDBIA1HkAQBjBKTdI6Jwe+eGC+GiRs+fGJAydEfXpp59SYAgjAEAYQVUZJILb
reNuZS8LFRn3iUBb8+V8Vt7lddTBNddck1JUyvGrTqPWFn+dyg0IIwBAGEEFDhLyOj9t2rQKEUaz
Z892s2bNqpC8VmTcJ4IXX3zRvf322/a3DsyUzzSJpOC29ttuu809+uij7vzzz0cYIYwAAGEEFT1I
pHMMmw1hBPF56aWX7Pfbvn17yu91GjXCCGEEAAgjyMIg8cknn7h+/frZCcP169c3Fx5i6tSp5rZB
JxPLP5hOsRYDBgxwEydOTITXAXz63nOd4d0bPXq0WTl0grHcaASF0ahRo9ywYcOSwowbN841bNjQ
0jF58uRY6UxFMO6yhF29erVNYTVq1KiUKwqlVW47mjZtaqdiX3vttUkuLXr16pXkOkRlozJ67733
EveUv7guLnTys34/HXiIMEIYAQDCCCpwkBgyZIjr1q2b27Fjh1u7dq3buHGj3d+5c6c5F83NzXWr
Vq0yp7Aijjd7eU6vU6eOuZZQOD0vv2lha4y0OLtZs2Zu+fLlFpdcU8h/V1Q6UxGMO9OwEjwtW7Y0
1xmTJk2y/OmEZn/+JBo1jSVfXgoj9xYqM3Hvvffa9JeHLG+Kwy+EJGYWL14c67dT/EpPOhBGCCMA
QBhBlgYJWUX69u2b0vVCqqm0KGGkHVJytjpy5MikcLIY+YWBX7zId5YsU7JSechPmZyJxklnlDDK
NKz8iXnTVspPTk6Omz59ul0fP37c0jp8+PBEGDlflZCTABPyO6cwnksRWZ2Unq5du9q1fIHpecUV
xQsvvGDl6QlThBHCCAAQRlCBg4S8pMvaIQeqstaUVxjJ87qui4uLSwmjdBajDz/80MLk5eWZ01Z9
9Hx+fn6sdEYJo/KEFX7Hq9u2bStlIRM33HBDwkokn2dyprtw4ULzVq+8yGGtnMBKaEnEyGlsFHPm
zDHL1Jo1a0KfQxghjAAAYQRZHCQ2b97sCgoKbLrLP8CWRRjJGqLrZcuWxRZGEg8KoykqiRjvs3Tp
0ljpjCNuyhPWL4w2bdpkaZVVyE/Pnj3d1VdfnbiWuNOUmvI8cOBAs4rJi/y6detc27ZtbedcGIsW
LTIhpWnMKBBGCCMAQBhBBQwSY8eONRHgTTlpQG/fvn3SM126dHF9+vRJXK9cuTJJGMk7uxY5+0WQ
REHwXnAqTRaWoUOHxspLMJ1xxE15wvqFkabHzjjjDFsT5adu3bruzjvvTFxrcbYWXF933XVu/vz5
dq9z587u7rvvtrx+/vnnafOn9UyarvOm7xBGCCMAQBjBCRokZsyYYbu2JBRGjBjhOnTokPSdrBw6
S8djwoQJNhBrykxWnRYtWpSaWtLaoCZNmpjVSIuTZanRIYTp1hiJMWPG2LRRUVGRO3bsmCspKUna
6RWWzihxU56wQWEk+vfvb/nTFJeEkkSQykDWII8NGzbYPVl9NLXmiaXq1aub1S0MTbMpnHbGvfXW
W4mPF4/H0aNH7d5FF11k1jb9rak6QBgBAMIIyjhIaGGyBmst8G3Tpk3SepZDhw65du3amYVj0KBB
du+jjz5yrVu3tviaN2/utm7dWkoYaTpN2/R1X5YibTePOvlaVqPCwkJbCyRriQSZnomTzihxU56w
qYSRRJvEiyxHEnz6fubMmUlhPMuZRKHHO++8Y2Xy1FNPhf5WKlc94hwSwAAAAO1JREFUF/xoGs/P
BRdcUOoZ/1EK1Hm6JgBAGEEZBglZaMJ8cu3du9ee8SM/XlHo3J04O8H86HRnTSUFT3mOk84wyhM2
HbLQ7Nq1y0QQIIwAABBGDBIA1HkAAIQRgwQAdR4AAGHEIAFAnQcAQBgxSABQ5wEAEEYMEgDUeQAA
hBGDBAB1HgAAYcQgAUCdBwBAGDFIAFDnAQAQRgwSANR5AACEEYMEAHUeAABhxCABQJ0HAEAYMUgA
UOcBABBGDBIUAlDnAQAQRsAgAdR5AACEETBQAHUdAABhBAwYQB0HAEAYQeyBgw+fU/UDAHCy+X9l
ovCllDx22gAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-02-26 19:50:12 +1300" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAm8AAADnCAMAAAB/lEEmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-02-26 19:50:12 +1300" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVYAAAP3CAIAAAD4EvG2AABOD0lEQVR42u2dC4xVVZ7utzYgQtnU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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-03-08 12:18:16 +1300" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Ultrasound-guided embryo transfer versus 'clinical touch', outcome: 1.1 Live birth and ongoing pregnancy (per woman randomised).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA08AAAKACAMAAABzKbP9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="LBR - Trim and Fill.jpg" FILE_TYPE="JPG" ID="FIG-05" MODIFIED="2016-03-03 11:18:35 +1300" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Live-birth/ongoing pregnancy rate trim-and-fill plot.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="CPR - Trim and Fill.jpg" FILE_TYPE="JPG" ID="FIG-06" MODIFIED="2016-03-03 11:18:32 +1300" MODIFIED_BY="[Empty name]" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Clinical pregnancy rate trim-and-fill plot.</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-03-04 13:12:26 +1300" MODIFIED_BY="Helen E Nagels">
<APPENDIX ID="APP-01" MODIFIED="2016-03-04 13:12:26 +1300" MODIFIED_BY="Helen E Nagels" NO="1">
<TITLE MODIFIED="2016-03-04 13:12:26 +1300" MODIFIED_BY="Helen E Nagels">Gynaecology and Fertility Group key words</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-26 13:12:37 +1200" MODIFIED_BY="[Empty name]">
<P>Keywords CONTAINS "Embryo Transfer" or "embryo transfer techniques" or "Embryo Transfer-uterine" or "frozen embryo transfer" or "frozen-thawed embryo transfer" or "ET" or "FET" or "embryo placement" or "Embryo transfer-tubal" or "embryos transferred" or "blastocyst transfer" or Title CONTAINS "embryo placement" or "Embryo transfer-tubal" or "embryos transferred" or "blastocyst transfer" or "Embryo Transfer" or "embryo transfer techniques" or "Embryo Transfer-uterine" or "frozen embryo transfer" or "frozen-thawed embryo transfer" or "ET" or "FET"</P>
<P>AND</P>
<P>Keywords CONTAINS "ultrasonography" or "ultrasound" or "ultrasound guidance" or "ultrasound guided" or "ultrasound guided embryo transfer" or "ultrasound, pelvic" or "sonographic" or "imaging" or "sonographic" or "sonohysterogram" or "sonohysterography" or "hysterosonography" or Title CONTAINS "ultrasonography" or "ultrasound" or "ultrasound guidance" or "ultrasound guided" or "ultrasound guided embryo transfer" or "ultrasound, pelvic" or "sonographic" or "imaging" or "sonographic" or "sonohysterogram" or "sonohysterography" or "hysterosonography"</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-12-15 09:42:55 +1300" MODIFIED_BY="Helen E Nagels" NO="2">
<TITLE MODIFIED="2015-05-26 13:14:42 +1200" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-26 13:14:46 +1200" MODIFIED_BY="[Empty name]">
<P>Database: EBM Reviews - Cochrane Central Register of Controlled Trials &lt;March 2015&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 exp embryo transfer/ (827)<BR/>2 ivf-et.tw. (316)<BR/>3 (embryo$ adj2 transfer$).tw. (1403)<BR/>4 (blastocyst$ adj2 transfer$).tw. (148)<BR/>5 (embryo$ adj2 place$).tw. (12)<BR/>6 (embryo$ adj2 replac$).tw. (89)<BR/>7 (embryo$ adj2 position$).tw. (3)<BR/>8 or/1-7 (1825)<BR/>9 ultrasonography/ or endosonography/ or ultrasonography, interventional/ (1759)<BR/>10 ultrasonogra$.tw. (3567)<BR/>11 ultrasound$.tw. (8863)<BR/>12 sonograph$.tw. (1495)<BR/>13 sonogram$.tw. (70)<BR/>14 (echograph$ or echogram$).tw. (174)<BR/>15 hysterosono$.tw. (12)<BR/>16 endosonogra$.tw. (92)<BR/>17 or/9-16 (13257)<BR/>18 8 and 17 (204)<BR/>19 limit 18 to yr="2009 -Current" (57)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-12-15 09:42:55 +1300" MODIFIED_BY="Helen E Nagels" NO="3">
<TITLE MODIFIED="2009-02-24 13:03:24 +1300" MODIFIED_BY="Julie A Brown">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-26 13:12:05 +1200" MODIFIED_BY="[Empty name]">
<P>Database: Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) &lt;1946 to Present&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 exp embryo transfer/ (13099)<BR/>2 ivf-et.tw. (1899)<BR/>3 (embryo$ adj2 transfer$).tw. (12109)<BR/>4 (blastocyst$ adj2 transfer$).tw. (1083)<BR/>5 (embryo$ adj2 place$).tw. (1029)<BR/>6 (embryo$ adj2 replac$).tw. (603)<BR/>7 (embryo$ adj2 position$).tw. (186)<BR/>8 or/1-7 (20203)<BR/>9 ultrasonography/ or endosonography/ or ultrasonography, interventional/ (87377)<BR/>10 ultrasonogra$.tw. (81827)<BR/>11 ultrasound$.tw. (165388)<BR/>12 sonograph$.tw. (44691)<BR/>13 sonogram$.tw. (3346)<BR/>14 (echograph$ or echogram$).tw. (9315)<BR/>15 hysterosono$.tw. (111)<BR/>16 endosonogra$.tw. (2116)<BR/>17 or/9-16 (297635)<BR/>18 8 and 17 (1630)<BR/>19 randomized controlled trial.pt. (392819)<BR/>20 controlled clinical trial.pt. (89297)<BR/>21 randomized.ab. (318332)<BR/>22 randomised.ab. (63190)<BR/>23 placebo.tw. (166071)<BR/>24 clinical trials as topic.sh. (172401)<BR/>25 randomly.ab. (229693)<BR/>26 trial.ti. (137331)<BR/>27 (crossover or cross-over or cross over).tw. (63850)<BR/>28 or/19-27 (999407)<BR/>29 exp animals/ not humans.sh. (4028808)<BR/>30 28 not 29 (921377)<BR/>31 18 and 30 (198)<BR/>32 (2009$ or 2010$ or 2011$ or 2012$ or 2013$ or 2014$ or 2015$).ed. (6001613)<BR/>33 (2009$ or 2010$ or 2011$ or 2012$ or 2013$ or 2014$ or 2015$).dp. (5814773)<BR/>34 32 or 33 (6674457)<BR/>35 31 and 34 (62)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-12-15 09:42:54 +1300" MODIFIED_BY="Helen E Nagels" NO="4">
<TITLE MODIFIED="2009-02-24 13:05:03 +1300" MODIFIED_BY="Julie A Brown">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-26 13:13:07 +1200" MODIFIED_BY="[Empty name]">
<P>Database: Embase &lt;1980 to 2015 Week 18&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 exp embryo transfer/ (21998)<BR/>2 (embryo$ adj2 transfer$).tw. (16959)<BR/>3 ivf-et.tw. (2510)<BR/>4 (blastocyst$ adj2 transfer$).tw. (1836)<BR/>5 (embryo$ adj2 place$).tw. (1228)<BR/>6 (embryo$ adj2 replace$).tw. (829)<BR/>7 (embryo$ adj2 position$).tw. (196)<BR/>8 or/1-7 (28966)<BR/>9 transvaginal echography/ (12976)<BR/>10 ultrasound$.tw. (234070)<BR/>11 ultrasonogr$.tw. (105392)<BR/>12 sonograph$.tw. (57508)<BR/>13 sonogram$.tw. (3974)<BR/>14 (echograph$ or echogram$).tw. (10994)<BR/>15 hysterosono$.tw. (143)<BR/>16 or/9-15 (366886)<BR/>17 Clinical Trial/ (843553)<BR/>18 Randomized Controlled Trial/ (369125)<BR/>19 exp randomization/ (66088)<BR/>20 Single Blind Procedure/ (20079)<BR/>21 Double Blind Procedure/ (119899)<BR/>22 Crossover Procedure/ (42594)<BR/>23 Placebo/ (255278)<BR/>24 Randomi?ed controlled trial$.tw. (114897)<BR/>25 Rct.tw. (16728)<BR/>26 random allocation.tw. (1402)<BR/>27 randomly allocated.tw. (22147)<BR/>28 allocated randomly.tw. (2011)<BR/>29 (allocated adj2 random).tw. (721)<BR/>30 Single blind$.tw. (15643)<BR/>31 Double blind$.tw. (149839)<BR/>32 ((treble or triple) adj blind$).tw. (440)<BR/>33 placebo$.tw. (212811)<BR/>34 prospective study/ (287679)<BR/>35 or/17-34 (1452441)<BR/>36 case study/ (31373)<BR/>37 case report.tw. (279675)<BR/>38 abstract report/ or letter/ (921238)<BR/>39 or/36-38 (1226085)<BR/>40 35 not 39 (1413427)<BR/>41 (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.) (5260646)<BR/>42 40 not 41 (1358099)<BR/>43 8 and 16 and 42 (443)<BR/>44 (2013$ or 2014$ or 2015$).em. (3872912)<BR/>45 (2013$ or 2014$ or 2015$).dp. (528499)<BR/>46 44 or 45 (3873631)<BR/>47 43 and 46 (101)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-02-27 22:27:49 +1300" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2016-02-27 22:27:49 +1300" MODIFIED_BY="[Empty name]">PsycINFO search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-26 13:14:12 +1200" MODIFIED_BY="[Empty name]">
<P>Database: PsycINFO &lt;1806 to April Week 4 2015&gt;<BR/>Search Strategy:<BR/>--------------------------------------------------------------------------------<BR/>1 exp Infertility/ or exp Reproductive Technology/ or exp Embryo/ (4150)<BR/>2 (embryo$ adj2 transfer$).tw. (123)<BR/>3 (blastocyst$ adj2 transfer$).tw. (4)<BR/>4 (embryo$ adj2 place$).tw. (18)<BR/>5 (embryo$ adj2 replac$).tw. (7)<BR/>6 or/1-5 (4200)<BR/>7 exp Ultrasound/ (1096)<BR/>8 ultrasonogra$.tw. (763)<BR/>9 ultrasound$.tw. (2486)<BR/>10 sonograph$.tw. (551)<BR/>11 sonogram$.tw. (66)<BR/>12 (echograph$ or echogram$).tw. (57)<BR/>13 or/7-12 (3796)<BR/>14 6 and 13 (24)<BR/>15 random.tw. (43430)<BR/>16 control.tw. (337122)<BR/>17 double-blind.tw. (18791)<BR/>18 clinical trials/ (8613)<BR/>19 placebo/ (4057)<BR/>20 exp Treatment/ (613111)<BR/>21 or/15-20 (940087)<BR/>22 14 and 21 (11)<BR/>23 limit 22 to yr="2009 -Current" (4)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2015-12-15 09:44:04 +1300" MODIFIED_BY="Helen E Nagels" NO="6">
<TITLE MODIFIED="2015-12-15 09:42:45 +1300" MODIFIED_BY="Helen E Nagels">CINAHL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-12-15 09:44:04 +1300" MODIFIED_BY="Helen E Nagels">
<P>CINAHL search strategy for JB604 06.05.15</P>
<TABLE COLS="3" ROWS="32">
<TR>
<TD>
<P>
<B># </B>
</P>
</TD>
<TD>
<P>
<B>Query </B>
</P>
</TD>
<TD>
<P>
<B>Results </B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>S31</P>
</TD>
<TD>
<P>S18 AND S30</P>
</TD>
<TD>
<P>37</P>
</TD>
</TR>
<TR>
<TD>
<P>S30</P>
</TD>
<TD>
<P>S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29</P>
</TD>
<TD>
<P>957,665</P>
</TD>
</TR>
<TR>
<TD>
<P>S29</P>
</TD>
<TD>
<P>TX allocat* random*</P>
</TD>
<TD>
<P>4,263</P>
</TD>
</TR>
<TR>
<TD>
<P>S28</P>
</TD>
<TD>
<P>(MH "Quantitative Studies")</P>
</TD>
<TD>
<P>13,366</P>
</TD>
</TR>
<TR>
<TD>
<P>S27</P>
</TD>
<TD>
<P>(MH "Placebos")</P>
</TD>
<TD>
<P>9,206</P>
</TD>
</TR>
<TR>
<TD>
<P>S26</P>
</TD>
<TD>
<P>TX placebo*</P>
</TD>
<TD>
<P>33,746</P>
</TD>
</TR>
<TR>
<TD>
<P>S25</P>
</TD>
<TD>
<P>TX random* allocat*</P>
</TD>
<TD>
<P>4,263</P>
</TD>
</TR>
<TR>
<TD>
<P>S24</P>
</TD>
<TD>
<P>(MH "Random Assignment")</P>
</TD>
<TD>
<P>39,076</P>
</TD>
</TR>
<TR>
<TD>
<P>S23</P>
</TD>
<TD>
<P>TX randomi* control* trial*</P>
</TD>
<TD>
<P>86,804</P>
</TD>
</TR>
<TR>
<TD>
<P>S22</P>
</TD>
<TD>
<P>TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )</P>
</TD>
<TD>
<P>765,707</P>
</TD>
</TR>
<TR>
<TD>
<P>S21</P>
</TD>
<TD>
<P>TX clinic* n1 trial*</P>
</TD>
<TD>
<P>171,460</P>
</TD>
</TR>
<TR>
<TD>
<P>S20</P>
</TD>
<TD>
<P>PT Clinical trial</P>
</TD>
<TD>
<P>77,813</P>
</TD>
</TR>
<TR>
<TD>
<P>S19</P>
</TD>
<TD>
<P>(MH "Clinical Trials+")</P>
</TD>
<TD>
<P>186,869</P>
</TD>
</TR>
<TR>
<TD>
<P>S18</P>
</TD>
<TD>
<P>S8 AND S17</P>
</TD>
<TD>
<P>135</P>
</TD>
</TR>
<TR>
<TD>
<P>S17</P>
</TD>
<TD>
<P>S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16</P>
</TD>
<TD>
<P>71,153</P>
</TD>
</TR>
<TR>
<TD>
<P>S16</P>
</TD>
<TD>
<P>TX endosonogra*</P>
</TD>
<TD>
<P>2,392</P>
</TD>
</TR>
<TR>
<TD>
<P>S15</P>
</TD>
<TD>
<P>TX hysterosono*</P>
</TD>
<TD>
<P>9</P>
</TD>
</TR>
<TR>
<TD>
<P>S14</P>
</TD>
<TD>
<P>TX (echograph* or echogram*)</P>
</TD>
<TD>
<P>208</P>
</TD>
</TR>
<TR>
<TD>
<P>S13</P>
</TD>
<TD>
<P>TX sonogram*</P>
</TD>
<TD>
<P>242</P>
</TD>
</TR>
<TR>
<TD>
<P>S12</P>
</TD>
<TD>
<P>TX sonograph*</P>
</TD>
<TD>
<P>6,497</P>
</TD>
</TR>
<TR>
<TD>
<P>S11</P>
</TD>
<TD>
<P>TX ultrasound</P>
</TD>
<TD>
<P>29,600</P>
</TD>
</TR>
<TR>
<TD>
<P>S10</P>
</TD>
<TD>
<P>TX ultrasonogra*</P>
</TD>
<TD>
<P>59,808</P>
</TD>
</TR>
<TR>
<TD>
<P>S9</P>
</TD>
<TD>
<P>(MM "Ultrasonography") OR (MM "Endosonography")</P>
</TD>
<TD>
<P>10,870</P>
</TD>
</TR>
<TR>
<TD>
<P>S8</P>
</TD>
<TD>
<P>S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7</P>
</TD>
<TD>
<P>1,938</P>
</TD>
</TR>
<TR>
<TD>
<P>S7</P>
</TD>
<TD>
<P>TX (embryo* N2 replac*)</P>
</TD>
<TD>
<P>13</P>
</TD>
</TR>
<TR>
<TD>
<P>S6</P>
</TD>
<TD>
<P>TX (embryo* N2 place*)</P>
</TD>
<TD>
<P>22</P>
</TD>
</TR>
<TR>
<TD>
<P>S5</P>
</TD>
<TD>
<P>TX (blastocyst* N2 transfer*)</P>
</TD>
<TD>
<P>52</P>
</TD>
</TR>
<TR>
<TD>
<P>S4</P>
</TD>
<TD>
<P>TX (embryo* N2 transfer*)</P>
</TD>
<TD>
<P>771</P>
</TD>
</TR>
<TR>
<TD>
<P>S3</P>
</TD>
<TD>
<P>(MM "Embryo Transfer")</P>
</TD>
<TD>
<P>262</P>
</TD>
</TR>
<TR>
<TD>
<P>S2</P>
</TD>
<TD>
<P>TX embryo* N3 transfer*</P>
</TD>
<TD>
<P>777</P>
</TD>
</TR>
<TR>
<TD>
<P>S1</P>
</TD>
<TD>
<P>(MM "Fertilization in Vitro")</P>
</TD>
<TD>
<P>1,450</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;4 new studies included in quantitative synthesis (meta-analysis) in &lt;span&gt;2016&lt;/span&gt;. Total number of included studies is now 21&lt;/p&gt;" WIDTH="180">
<FLOWCHARTBOX TEXT="&lt;p&gt;17 studies included in previous published version (&lt;a href=&quot;Brown 2010&quot; link_type=&quot;REFERENCE&quot; protected=&quot;true&quot;&gt;Brown 2010&lt;/a&gt;)&lt;/p&gt;" WIDTH="140"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;4 new studies included in qualitative synthesis in &lt;span&gt;2016&lt;/span&gt;&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;9 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;229 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;229 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;CENTRAL = 58&lt;/p&gt;&lt;p&gt;CINAHL = 37&lt;/p&gt;&lt;p&gt;EMBASE = 101&lt;/p&gt;&lt;p&gt;&lt;span&gt;Gynaecology and Fertility Specialised Register = 50&lt;/span&gt;&lt;/p&gt;&lt;p&gt;MEDLINE = 62&lt;/p&gt;&lt;p&gt;PsycINFO = 4&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;TOTAL = 312&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 additional record identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;220 records excluded&lt;/p&gt;&lt;p&gt;176 studies discarded as clearly irrelevant&lt;/p&gt;&lt;p&gt;44 potentially eligible studies excluded; see Characteristics of Excluded Studies table for details&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;A further 5 full-text articles excluded for wrong comparison; see Characteristics of Excluded Studies table for details&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>